<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd"><key id="d6" for="edge" attr.name="source_id" attr.type="string"/>
<key id="d5" for="edge" attr.name="keywords" attr.type="string"/>
<key id="d4" for="edge" attr.name="description" attr.type="string"/>
<key id="d3" for="edge" attr.name="weight" attr.type="double"/>
<key id="d2" for="node" attr.name="source_id" attr.type="string"/>
<key id="d1" for="node" attr.name="description" attr.type="string"/>
<key id="d0" for="node" attr.name="entity_type" attr.type="string"/>
<graph edgedefault="undirected"><node id="&quot;TNFSF4/OX40L&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"TNFSF4, also known as OX40L, is a tumor necrosis factor ligand superfamily member 4 that encodes a T cell costimulatory molecule called OX40 ligand, and is associated with autoimmune diseases like SLE and systemic sclerosis."</data>
  <data key="d2">chunk-cd1ab204b4a907f594ee95c28910787a</data>
</node>
<node id="&quot;SYSTEMIC SCLEROSIS (SSC)&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Systemic sclerosis, also referred to as SSc, is an autoimmune disease that leads to the development of cutaneous and visceral fibrosis."&lt;SEP&gt;"Systemic sclerosis, an autoimmune disease characterized by fibrosis, involves sclerosis of the skin and internal organs."</data>
  <data key="d2">chunk-b267f7459d573ed53adff3f27835bd72&lt;SEP&gt;chunk-cd1ab204b4a907f594ee95c28910787a</data>
</node>
<node id="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"An autoimmune disease linked with PTPN22 and STAT4 genes."&lt;SEP&gt;"Systemic lupus erythematosus is an autoimmune disease with diverse manifestations including skin rashes, joint pain, and organ involvement."&lt;SEP&gt;"Systemic lupus erythematosus, also referred to as SLE, is an autoimmune disease for which TNFSF4 is a susceptibility gene."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1&lt;SEP&gt;chunk-cd1ab204b4a907f594ee95c28910787a&lt;SEP&gt;chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</node>
<node id="&quot;FIBROSIS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Fibrosis involves excessive deposition of extracellular matrix proteins, leading to tissue scarring."&lt;SEP&gt;"Fibrosis is a pathological condition involving excessive tissue scarring, a notable feature of systemic sclerosis."&lt;SEP&gt;"Fibrosis is characterized by pathological scarring and thickening of connective tissue, often seen in systemic sclerosis affecting both skin and internal organs."&lt;SEP&gt;"Fibrosis is the thickening and scarring of connective tissue, often a result of systemic sclerosis."&lt;SEP&gt;"Fibrosis refers to pathological scarring, often a symptom in diseases like systemic sclerosis."&lt;SEP&gt;"Fibrosis refers to the thickening and scarring of connective tissue, a common feature in systemic sclerosis."&lt;SEP&gt;"Fibrosis, a hallmark of systemic sclerosis, involves the thickening and scarring of connective tissues."</data>
  <data key="d2">chunk-ca51be81b7248c4c4ca5fd0218eb755d&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51&lt;SEP&gt;chunk-b267f7459d573ed53adff3f27835bd72&lt;SEP&gt;chunk-96fee34b88b939b7834b2cdcf98d7366&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-cd1ab204b4a907f594ee95c28910787a</data>
</node>
<node id="&quot;T CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"T cell is a type of lymphocyte that plays a central role in cell-mediated immunity."&lt;SEP&gt;"T cells are a type of immune cell involved in the body's defense mechanisms, playing a crucial role in adaptive immunity and being affected by the TNFSF4 gene."&lt;SEP&gt;"T cells are a type of lymphocyte that play a central role in cell-mediated immunity and can be activated by the OX40 system."&lt;SEP&gt;"T cells are a type of lymphocyte that play a central role in cell-mediated immunity."&lt;SEP&gt;"T cells express OX40L and OX40 and are involved in immune responses including proliferation and cytokine production."&lt;SEP&gt;"T cells proliferate and survive due to OX40-OX40L interaction."</data>
  <data key="d2">chunk-cd1ab204b4a907f594ee95c28910787a&lt;SEP&gt;chunk-a1e55c0d3e82798ca6e2849fe54d23ff&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892&lt;SEP&gt;chunk-8a79a32d7c9115e6aa8a38cfe7e0fb8d&lt;SEP&gt;chunk-1d58826a27e5d4fa79e478dc1995650f&lt;SEP&gt;chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</node>
<node id="&quot;AUTOIMMUNE DISEASES&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A group of diseases characterized by the immune system attacking the body's own tissues, with shared genetic risk factors and associations with genes like TNFSF4, PTPN22, and STAT4."&lt;SEP&gt;"A group of diseases where the immune system attacks healthy cells, linked with genetic variants."&lt;SEP&gt;"A group of diseases, including SSc and SLE, characterized by the immune system attacking its own body."&lt;SEP&gt;"Autoimmune diseases are conditions where the immune system mistakenly attacks the body's own tissues, often sharing common susceptibility genes, such as TNFSF4."&lt;SEP&gt;"Autoimmune diseases involve the immune system attacking the body's own tissues."</data>
  <data key="d2">chunk-ff6038a6a2d79f1e763ca1f367a21f51&lt;SEP&gt;chunk-dbadb4d9b74b89122cd7868a0008eea7&lt;SEP&gt;chunk-d3f80deee592fd8d98f9795daf2b98ca&lt;SEP&gt;chunk-f40d75c218dbbd371d3444666f5fa395&lt;SEP&gt;chunk-cd1ab204b4a907f594ee95c28910787a</data>
</node>
<node id="&quot;OX40L&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"OX40 Ligand (OX40L) is a ligand for the OX40 receptor involved in T cell costimulation and inflammation."&lt;SEP&gt;"OX40 Ligand is a protein encoded by TNFSF4 and is expressed on dendritic cells, macrophages, B cells, T cells, natural killer cells, endothelial cells, and smooth muscle cells. It provides a costimulatory signal resulting in T cell proliferation, survival, and cytokine production."&lt;SEP&gt;"OX40 ligand plays a role in the immunological pathways involved in atopic dermatitis."&lt;SEP&gt;"OX40 ligand, involved in costimulation and regulation of T-cell responses."&lt;SEP&gt;"OX40L is a T cell costimulatory molecule and a member of the TNF receptor superfamily."&lt;SEP&gt;"OX40L is a gene encoding a ligand known to interact with the OX40 T-cell receptor."&lt;SEP&gt;"OX40L is a gene linked with immune response pathways."&lt;SEP&gt;"OX40L is a gene whose protein product, OX40 ligand, is associated with immune responses and expressed primarily by monocytes."&lt;SEP&gt;"OX40L is a ligand for OX40, crucial for T cell costimulation and immune responses."&lt;SEP&gt;"OX40L is a ligand for OX40, playing a crucial role in T-cell activation and survival in AD."&lt;SEP&gt;"OX40L is a ligand for OX40, playing a crucial role in the development of Th2 memory cells and participating in the inflammatory reaction."&lt;SEP&gt;"OX40L is a ligand for OX40, playing a role in immune system regulation in conditions such as AD."&lt;SEP&gt;"OX40L is a ligand for the OX40 receptor, playing a role in immune responses."&lt;SEP&gt;"OX40L is a protein targeted by antibodies along with OX40 in the study."&lt;SEP&gt;"OX40L is crucial for B cell activation and has increased expression in allergic asthma."&lt;SEP&gt;"OX40L is the ligand for OX40 and is involved in immune system regulation, especially significant in skin-related conditions like AD."&lt;SEP&gt;"OX40L is the ligand for OX40 and plays a crucial role in T-cell activation and immune response modulation."&lt;SEP&gt;"OX40L is the ligand for OX40, acting as a costimulatory molecule important in T-cell proliferation, especially in asthma."&lt;SEP&gt;"OX40L is the ligand for OX40, expressed on monocytes and related to immune system signaling."&lt;SEP&gt;"OX40L is the ligand for OX40, involved in T-cell costimulation, especially significant in the context of atopic dermatitis."&lt;SEP&gt;"OX40L is the ligand for OX40, involved in the costimulation of T cells and plays a role in the pathogenesis of AD."&lt;SEP&gt;"OX40L is the ligand for OX40, playing a crucial role in immune response and T-cell activation."&lt;SEP&gt;"OX40L is the ligand for OX40, playing a role in T-cell costimulation."&lt;SEP&gt;"OX40L is the ligand for the gene OX40 and is important in T-cell costimulatory pathways."&lt;SEP&gt;"OX40L, also known as OX40 ligand, is expressed by various immune and non-immune cells and mediates T-cell costimulation."&lt;SEP&gt;"OX40L, also known as TNFSF4, encodes for the costimulatory molecule OX40 ligand, playing a role in autoimmune disease susceptibility."&lt;SEP&gt;"OX40L, or OX40 ligand, is the binding partner of OX40. It is an important inflammatory mediator and plays a role in conditions such as rheumatoid arthritis and bronchial asthma."&lt;SEP&gt;"OX40L, the ligand for OX40, is involved in immune cell interactions, particularly with T cells and IgE-activated mast cells."&lt;SEP&gt;"OX40L, the ligand for OX40, mediates T-cell costimulation and plays a role in immunological responses."&lt;SEP&gt;"OX40L, the ligand for OX40, plays a central role in atopic dermatitis by mediating T-cell costimulation."</data>
  <data key="d2">chunk-9c36c2978a0bf868f306a82e42a345a9&lt;SEP&gt;chunk-725c3e7fa459b4b8ee95682739cfe06e&lt;SEP&gt;chunk-afdd4c61cd0aee9cfa4fdd53c26ad339&lt;SEP&gt;chunk-a1e55c0d3e82798ca6e2849fe54d23ff&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892&lt;SEP&gt;chunk-1d58826a27e5d4fa79e478dc1995650f&lt;SEP&gt;chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-0901633e83241bf8c1296a2bb24a3099&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51&lt;SEP&gt;chunk-ac36f1e468a863c1ae0527829717bfcf&lt;SEP&gt;chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-ad6451630cadf61d3fe3c4b59f09d5c2&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae&lt;SEP&gt;chunk-6ef6d5065a278b01d19708d678d3b3e2&lt;SEP&gt;chunk-0727a0b1079f66832280de80d4cf2c98&lt;SEP&gt;chunk-90301ff694034070e60e3a68b15a982a&lt;SEP&gt;chunk-dd1abca19a92c3ea17e849ebfe392af1&lt;SEP&gt;chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-3c10f775faa2c2d2c39dc1cd18158a80&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-bf0a9d6fcaf06c245c2b80667c7f3261&lt;SEP&gt;chunk-4486b79fa295f4486ae8f31f789db642&lt;SEP&gt;chunk-8a79a32d7c9115e6aa8a38cfe7e0fb8d&lt;SEP&gt;chunk-108cd1073705362b3d684cc095446c30&lt;SEP&gt;chunk-535005279394e36a8c0e64ebe74fff88&lt;SEP&gt;chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808&lt;SEP&gt;chunk-801108ac3e166907ed4b5f552b259a53</data>
</node>
<node id="&quot;TNFSF4&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"TNFSF4 encodes for the protein OX40 ligand, crucial in immune responses."&lt;SEP&gt;"TNFSF4 encodes for the tumour necrosis factor ligand superfamily member 4, associated with systemic sclerosis susceptibility."&lt;SEP&gt;"TNFSF4 encodes the ligand for the T cell costimulatory molecule OX40L."&lt;SEP&gt;"TNFSF4 gene is associated with susceptibility to systemic sclerosis and other autoimmune diseases."&lt;SEP&gt;"TNFSF4 is a gene associated with susceptibility to systemic lupus erythematosus and systemic sclerosis through polymorphisms."&lt;SEP&gt;"TNFSF4 is a gene associated with systemic sclerosis susceptibility."&lt;SEP&gt;"TNFSF4 is a gene associated with systemic sclerosis through its SNPs."&lt;SEP&gt;"TNFSF4 is a gene from the tumor necrosis factor ligand superfamily, associated with certain polymorphisms in systemic sclerosis."&lt;SEP&gt;"TNFSF4 is a gene from the tumour necrosis factor ligand superfamily member 4 associated with systemic sclerosis."&lt;SEP&gt;"TNFSF4 is a gene from the tumour necrosis factor ligand superfamily member 4, associated with immune response regulation."&lt;SEP&gt;"TNFSF4 is a gene from the tumour necrosis factor ligand superfamily member 4, involved in immune system processes."&lt;SEP&gt;"TNFSF4 is a gene in the tumor necrosis factor superfamily member 4, associated with susceptibility to systemic lupus erythematosus and other conditions like atherothrombosis and venous thromboembolism."&lt;SEP&gt;"TNFSF4 is a gene involved in the immune response, encoding for a member of the tumor necrosis factor superfamily."&lt;SEP&gt;"TNFSF4 is a gene involved in the tumour necrosis factor ligand superfamily linked to SSc susceptibility."&lt;SEP&gt;"TNFSF4 is a gene known as the tumour necrosis factor ligand superfamily member 4 and is associated with systemic sclerosis (SSc) susceptibility."&lt;SEP&gt;"TNFSF4 is a gene that encodes OX40 ligand, influencing atherosclerosis and carotid artery disease susceptibility."&lt;SEP&gt;"TNFSF4 is a gene that encodes the protein OX40 ligand (OX40L), associated with susceptibility to systemic sclerosis (SSc)."&lt;SEP&gt;"TNFSF4 is associated with autoimmune diseases like SLE and is under consideration for its role in SSc susceptibility."&lt;SEP&gt;"TNFSF4 is associated with genetic susceptibility to systemic sclerosis."&lt;SEP&gt;"TNFSF4 is associated with susceptibility to systemic sclerosis (SSc) and may confer risk to multiple autoimmune diseases."&lt;SEP&gt;"TNFSF4 is associated with systemic sclerosis through various polymorphisms."&lt;SEP&gt;"TNFSF4 is identified as a susceptibility gene for systemic sclerosis, involved in the immunopathogenesis of multiple autoimmune diseases."&lt;SEP&gt;"TNFSF4 is part of the tumor necrosis factor ligand superfamily and is associated with genetic predisposition to systemic sclerosis."&lt;SEP&gt;"TNFSF4, also referred to as OX40L, is a gene that encodes the costimulatory molecule OX40 ligand, identified as a susceptibility gene for several autoimmune diseases including SLE."</data>
  <data key="d2">chunk-e785e8a37b35cb99202b04012deed634&lt;SEP&gt;chunk-d3f80deee592fd8d98f9795daf2b98ca&lt;SEP&gt;chunk-c2823bcad3d01b2fb4bdef5f8aa96865&lt;SEP&gt;chunk-72875ba549df0c7c1e9bd9550ffbe3a8&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892&lt;SEP&gt;chunk-d76b2781d29c6f7d7c381b50337a12a0&lt;SEP&gt;chunk-eeb39a2fa5676c3abaaa455a6c7075ba&lt;SEP&gt;chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51&lt;SEP&gt;chunk-22c95d151784bab494732266d8aaf873&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-4e90f51a9fd956d75a15a68bb461dbf0&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-f40d75c218dbbd371d3444666f5fa395&lt;SEP&gt;chunk-e19459917d5c48c6b875c4a30fdad3b1&lt;SEP&gt;chunk-dfad4826c0b7e6a17d2e0d647d8df903&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-b267f7459d573ed53adff3f27835bd72&lt;SEP&gt;chunk-88b78ed0abef17d11ffa6aefaa201bcd&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534</data>
</node>
<node id="&quot;SLE&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Systemic lupus erythematosus (SLE) is an autoimmune disease affecting connective tissues."&lt;SEP&gt;"Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the body's immune system attacking its own tissues."&lt;SEP&gt;"Systemic lupus erythematosus (SLE) is an autoimmune disease distinct from systemic sclerosis."&lt;SEP&gt;"Systemic lupus erythematosus is a chronic autoimmune disease affecting various systems with circulating antinuclear antibodies."&lt;SEP&gt;"Systemic lupus erythematosus is an autoimmune disease associated with the TNFSF4 gene and SNPs."&lt;SEP&gt;"Systemic lupus erythematosus, a disease previously associated with the TNFSF4 gene."&lt;SEP&gt;"Systemic lupus erythematosus, an autoimmune disease associated with TNFSF4 polymorphisms."&lt;SEP&gt;"Systemic lupus erythematosus, an autoimmune disease associated with genes such as PTPN22 and STAT4."&lt;SEP&gt;"Systemic lupus erythematosus, an autoimmune disease associated with genetic variants like TNFSF4."&lt;SEP&gt;"Systemic lupus erythematosus, an autoimmune disease linked with IRF5 gene expression."&lt;SEP&gt;"Systemic lupus erythematosus, an autoimmune disease often examined in conjunction with TNFSF4."&lt;SEP&gt;"Systemic lupus erythematosus, an autoimmune disease that may involve anti-RNP antibodies"&lt;SEP&gt;"Systemic lupus erythematosus, an autoimmune disease that shares similarities with systemic sclerosis in terms of immune alterations and gene polymorphisms."&lt;SEP&gt;"Systemic lupus erythematosus, an autoimmune disease, potentially involves shared genetic features with SSc."&lt;SEP&gt;"Systemic lupus erythematosus, an autoimmune disease."&lt;SEP&gt;"Systemic lupus erythematosus, an autoimmune disorder."</data>
  <data key="d2">chunk-b8c59e84703c3508fdcaea1e0f1d798b&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51&lt;SEP&gt;chunk-5d3273222cddef8cb212284d98ad6ea3&lt;SEP&gt;chunk-bc41401afd8fbd1a0e1739441ffe8577&lt;SEP&gt;chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-039888df49d04e1f7f17eea69b15a3a2&lt;SEP&gt;chunk-f40d75c218dbbd371d3444666f5fa395&lt;SEP&gt;chunk-d3f80deee592fd8d98f9795daf2b98ca&lt;SEP&gt;chunk-4e90f51a9fd956d75a15a68bb461dbf0&lt;SEP&gt;chunk-fba739fd54b7c4be7dcfb724ce517bfc&lt;SEP&gt;chunk-d177121ee3e32d25172682ac2df0f91b&lt;SEP&gt;chunk-dfad4826c0b7e6a17d2e0d647d8df903&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324</data>
</node>
<node id="&quot;SSC&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A chronic autoimmune disease characterized by pathological fibrosis affecting the skin and internal organs."&lt;SEP&gt;"Systemic sclerosis (SSC) is a chronic autoimmune disease characterized by excessive fibrosis of the skin and internal organs."&lt;SEP&gt;"Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin and internal organs."&lt;SEP&gt;"Systemic sclerosis also referred to as SSc is an autoimmune disease characterized by fibrosis of the skin and internal organs."&lt;SEP&gt;"Systemic sclerosis also referred to as SSc, a disease characterized by skin and internal organ fibrosis."&lt;SEP&gt;"Systemic sclerosis is a chronic autoimmune disease characterized by skin and internal organ fibrosis."&lt;SEP&gt;"Systemic sclerosis is an autoimmune disease characterized by fibrosis and associated with the TNFSF4 gene and SNPs."&lt;SEP&gt;"Systemic sclerosis is an autoimmune disease characterized by fibrosis of skin and internal organs."&lt;SEP&gt;"Systemic sclerosis is characterized by chronic connective tissue complications."&lt;SEP&gt;"Systemic sclerosis, a chronic connective tissue disease."&lt;SEP&gt;"Systemic sclerosis, a complex polygenic autoimmune disease related to TNFSF4 and characterized by pathological fibrosis."&lt;SEP&gt;"Systemic sclerosis, a disease potentially linked with variations in specific SNPs."&lt;SEP&gt;"Systemic sclerosis, abbreviated as SSc, is a clinically heterogeneous autoimmune disease characterized by cutaneous involvement and organ pattern involvement."&lt;SEP&gt;"Systemic sclerosis, also abbreviated as SSC, is an autoimmune disease associated with pathological fibrosis of the skin and internal organs."&lt;SEP&gt;"Systemic sclerosis, also abbreviated as SSC, is an autoimmune disease characterized by fibrosis."&lt;SEP&gt;"Systemic sclerosis, also known as SSC, is a chronic connective tissue disease characterized by skin thickening and fibrosis in various organs."&lt;SEP&gt;"Systemic sclerosis, also known as SSc, a connective tissue disease."&lt;SEP&gt;"Systemic sclerosis, also known as SSc, a disease studied in relation to TNFSF4."&lt;SEP&gt;"Systemic sclerosis, also known as SSc, is an autoimmune disease associated with fibrosis of the skin and internal organs."&lt;SEP&gt;"Systemic sclerosis, also known as SSc."&lt;SEP&gt;"Systemic sclerosis, also known as scleroderma, with immunogenetic and serologic implications"&lt;SEP&gt;"Systemic sclerosis, also referred to as SSC."&lt;SEP&gt;"Systemic sclerosis, also referred to as SSc, is a disease with pathological fibrosis and a complex immunopathogenesis."&lt;SEP&gt;"Systemic sclerosis, also referred to as SSc, is an autoimmune disease characterized by fibrosis of the skin and internal organs."&lt;SEP&gt;"Systemic sclerosis, also referred to as scleroderma, is a chronic disease characterized by progressive fibrosis in the skin and internal organs."&lt;SEP&gt;"Systemic sclerosis, an autoimmune disease associated with IRF5 gene polymorphisms and characteristic of vasculotrophism and pulmonary fibrosis."&lt;SEP&gt;"Systemic sclerosis, an autoimmune disease associated with a myriad of circulating antinuclear antibodies and polymorphisms in several genes."&lt;SEP&gt;"Systemic sclerosis, an autoimmune disease characterized by fibrosis of skin and internal organs."&lt;SEP&gt;"Systemic sclerosis, an autoimmune disease characterized by fibrosis of the skin and internal organs."&lt;SEP&gt;"Systemic sclerosis, an autoimmune disease related to TNFSF4 gene polymorphisms, characterized by fibrosis."&lt;SEP&gt;"Systemic sclerosis, an autoimmune disease, shows an association with polymorphisms in the TNFSF4 gene region among North American Caucasians."&lt;SEP&gt;"Systemic sclerosis, an autoimmune disease."&lt;SEP&gt;"Systemic sclerosis, associated with TNFSF4 gene polymorphisms and characterized by its clinical and autoantibody subsets."&lt;SEP&gt;"Systemic sclerosis, where OX40 serum levels are elevated, linked to OX40-OX40L pathway."</data>
  <data key="d2">chunk-e785e8a37b35cb99202b04012deed634&lt;SEP&gt;chunk-d3f80deee592fd8d98f9795daf2b98ca&lt;SEP&gt;chunk-039888df49d04e1f7f17eea69b15a3a2&lt;SEP&gt;chunk-c2823bcad3d01b2fb4bdef5f8aa96865&lt;SEP&gt;chunk-72875ba549df0c7c1e9bd9550ffbe3a8&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892&lt;SEP&gt;chunk-eeb39a2fa5676c3abaaa455a6c7075ba&lt;SEP&gt;chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-210e345ac292a0c3ccf4c2c84f6ad8b3&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51&lt;SEP&gt;chunk-bc41401afd8fbd1a0e1739441ffe8577&lt;SEP&gt;chunk-22c95d151784bab494732266d8aaf873&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7&lt;SEP&gt;chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-5d3273222cddef8cb212284d98ad6ea3&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-5603d604754b1f5919bd4f70c43da7c8&lt;SEP&gt;chunk-f40d75c218dbbd371d3444666f5fa395&lt;SEP&gt;chunk-d177121ee3e32d25172682ac2df0f91b&lt;SEP&gt;chunk-dfad4826c0b7e6a17d2e0d647d8df903&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-457c8cc26a6098970ec760d84c398a2a&lt;SEP&gt;chunk-b8c59e84703c3508fdcaea1e0f1d798b&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8&lt;SEP&gt;chunk-c3d25dc1bb5909ac0c6c506368f54f42&lt;SEP&gt;chunk-7c5f5c049c4de2e225436b011b91505b&lt;SEP&gt;chunk-88b78ed0abef17d11ffa6aefaa201bcd&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-ece9281114fbd43ea91166a7803561b5</data>
</node>
<node id="&quot;CUTANEOUS AND VISCERAL FIBROSIS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Fibrosis of the skin and internal organs is characteristic of systemic sclerosis."</data>
  <data key="d2">chunk-d548e9ff6c14d77f5815c38f5bb0c54f</data>
</node>
<node id="&quot;AUTOIMMUNE DISEASE&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A range of diseases where the body's immune system attacks healthy cells."&lt;SEP&gt;"Autoimmune diseases involve the immune system attacking healthy cells, including diseases like SLE and SSc."</data>
  <data key="d2">chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f</data>
</node>
<node id="&quot;RS1234314&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"A minor allele polymorphism of the TNFSF4 gene found more commonly in systemic sclerosis patients."&lt;SEP&gt;"RS1234314 is a single nucleotide polymorphism potentially linked to genetic traits."&lt;SEP&gt;"RS1234314 is a single nucleotide polymorphism that has been studied in the context of systemic sclerosis."&lt;SEP&gt;"SNP rs1234314 is a minor allele associated with limited systemic sclerosis."&lt;SEP&gt;"SNP rs1234314 is a minor allele of the TNFSF4 gene associated with limited systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism in the TNFSF4 gene associated with SSc."&lt;SEP&gt;"Single nucleotide polymorphism rs1234314 associated with TNFSF4."&lt;SEP&gt;"Single nucleotide polymorphism rs1234314 associated with the TNFSF4 gene."&lt;SEP&gt;"Single nucleotide polymorphism rs1234314 is associated with SSc susceptibility."&lt;SEP&gt;"Single nucleotide polymorphism rs1234314 is associated with SSc."&lt;SEP&gt;"Single nucleotide polymorphism rs1234314 is associated with systemic sclerosis with an increased occurrence of the minor allele G."&lt;SEP&gt;"Single nucleotide polymorphism rs1234314 is associated with systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs1234314 potentially associated with disease outcomes."&lt;SEP&gt;"Single nucleotide polymorphism rs1234314 with associations in lSSc, ACA, and ATA groups."&lt;SEP&gt;"Single nucleotide polymorphism rs1234314, linked with systemic disease study."&lt;SEP&gt;"rs1234314 is a single nucleotide polymorphism associated with increased risk of systemic sclerosis."&lt;SEP&gt;"rs1234314 is referenced without description."&lt;SEP&gt;"rs1234314 refers to a specific single nucleotide polymorphism (SNP) that is being studied in relation to systemic sclerosis, with comparative results between controls and patients."</data>
  <data key="d2">chunk-457c8cc26a6098970ec760d84c398a2a&lt;SEP&gt;chunk-210e345ac292a0c3ccf4c2c84f6ad8b3&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-5603d604754b1f5919bd4f70c43da7c8&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-c3d25dc1bb5909ac0c6c506368f54f42&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8&lt;SEP&gt;chunk-c2823bcad3d01b2fb4bdef5f8aa96865&lt;SEP&gt;chunk-88b78ed0abef17d11ffa6aefaa201bcd&lt;SEP&gt;chunk-d177121ee3e32d25172682ac2df0f91b&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7&lt;SEP&gt;chunk-eeb39a2fa5676c3abaaa455a6c7075ba&lt;SEP&gt;chunk-d76b2781d29c6f7d7c381b50337a12a0</data>
</node>
<node id="&quot;RS2205960&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"A minor allele polymorphism of the TNFSF4 gene more frequent in systemic sclerosis."&lt;SEP&gt;"A single nucleotide polymorphism of TNFSF4 associated with SSc."&lt;SEP&gt;"RS2205960 is a single nucleotide polymorphism associated with susceptibility to systemic sclerosis."&lt;SEP&gt;"RS2205960 is a single nucleotide polymorphism associated with systemic sclerosis."&lt;SEP&gt;"RS2205960 is linked to genetic variation and associated functions."&lt;SEP&gt;"SNP rs2205960 is a minor allele of the TNFSF4 gene observed in limited systemic sclerosis."&lt;SEP&gt;"SNP rs2205960 is also a minor allele more common in limited systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism in the TNFSF4 gene associated with SSc."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 associated with susceptibility to systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 associated with systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 associated with the TNFSF4 gene, linked to systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 in the TNFSF4 gene associated with SSc."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 in the TNFSF4 gene is associated with systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 is associated with SSc susceptibility."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 is involved in systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 is linked to ATA-positive SSc."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 is linked to systemic sclerosis susceptibility."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 potentially associated with disease outcomes."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 shows increased frequency in systemic sclerosis for the minor allele T."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960, associated potentially with autoimmune disease."&lt;SEP&gt;"rs2205960 is a single nucleotide polymorphism (SNP) in the TNFSF4 gene associated with increased risk for SSc in certain genotypes."&lt;SEP&gt;"rs2205960 is a single nucleotide polymorphism associated with susceptibility to systemic sclerosis."&lt;SEP&gt;"rs2205960 is referenced without description."</data>
  <data key="d2">chunk-c2823bcad3d01b2fb4bdef5f8aa96865&lt;SEP&gt;chunk-72875ba549df0c7c1e9bd9550ffbe3a8&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892&lt;SEP&gt;chunk-d76b2781d29c6f7d7c381b50337a12a0&lt;SEP&gt;chunk-eeb39a2fa5676c3abaaa455a6c7075ba&lt;SEP&gt;chunk-210e345ac292a0c3ccf4c2c84f6ad8b3&lt;SEP&gt;chunk-22c95d151784bab494732266d8aaf873&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7&lt;SEP&gt;chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-3184335b83c100772059d085ae00b750&lt;SEP&gt;chunk-d177121ee3e32d25172682ac2df0f91b&lt;SEP&gt;chunk-dfad4826c0b7e6a17d2e0d647d8df903&lt;SEP&gt;chunk-457c8cc26a6098970ec760d84c398a2a&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8&lt;SEP&gt;chunk-c3d25dc1bb5909ac0c6c506368f54f42&lt;SEP&gt;chunk-88b78ed0abef17d11ffa6aefaa201bcd&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534</data>
</node>
<node id="&quot;RS844648&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"A minor allele polymorphism of the TNFSF4 gene associated with systemic sclerosis."&lt;SEP&gt;"RS844648 is a single nucleotide polymorphism associated with systemic sclerosis."&lt;SEP&gt;"RS844648 is another SNP within a similar region, potentially affecting gene regulation."&lt;SEP&gt;"Single nucleotide polymorphism linked to systemic sclerosis susceptibility."&lt;SEP&gt;"Single nucleotide polymorphism rs844648 associated with susceptibility to systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs844648 is associated with ARA-positive SSc."&lt;SEP&gt;"Single nucleotide polymorphism rs844648 is associated with SSc susceptibility, but its minor allele is protective."&lt;SEP&gt;"Single nucleotide polymorphism rs844648 is associated with systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs844648 linked to dSSc and ARA."&lt;SEP&gt;"Single nucleotide polymorphism rs844648 potentially associated with disease outcomes."&lt;SEP&gt;"Single nucleotide polymorphism rs844648 shows association with systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs844648, associated potentially with systemic sclerosis."&lt;SEP&gt;"rs844648 is a single nucleotide polymorphism associated with systemic sclerosis, although its frequency can vary."&lt;SEP&gt;"rs844648 is a single nucleotide polymorphism involved in TNFSF4 gene region analysis for systemic sclerosis susceptibility."&lt;SEP&gt;"rs844648 is a single nucleotide polymorphism involved in genetic studies and disease association."&lt;SEP&gt;"rs844648 is referenced without description."</data>
  <data key="d2">chunk-457c8cc26a6098970ec760d84c398a2a&lt;SEP&gt;chunk-210e345ac292a0c3ccf4c2c84f6ad8b3&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-c3d25dc1bb5909ac0c6c506368f54f42&lt;SEP&gt;chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-72875ba549df0c7c1e9bd9550ffbe3a8&lt;SEP&gt;chunk-88b78ed0abef17d11ffa6aefaa201bcd&lt;SEP&gt;chunk-d177121ee3e32d25172682ac2df0f91b&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7&lt;SEP&gt;chunk-d76b2781d29c6f7d7c381b50337a12a0&lt;SEP&gt;chunk-eeb39a2fa5676c3abaaa455a6c7075ba</data>
</node>
<node id="&quot;RS844644&quot;">
  <data key="d0">"SNP"</data>
  <data key="d1">"A minor allele polymorphism of the TNFSF4 gene less frequent in some systemic sclerosis subtypes."&lt;SEP&gt;"RS844644 is a genetic variant studied for its association in conditions like systemic sclerosis."&lt;SEP&gt;"RS844644 is a single nucleotide polymorphism associated with certain genetic expressions."&lt;SEP&gt;"RS844644 is a single nucleotide polymorphism associated with systemic sclerosis."&lt;SEP&gt;"SNP rs844644 is a variant observed in TNFSF4 gene studies on systemic sclerosis."&lt;SEP&gt;"SNP rs844644 is related to TNFSF4 gene studies in systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism in the TNFSF4 gene showing genetic associations with SSc."&lt;SEP&gt;"Single nucleotide polymorphism rs844644 is associated with systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs844644 is linked to systemic sclerosis, with a decreased frequency of the minor allele A."&lt;SEP&gt;"Single nucleotide polymorphism rs844644 potentially associated with disease outcomes."&lt;SEP&gt;"Single nucleotide polymorphism rs844644, protective in most SSc subsets."&lt;SEP&gt;"Single nucleotide polymorphism rs844644, with a protective role in systemic sclerosis."&lt;SEP&gt;"The minor allele of single nucleotide polymorphism rs844644 is protective against SSc."&lt;SEP&gt;"rs844644 is a single nucleotide polymorphism in the TNFSF4 gene potentially associated with autoimmune conditions."</data>
  <data key="d2">chunk-457c8cc26a6098970ec760d84c398a2a&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-c9c83616fb0c96ebed93b26d5ad94820&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-c3d25dc1bb5909ac0c6c506368f54f42&lt;SEP&gt;chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-e19459917d5c48c6b875c4a30fdad3b1&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7&lt;SEP&gt;chunk-d76b2781d29c6f7d7c381b50337a12a0&lt;SEP&gt;chunk-eeb39a2fa5676c3abaaa455a6c7075ba</data>
</node>
<node id="&quot;PATIENTS&quot;">
  <data key="d0">"SPECIES_OR_MODEL"</data>
  <data key="d1">"Human participants included in the scleroderma study."&lt;SEP&gt;"Human patients are involved in the studies with atopic dermatitis and healthy controls."&lt;SEP&gt;"Human patients involved in studies relating SNPs and diseases."&lt;SEP&gt;"Human patients involved in systemic sclerosis studies."&lt;SEP&gt;"Human patients participating in the study, specifically North American Caucasian individuals with systemic sclerosis."&lt;SEP&gt;"Human patients, specifically children and adults, involved in studying serum levels of sOX40 related to AD."&lt;SEP&gt;"Human subjects involved in the study of atopic dermatitis and related inflammatory conditions."&lt;SEP&gt;"Human subjects involved in the study of systemic sclerosis and genetic associations."&lt;SEP&gt;"Humans or human subjects in a study examining genetic variants related to systemic sclerosis."&lt;SEP&gt;"Humans with atopic dermatitis who are being studied for disease markers."&lt;SEP&gt;"Humans, specifically referencing individuals with systemic sclerosis in the study."&lt;SEP&gt;"Individuals diagnosed with Atopic Dermatitis, analyzed for immune responses."&lt;SEP&gt;"Individuals participating in the study, including those with AD and asthma."&lt;SEP&gt;"Patients are human subjects used in the study of SSc and its genetic associations."&lt;SEP&gt;"Patients in the context of atopic dermatitis referring to individuals with this disease."&lt;SEP&gt;"Patients in this context refers to individuals, specifically the North American Caucasian population, involved in the study of TNFSF4 associated with autoimmune diseases."&lt;SEP&gt;"Patients refer to human subjects involved in studies to understand disease mechanisms and responses."&lt;SEP&gt;"Patients refers to human subjects involved in the study of systemic sclerosis."&lt;SEP&gt;"Patients with AD exhibit increased expression of OX40 on T cells and co-localization with mast cells in the skin."&lt;SEP&gt;"Patients with atopic dermatitis used in serum level studies."</data>
  <data key="d2">chunk-9c36c2978a0bf868f306a82e42a345a9&lt;SEP&gt;chunk-5523421a7f3eaa630cb13416842f81a5&lt;SEP&gt;chunk-039888df49d04e1f7f17eea69b15a3a2&lt;SEP&gt;chunk-d76b2781d29c6f7d7c381b50337a12a0&lt;SEP&gt;chunk-22c95d151784bab494732266d8aaf873&lt;SEP&gt;chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7&lt;SEP&gt;chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-f17f68c620d56dddb447652de4fee94c&lt;SEP&gt;chunk-dd1abca19a92c3ea17e849ebfe392af1&lt;SEP&gt;chunk-d177121ee3e32d25172682ac2df0f91b&lt;SEP&gt;chunk-bf0a9d6fcaf06c245c2b80667c7f3261&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-e4a9d1698278391ab0182f138d50f659</data>
</node>
<node id="&quot;ASSOCIATION WITH SSC&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Genetic association indicating susceptibility to systemic sclerosis."</data>
  <data key="d2">chunk-d548e9ff6c14d77f5815c38f5bb0c54f</data>
</node>
<node id="&quot;SNPS IN TNFSF4&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Nine single nucleotide polymorphisms in the TNFSF4 gene previously associated with SLE susceptibility were tested for associations with SSc."</data>
  <data key="d2">chunk-d548e9ff6c14d77f5815c38f5bb0c54f</data>
</node>
<node id="&quot;MINOR ALLELES AT SNPS&quot;">
  <data key="d0">"GENE_VARIANTS"</data>
  <data key="d1">"Minor alleles at specific SNPs, such as rs1234314, rs2205960, and rs844648, showing significant association with SSc susceptibility."</data>
  <data key="d2">chunk-d548e9ff6c14d77f5815c38f5bb0c54f</data>
</node>
<node id="&quot;LIMITED AND DIFFUSE SSC&quot;">
  <data key="d0">"DISEASE_SUBTYPE"</data>
  <data key="d1">"Subtypes of systemic sclerosis associated with specific genetic markers in the study."</data>
  <data key="d2">chunk-d548e9ff6c14d77f5815c38f5bb0c54f</data>
</node>
<node id="&quot;PTPN22&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"PTPN22 encodes lymphoid protein phosphatase and is associated with autoimmune diseases such as type I diabetes, rheumatoid arthritis, and systemic lupus erythematosus."&lt;SEP&gt;"PTPN22 gene is associated with the R620W polymorphism and systemic sclerosis susceptibility."&lt;SEP&gt;"PTPN22 is a protein tyrosine phosphatase gene associated with rheumatoid arthritis and involved in immune system regulation."&lt;SEP&gt;"PTPN22 is associated with the development of multiple autoimmune diseases, including type I diabetes mellitus (TIDM), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE)."&lt;SEP&gt;"Protein tyrosine phosphatase, non-receptor type 22 is involved in immune regulation, with gene polymorphisms associated with SSC and SLE."</data>
  <data key="d2">chunk-b8c59e84703c3508fdcaea1e0f1d798b&lt;SEP&gt;chunk-dbadb4d9b74b89122cd7868a0008eea7&lt;SEP&gt;chunk-f40d75c218dbbd371d3444666f5fa395&lt;SEP&gt;chunk-b4ff39770b5e8cbf3dedd6876a26cb9d&lt;SEP&gt;chunk-fba739fd54b7c4be7dcfb724ce517bfc</data>
</node>
<node id="&quot;STAT4&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"STAT4 is a gene associated with immune responses and has implications in autoimmune diseases."&lt;SEP&gt;"STAT4 is a gene listed in the document without a detailed description of its function."&lt;SEP&gt;"STAT4 is a susceptibility gene linked to the development of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)."&lt;SEP&gt;"STAT4 is associated with an increased risk of rheumatoid arthritis, systemic lupus erythematosus, and influences genetic predisposition to systemic sclerosis phenotype."&lt;SEP&gt;"Signal Transducer and Activator of Transcription 4, a gene with polymorphisms associated with autoimmune diseases like SSC and SLE."</data>
  <data key="d2">chunk-b8c59e84703c3508fdcaea1e0f1d798b&lt;SEP&gt;chunk-dbadb4d9b74b89122cd7868a0008eea7&lt;SEP&gt;chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-4e90f51a9fd956d75a15a68bb461dbf0&lt;SEP&gt;chunk-f40d75c218dbbd371d3444666f5fa395</data>
</node>
<node id="&quot;TIDM&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Type I diabetes mellitus is an autoimmune disease that affects insulin production in the pancreas."&lt;SEP&gt;"Type I diabetes mellitus, an autoimmune disease linked to the gene PTPN22."</data>
  <data key="d2">chunk-f40d75c218dbbd371d3444666f5fa395&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51</data>
</node>
<node id="&quot;RA&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Rheumatoid arthritis is a chronic inflammatory autoimmune disease."&lt;SEP&gt;"Rheumatoid arthritis, an autoimmune disease associated with genes like PTPN22 and STAT4."&lt;SEP&gt;"Rheumatoid arthritis, another autoimmune disease referred to in the text."</data>
  <data key="d2">chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-f40d75c218dbbd371d3444666f5fa395&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51</data>
</node>
<node id="&quot;POLYMORPHISMS&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Genetic variations or polymorphisms in genes such as TNFSF4 contribute to susceptibility to autoimmune diseases."</data>
  <data key="d2">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</node>
<node id="&quot;CLINICAL AND AUTOANTIBODY SUBSETS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Different clinical presentations and autoantibody profiles of diseases like systemic sclerosis."</data>
  <data key="d2">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</node>
<node id="&quot;ATHEROSCLEROSIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Atherosclerosis is a disease in which plaque builds up inside arteries."&lt;SEP&gt;"Atherosclerosis is characterized by the build-up of fats, cholesterol, and other substances in and on the artery walls, with possible involvement of the OX40-OX40L pathway."&lt;SEP&gt;"Atherosclerosis susceptibility is influenced by the TNFSF4 gene encoding OX40 ligand."</data>
  <data key="d2">chunk-b267f7459d573ed53adff3f27835bd72&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51&lt;SEP&gt;chunk-a1e55c0d3e82798ca6e2849fe54d23ff</data>
</node>
<node id="&quot;OX40 LIGAND&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"OX40 Ligand is a ligand for the OX40 receptor, playing a role in the migration and activity of T cells in autoimmune diseases."&lt;SEP&gt;"OX40 Ligand is a member of the TNF/NGF cytokine family and induces proliferation and differentiation in murine splenic B cells."&lt;SEP&gt;"OX40 Ligand is the protein product encoded by the TNFSF4 gene, involved in costimulation."&lt;SEP&gt;"OX40 Ligand plays a critical role in the development of pathogenic Th2 cells in asthma models."&lt;SEP&gt;"OX40 ligand functions as a costimulatory signal for T-cells, playing roles in asthma and systemic sclerosis."&lt;SEP&gt;"OX40 ligand is encoded by the TNFSF4 gene and is involved in immune response modulation."</data>
  <data key="d2">chunk-076b3b9ec096111e268d9d6a571decfd&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51&lt;SEP&gt;chunk-4cc60d46174dbafbe3376fe5793a500f&lt;SEP&gt;chunk-7c5f5c049c4de2e225436b011b91505b&lt;SEP&gt;chunk-b267f7459d573ed53adff3f27835bd72&lt;SEP&gt;chunk-e6d4cc75e3f259d8ad15f49ab499fddf</data>
</node>
<node id="&quot;ANTINUCLEAR ANTIBODIES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Antinuclear antibodies are autoantibodies that target substances in the cell nucleus and are often present in autoimmune disorders."&lt;SEP&gt;"Circulating antinuclear antibodies are often found in patients with autoimmune diseases like SLE and SSc."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51</data>
</node>
<node id="&quot;TYPE I INTERFERON&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"A class of interferons involved in the innate immune response, often dysregulated in autoimmune diseases like SLE."&lt;SEP&gt;"Type I interferon is a group of proteins with roles in the immune response, including upregulation in autoimmune diseases like SLE and SSc."&lt;SEP&gt;"Type I interferon modulates immune response, inducing Th1 when co-expressed with OX40L."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-5d3273222cddef8cb212284d98ad6ea3&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51</data>
</node>
<node id="&quot;PERIPHERAL BLOOD CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Peripheral blood cells are involved in the body's immune response, with gene expression patterns found in autoimmune diseases."&lt;SEP&gt;"Peripheral blood cells display interferon-inducible gene expression signatures in patients with autoimmune diseases."&lt;SEP&gt;"Peripheral blood cells play a role in immune response and exhibit a pattern of upregulation in certain autoimmune conditions like SSC and SLE."</data>
  <data key="d2">chunk-5d3273222cddef8cb212284d98ad6ea3&lt;SEP&gt;chunk-b8c59e84703c3508fdcaea1e0f1d798b&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51</data>
</node>
<node id="&quot;INTERNAL ORGANS&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"Internal organs may be affected by diseases such as systemic sclerosis, which causes fibrosis."&lt;SEP&gt;"Internal organs may be affected by systemic autoimmune diseases like systemic lupus erythematosus."&lt;SEP&gt;"Internal organs, including lungs and kidneys, can be affected by fibrosis in systemic sclerosis."&lt;SEP&gt;"Refers to the organs inside the body that can be affected by systemic sclerosis."</data>
  <data key="d2">chunk-fba739fd54b7c4be7dcfb724ce517bfc&lt;SEP&gt;chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534</data>
</node>
<node id="&quot;IRF5&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"IRF5 is a gene encoding the Interferon Regulatory Factor 5, associated with lupus and systemic sclerosis."&lt;SEP&gt;"IRF5 is a gene mentioned in the study with its specific function not detailed in the given text."&lt;SEP&gt;"Interferon regulatory factor 5 is a gene associated with type I interferon responses, where polymorphisms are linked to SSC and SLE."</data>
  <data key="d2">chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-5d3273222cddef8cb212284d98ad6ea3&lt;SEP&gt;chunk-b8c59e84703c3508fdcaea1e0f1d798b</data>
</node>
<node id="&quot;FAS&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"FAS gene contains the -670G&gt;A polymorphism influencing systemic sclerosis susceptibility."&lt;SEP&gt;"FAS is a gene associated with the development of anti-RNP antibodies in systemic lupus erythematosus"&lt;SEP&gt;"FAS is identified as a gene in this text, with no specific roles outlined."&lt;SEP&gt;"FAS is known for its role in apoptosis, with polymorphisms associated with systemic sclerosis and systemic lupus erythematosus."</data>
  <data key="d2">chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-b8c59e84703c3508fdcaea1e0f1d798b&lt;SEP&gt;chunk-bc41401afd8fbd1a0e1739441ffe8577&lt;SEP&gt;chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</node>
<node id="&quot;VASCULOPATHY&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Vasculopathy is a condition involving abnormalities or diseases affecting blood vessels, often associated with systemic sclerosis."</data>
  <data key="d2">chunk-b8c59e84703c3508fdcaea1e0f1d798b</data>
</node>
<node id="&quot;AUTOIMMUNITY&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Autoimmunity is a condition where the immune system attacks the body's own cells, contributing to diseases like SLE and SSc."&lt;SEP&gt;"Autoimmunity refers to a condition in which the immune system attacks the body's own cells and tissues, contributing to diseases like SSC and SLE."</data>
  <data key="d2">chunk-b8c59e84703c3508fdcaea1e0f1d798b&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324</data>
</node>
<node id="&quot;INFLAMMATION&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"A biological response to harmful stimuli, often involving immune cells and inflammatory cytokines."&lt;SEP&gt;"Inflammation is a biological response to harmful stimuli, often involved in autoimmune diseases such as SSC and SLE."&lt;SEP&gt;"Inflammation is a common immune response often observed in autoimmune conditions such as SLE and SSc."</data>
  <data key="d2">chunk-b8c59e84703c3508fdcaea1e0f1d798b&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-dd1abca19a92c3ea17e849ebfe392af1</data>
</node>
<node id="&quot;CALCINOSIS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Calcinosis is a condition characterized by calcium deposits in the skin, associated with systemic sclerosis."&lt;SEP&gt;"Calcinosis refers to abnormal calcium deposits in tissues, often seen in scleroderma patients."</data>
  <data key="d2">chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</node>
<node id="&quot;RAYNAUD'S PHENOMENON&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Raynaud's phenomenon is a condition characterized by episodes of reduced blood flow to the fingers and toes, often triggered by cold temperatures or stress."&lt;SEP&gt;"Raynaud's phenomenon is a condition where blood flow to extremities is restricted, often associated with cold or stress."&lt;SEP&gt;"Raynaud's phenomenon is a symptom where fingers and toes change color and may lead to discomfort, associated with systemic sclerosis."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</node>
<node id="&quot;ESOPHAGEAL DYSFUNCTION&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Esophageal dysfunction in scleroderma involves difficulty in swallowing due to esophagus hardening."&lt;SEP&gt;"Esophageal dysfunction involves difficulties in the esophagus related to conditions like systemic sclerosis."</data>
  <data key="d2">chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</node>
<node id="&quot;SCLERODACTYLY&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Sclerodactyly is a condition characterized by tightening and thickening of the skin on the fingers and toes."&lt;SEP&gt;"Sclerodactyly is a symptom characterized by thickening and tightening of the skin on the fingers and hands, often associated with systemic sclerosis."&lt;SEP&gt;"Sclerodactyly is a symptom involving skin thickening in the fingers, often related to systemic sclerosis."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</node>
<node id="&quot;TELANGIECTASIAS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Telangiectasias are small dilated blood vessels near the surface of the skin or mucous membranes."&lt;SEP&gt;"Telangiectasias are small dilated blood vessels visible near the skin surface, associated with systemic sclerosis."&lt;SEP&gt;"Telangiectasias are small, widened blood vessels visible on the skin, commonly found in systemic sclerosis."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</node>
<node id="&quot;SJOGREN'S SYNDROME&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Sjogren's syndrome is an autoimmune disease characterized by dry eyes and dry mouth."</data>
  <data key="d2">chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</node>
<node id="&quot;UNIVERSITY OF TEXAS RHEUMATOLOGY DIVISION&quot;">
  <data key="d0">"INSTITUTION"</data>
  <data key="d1">"The institution conducting the study on scleroderma outcomes."</data>
  <data key="d2">chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</node>
<node id="&quot;AMERICAN COLLEGE OF RHEUMATOLOGY (ACR)&quot;">
  <data key="d0">"ORGANIZATION"</data>
  <data key="d1">"The organization responsible for criteria used in disease classification for scleroderma."</data>
  <data key="d2">chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</node>
<node id="&quot;GENETICS VERSUS ENVIRONMENT IN SCLERODERMA OUTCOMES STUDY (GENISOS)&quot;">
  <data key="d0">"STUDY"</data>
  <data key="d1">"A study cohort involved in investigating genetic and environmental factors in scleroderma."</data>
  <data key="d2">chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</node>
<node id="&quot;COMMITTEE FOR THE PROTECTION OF HUMAN SUBJECTS OF THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTRE AT HOUSTON&quot;">
  <data key="d0">"ORGANIZATION"</data>
  <data key="d1">"The committee responsible for ethical oversight and approval of human studies at the University of Texas."</data>
  <data key="d2">chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</node>
<node id="&quot;EESOPHAGEAL DYSFUNCTION&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Esophageal dysfunction refers to abnormalities in the movement or function of the esophagus, which may include difficulty swallowing or reflux issues."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</node>
<node id="&quot;MYOSITIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Myositis is an inflammatory disease causing muscle weakness and damage."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</node>
<node id="&quot;HEP-2&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"HEp-2 cells are a type of human epithelial cell line commonly used as a substrate in immunofluorescence assays for detecting antinuclear antibodies."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</node>
<node id="&quot;TOPOISOMERASE I&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Topoisomerase I is an enzyme that helps in the unwinding of DNA and is a common target for autoantibodies in systemic sclerosis."&lt;SEP&gt;"Topoisomerase I is an enzyme that regulates the overwinding or underwinding of DNA, targeted by autoantibodies in scleroderma."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1&lt;SEP&gt;chunk-4a79520712d3df44b8051f092fcea618</data>
</node>
<node id="&quot;RNA POLYMERASE III&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"RNA polymerase III is an enzyme involved in the transcription of DNA into RNA and is a target for autoantibodies in systemic sclerosis."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</node>
<node id="&quot;RS2795288&quot;">
  <data key="d0">"SNP"</data>
  <data key="d1">"Single nucleotide polymorphism rs2795288, studied for genetic implication in diseases."&lt;SEP&gt;"rs2795288 is a single nucleotide polymorphism in the TNFSF4 gene linked to immune system functions."&lt;SEP&gt;"rs2795288 is referenced without description."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1&lt;SEP&gt;chunk-d177121ee3e32d25172682ac2df0f91b</data>
</node>
<node id="&quot;ANTI-CENTROMERE ANTIBODIES (ACA)&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-centromere antibodies are autoantibodies associated with specific patterns on immunofluorescence assays and linked with systemic sclerosis."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</node>
<node id="&quot;AUTOANTIBODIES TO TOPOISOMERASE I (ATA)&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Autoantibodies to topoisomerase I are key markers in diagnosing systemic sclerosis and play a role in disease pathogenesis."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</node>
<node id="&quot;ANTI-RNA POLYMERASE III ANTIBODIES (ARA)&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-RNA polymerase III antibodies are autoantibodies indicative of systemic sclerosis, associated with more severe disease manifestations."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</node>
<node id="&quot;SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS)&quot;">
  <data key="d0">"SNP"</data>
  <data key="d1">"SNPs are variations in a single nucleotide in the genome, relevant in understanding genetic susceptibility to diseases like SLE."</data>
  <data key="d2">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</node>
<node id="&quot;RS1234315&quot;">
  <data key="d0">"SNP"</data>
  <data key="d1">"Single nucleotide polymorphism rs1234315 of gene associated with systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs1234315 potentially associated with disease outcomes."</data>
  <data key="d2">chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-ece9281114fbd43ea91166a7803561b5</data>
</node>
<node id="&quot;RS844665&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"RS844665 is a SNP that may play a role in gene expression and genetic susceptibility."&lt;SEP&gt;"Single nucleotide polymorphism in the TNFSF4 gene associated with systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs844665 is associated with systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs844665 potentially associated with disease outcomes."&lt;SEP&gt;"Single nucleotide polymorphism rs844665, associated with the TNFSF4 gene in systemic sclerosis."</data>
  <data key="d2">chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-c3d25dc1bb5909ac0c6c506368f54f42&lt;SEP&gt;chunk-c2823bcad3d01b2fb4bdef5f8aa96865&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7</data>
</node>
<node id="&quot;RS12039904&quot;">
  <data key="d0">"SNP"</data>
  <data key="d1">"Single nucleotide polymorphism rs12039904 associated with systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs12039904 potentially associated with disease outcomes."&lt;SEP&gt;"Single nucleotide polymorphism rs12039904, associated potentially with genetic variation."&lt;SEP&gt;"rs12039904 is referenced without description."</data>
  <data key="d2">chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-d177121ee3e32d25172682ac2df0f91b&lt;SEP&gt;chunk-ece9281114fbd43ea91166a7803561b5</data>
</node>
<node id="&quot;RS10912580&quot;">
  <data key="d0">"SNP"</data>
  <data key="d1">"A single nucleotide polymorphism of TNFSF4 associated with SSc."&lt;SEP&gt;"Single nucleotide polymorphism rs10912580 potentially associated with disease outcomes."&lt;SEP&gt;"Single nucleotide polymorphism rs10912580, noted in the context of disease variability."&lt;SEP&gt;"Single nucleotide polymorphism rs10912580."&lt;SEP&gt;"rs10912580 is referenced without description."</data>
  <data key="d2">chunk-ece9281114fbd43ea91166a7803561b5&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-d177121ee3e32d25172682ac2df0f91b&lt;SEP&gt;chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</node>
<node id="&quot;CAUCASIAN&quot;">
  <data key="d0">"SPECIES_OR_MODEL"</data>
  <data key="d1">"Refers to the population demographic involved in the TNFSF4 gene study for systemic sclerosis."</data>
  <data key="d2">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</node>
<node id="&quot;HEALTHY CONTROLS&quot;">
  <data key="d0">"GROUP"</data>
  <data key="d1">"The control group used in the study to compare against patients with systemic sclerosis."</data>
  <data key="d2">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</node>
<node id="&quot;CANDIDATE GENE ASSOCIATION STUDY&quot;">
  <data key="d0">"STUDY_TYPE"</data>
  <data key="d1">"A study designed to identify genetic variants in TNFSF4 associated with SSc by comparing patients with healthy controls."</data>
  <data key="d2">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</node>
<node id="&quot;LD&quot;">
  <data key="d0">"GENETIC_CONCEPT"</data>
  <data key="d1">"Linkage disequilibrium, a concept used to measure genetic association in the study."</data>
  <data key="d2">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</node>
<node id="&quot;D'&quot;">
  <data key="d0">"STATISTIC"</data>
  <data key="d1">"A measure of linkage disequilibrium used to calculate pairwise LD between TNFSF4 SNPs."</data>
  <data key="d2">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</node>
<node id="&quot;R2&quot;">
  <data key="d0">"STATISTIC"</data>
  <data key="d1">"A measure of linkage disequilibrium, often used to indicate statistical correlation in genetic studies."</data>
  <data key="d2">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</node>
<node id="&quot;SKIN&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"Skin involvement is a characteristic of systemic sclerosis."&lt;SEP&gt;"Skin is a major organ affected by atopic dermatitis, leading to symptoms like eczema and rashes."&lt;SEP&gt;"Skin is the body's largest organ and is significantly affected in atopic dermatitis, showing increased OX40 expression."&lt;SEP&gt;"Skin is the primary tissue affected in atopic dermatitis, with manifestations involving skin-homing cells."&lt;SEP&gt;"Skin tissue, where biopsies were collected to study AD involvement."&lt;SEP&gt;"The outer covering of the human body, affected by inflammatory skin disease."&lt;SEP&gt;"The skin is a common site affected by autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis."&lt;SEP&gt;"The skin is a primary site where OX40 and OX40L interactions are observed, particularly in AD patients."&lt;SEP&gt;"The skin is affected by systemic sclerosis, leading to its thickening and hardening."&lt;SEP&gt;"The skin is involved in atopic dermatitis, especially with affected biopsies."&lt;SEP&gt;"The skin is one of the primary tissues affected by systemic sclerosis, leading to fibrosis and thickening."&lt;SEP&gt;"The skin is the body's largest organ and is often affected in inflammatory diseases like AD."&lt;SEP&gt;"The skin is the primary organ affected in atopic dermatitis and is involved in local inflammatory processes."&lt;SEP&gt;"The skin is the primary site affected by AD, exhibiting inflammation and increased thickness."&lt;SEP&gt;"The skin is the primary tissue affected in atopic dermatitis, characterized by inflammation and presence of OX40 and OX40L-positive cells."&lt;SEP&gt;"The skin is the primary tissue where atopic dermatitis manifests, showing inflammation and presence of certain immune cells."&lt;SEP&gt;"The target tissue for improvement observed with GBR 830 treatment in atopic dermatitis."</data>
  <data key="d2">chunk-9c36c2978a0bf868f306a82e42a345a9&lt;SEP&gt;chunk-ca51be81b7248c4c4ca5fd0218eb755d&lt;SEP&gt;chunk-90301ff694034070e60e3a68b15a982a&lt;SEP&gt;chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-afdd4c61cd0aee9cfa4fdd53c26ad339&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae&lt;SEP&gt;chunk-dd1abca19a92c3ea17e849ebfe392af1&lt;SEP&gt;chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-8a79a32d7c9115e6aa8a38cfe7e0fb8d&lt;SEP&gt;chunk-fba739fd54b7c4be7dcfb724ce517bfc&lt;SEP&gt;chunk-9ff7b47e334d062c5c0cc9daeae082d7&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-4486b79fa295f4486ae8f31f789db642&lt;SEP&gt;chunk-ece9281114fbd43ea91166a7803561b5&lt;SEP&gt;chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</node>
<node id="&quot;SKIN INVOLVEMENT&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Skin involvement refers to the pathological changes in the skin associated with systemic sclerosis."</data>
  <data key="d2">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</node>
<node id="&quot;SYSTEMIC SCLEROSIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A phenotype influenced by the STAT4 gene, involving skin and internal organ fibrosis."&lt;SEP&gt;"Autoimmune disease characterized by fibrosis of the skin and internal organs."&lt;SEP&gt;"Systemic sclerosis is an autoimmune disease featuring skin and organ fibrosis."&lt;SEP&gt;"Systemic sclerosis is an autoimmune disease that involves hardening and tightening of the skin and connective tissues."&lt;SEP&gt;"Systemic sclerosis, also called scleroderma, is an autoimmune disease characterized by skin and internal organ fibrosis."&lt;SEP&gt;"Systemic sclerosis, also known as SSC, is a condition characterized by fibrosis of the skin and internal organs, and is associated with AIF1."&lt;SEP&gt;"Systemic sclerosis, also known as SSc, is a chronic systemic autoimmune disease characterized by fibrosis."&lt;SEP&gt;"Systemic sclerosis, also known as scleroderma, is a chronic autoimmune disease characterized by fibrosis of the skin and internal organs."&lt;SEP&gt;"Systemic sclerosis, an autoimmune disease associated with PTPN22 and FAS gene polymorphisms."</data>
  <data key="d2">chunk-076b3b9ec096111e268d9d6a571decfd&lt;SEP&gt;chunk-ca51be81b7248c4c4ca5fd0218eb755d&lt;SEP&gt;chunk-320d0b743f738f2697e6cc5d5e524a9e&lt;SEP&gt;chunk-dbadb4d9b74b89122cd7868a0008eea7&lt;SEP&gt;chunk-c9c83616fb0c96ebed93b26d5ad94820&lt;SEP&gt;chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-3184335b83c100772059d085ae00b750&lt;SEP&gt;chunk-b4ff39770b5e8cbf3dedd6876a26cb9d&lt;SEP&gt;chunk-b267f7459d573ed53adff3f27835bd72&lt;SEP&gt;chunk-96fee34b88b939b7834b2cdcf98d7366</data>
</node>
<node id="&quot;LIMITED SYSTEMIC SCLEROSIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A form of systemic sclerosis involving limited skin involvement."&lt;SEP&gt;"A subtype of systemic sclerosis that is characterized by skin thickening limited to certain areas."&lt;SEP&gt;"A subtype of systemic sclerosis that tends to be less severe than other forms."&lt;SEP&gt;"Limited systemic sclerosis is a form of systemic sclerosis with less skin involvement."&lt;SEP&gt;"Limited systemic sclerosis is a form of systemic sclerosis with milder skin involvement."&lt;SEP&gt;"Limited systemic sclerosis is a subtype of systemic sclerosis characterized by restricted skin involvement."&lt;SEP&gt;"Limited systemic sclerosis is a subtype of systemic sclerosis with distinct symptoms and disease progression."&lt;SEP&gt;"Limited systemic sclerosis is a subtype of systemic sclerosis with limited skin involvement."</data>
  <data key="d2">chunk-320d0b743f738f2697e6cc5d5e524a9e&lt;SEP&gt;chunk-c9c83616fb0c96ebed93b26d5ad94820&lt;SEP&gt;chunk-5603d604754b1f5919bd4f70c43da7c8&lt;SEP&gt;chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8&lt;SEP&gt;chunk-3184335b83c100772059d085ae00b750&lt;SEP&gt;chunk-96fee34b88b939b7834b2cdcf98d7366&lt;SEP&gt;chunk-ed94dfc6eac64c9c719dd45723718c39</data>
</node>
<node id="&quot;DIFFUSE SYSTEMIC SCLEROSIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A form of systemic sclerosis with widespread skin involvement."&lt;SEP&gt;"A more severe form of systemic sclerosis with widespread skin and organ involvement."&lt;SEP&gt;"A more widespread form of systemic sclerosis, involving extensive skin thickening."&lt;SEP&gt;"Diffuse systemic sclerosis involves widespread skin involvement and rapid progression."&lt;SEP&gt;"Diffuse systemic sclerosis is a form of systemic sclerosis with widespread skin involvement and rapid progression."&lt;SEP&gt;"Diffuse systemic sclerosis is a more severe subtype of systemic sclerosis, characterized by widespread skin and organ involvement."&lt;SEP&gt;"Diffuse systemic sclerosis is a subtype of systemic sclerosis characterized by widespread skin involvement."</data>
  <data key="d2">chunk-320d0b743f738f2697e6cc5d5e524a9e&lt;SEP&gt;chunk-c9c83616fb0c96ebed93b26d5ad94820&lt;SEP&gt;chunk-5603d604754b1f5919bd4f70c43da7c8&lt;SEP&gt;chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8&lt;SEP&gt;chunk-96fee34b88b939b7834b2cdcf98d7366&lt;SEP&gt;chunk-ed94dfc6eac64c9c719dd45723718c39</data>
</node>
<node id="&quot;ANTI-CENTROMERE AUTOANTIBODIES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-centromere autoantibodies are associated with systemic sclerosis."</data>
  <data key="d2">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</node>
<node id="&quot;ANTI-TOPOISOMERASE I AUTOANTIBODIES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-topoisomerase I autoantibodies are markers associated with diffuse systemic sclerosis."</data>
  <data key="d2">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</node>
<node id="&quot;ANTI-RNA POLYMERASE III AUTOANTIBODIES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-RNA polymerase III autoantibodies are associated with a subset of patients with systemic sclerosis."</data>
  <data key="d2">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</node>
<node id="&quot;SSC-ASSOCIATED AUTOANTIBODIES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"SSc-associated autoantibodies are proteins indicating immune response in systemic sclerosis."</data>
  <data key="d2">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</node>
<node id="&quot;N&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"N represents the total number of a specific group or category being analyzed in the context."</data>
  <data key="d2">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</node>
<node id="&quot;MAF&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Minor Allele Frequency (MAF) is a measure of the frequency at which the minor allele occurs in a given population."</data>
  <data key="d2">chunk-457c8cc26a6098970ec760d84c398a2a</data>
</node>
<node id="&quot;ALLELIC CHI-SQUARED&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Allelic chi-squared () is a statistical method to determine if there are significant differences in allele frequencies between populations."</data>
  <data key="d2">chunk-457c8cc26a6098970ec760d84c398a2a</data>
</node>
<node id="&quot;P VALUE&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"The p value is a statistical measure that indicates the probability of an observed difference occurring by chance."</data>
  <data key="d2">chunk-457c8cc26a6098970ec760d84c398a2a</data>
</node>
<node id="&quot;OR&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Odds Ratio (OR) is a measure of association between exposure and an outcome, reflecting the odds that an outcome will occur given a particular exposure."</data>
  <data key="d2">chunk-457c8cc26a6098970ec760d84c398a2a</data>
</node>
<node id="&quot;FDR&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"False Discovery Rate (FDR) is a method used in multiple hypothesis testing to correct for multiple comparisons."</data>
  <data key="d2">chunk-457c8cc26a6098970ec760d84c398a2a</data>
</node>
<node id="&quot;ACA&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-centromere antibodies (ACA), a hallmark of limited cutaneous systemic sclerosis."&lt;SEP&gt;"Anticentromere antibodies are autoantibodies associated with certain subtypes of SSc."&lt;SEP&gt;"Anticentromere antibody, a type of autoantibody associated with systemic sclerosis clinical subsets."</data>
  <data key="d2">chunk-210e345ac292a0c3ccf4c2c84f6ad8b3&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-e785e8a37b35cb99202b04012deed634</data>
</node>
<node id="&quot;ATA&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-topoisomerase antibodies (ATA), typically found in diffuse cutaneous systemic sclerosis."&lt;SEP&gt;"Anti-topoisomerase antibodies are autoantibodies found in some SSc patients."&lt;SEP&gt;"Antitopoisomerase I antibody, an autoantibody linked to specific systemic sclerosis phenotypic subsets."</data>
  <data key="d2">chunk-210e345ac292a0c3ccf4c2c84f6ad8b3&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-e785e8a37b35cb99202b04012deed634</data>
</node>
<node id="&quot;ARA&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-RNA polymerase III antibody, identified in systemic sclerosis and related to disease phenotype."&lt;SEP&gt;"Anti-RNA polymerase antibodies are autoantibodies found in certain SSc patients."&lt;SEP&gt;"Antiribonucleoprotein antibodies, associated with systemic sclerosis."</data>
  <data key="d2">chunk-210e345ac292a0c3ccf4c2c84f6ad8b3&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-e785e8a37b35cb99202b04012deed634</data>
</node>
<node id="&quot;CUTANEOUS INVOLVEMENT&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Cutaneous involvement refers to the skin changes seen in systemic sclerosis, including limited and diffuse forms."</data>
  <data key="d2">chunk-e785e8a37b35cb99202b04012deed634</data>
</node>
<node id="&quot;NORTH AMERICAN CAUCASIAN PATIENTS&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"North American Caucasian patients refer to a group of individuals of Caucasian ethnicity from North America involved in the study of systemic sclerosis."</data>
  <data key="d2">chunk-e785e8a37b35cb99202b04012deed634</data>
</node>
<node id="&quot;GENETIC POLYMORPHISMS&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Genetic polymorphisms refer to variations in genes that may influence the phenotype and susceptibility of systemic sclerosis."</data>
  <data key="d2">chunk-e785e8a37b35cb99202b04012deed634</data>
</node>
<node id="&quot;AUTOANTIBODIES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Autoantibodies such as ACA, ATA, and ARA are involved in systemic sclerosis and characterize different clinical subsets."</data>
  <data key="d2">chunk-e785e8a37b35cb99202b04012deed634</data>
</node>
<node id="&quot;CLINICAL SUBSETS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Clinical subsets of systemic sclerosis are classifications based on patterns of cutaneous and organ involvement."</data>
  <data key="d2">chunk-e785e8a37b35cb99202b04012deed634</data>
</node>
<node id="&quot;ANTIBODIES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Antibodies are proteins produced by the immune system that target specific antigens, and in autoimmune conditions like systemic sclerosis, they target the body's own tissues."&lt;SEP&gt;"Antibodies are proteins used by the immune system to identify and neutralize foreign objects like bacteria and viruses."&lt;SEP&gt;"Proteins produced by the immune system that may be involved in the autoimmune mechanism of diseases like systemic sclerosis."</data>
  <data key="d2">chunk-5603d604754b1f5919bd4f70c43da7c8&lt;SEP&gt;chunk-96fee34b88b939b7834b2cdcf98d7366&lt;SEP&gt;chunk-c9c83616fb0c96ebed93b26d5ad94820</data>
</node>
<node id="&quot;PATIENTS WITH SYSTEMIC SCLEROSIS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Cells from patients with systemic sclerosis provide insights into the disease characteristics."&lt;SEP&gt;"Individuals diagnosed with systemic sclerosis, an autoimmune disorder."&lt;SEP&gt;"Patients diagnosed with systemic sclerosis, an autoimmune disease affecting skin and organs."&lt;SEP&gt;"Refers to the cohort of individuals diagnosed with systemic sclerosis, used for comparison in genetic analyses."</data>
  <data key="d2">chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-5603d604754b1f5919bd4f70c43da7c8&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8&lt;SEP&gt;chunk-3184335b83c100772059d085ae00b750</data>
</node>
<node id="&quot;CONTROLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A reference group in the study not affected by systemic sclerosis, used as a baseline for comparison with patients."&lt;SEP&gt;"Control cells are used as a baseline for comparison in studies involving patients with systemic sclerosis."&lt;SEP&gt;"Refers to the group of participants or samples that serve as a standard of comparison in an experiment."&lt;SEP&gt;"The control group in a clinical study typically refers to healthy subjects used for comparison with affected patients."</data>
  <data key="d2">chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-5603d604754b1f5919bd4f70c43da7c8&lt;SEP&gt;chunk-3184335b83c100772059d085ae00b750&lt;SEP&gt;chunk-c9c83616fb0c96ebed93b26d5ad94820</data>
</node>
<node id="&quot;ANTI-CENTROMERE&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-centromere antibodies are associated with autoimmune diseases."&lt;SEP&gt;"Anti-centromere antibodies are autoantibodies that target centromere proteins and are associated with systemic sclerosis."&lt;SEP&gt;"Anti-centromere is an autoantibody found in some sclerosis patients."</data>
  <data key="d2">chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8&lt;SEP&gt;chunk-3184335b83c100772059d085ae00b750</data>
</node>
<node id="&quot;ANTI-TOPOISOMERASE I&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-topoisomerase I antibodies are autoantibodies targeting topoisomerase I enzyme, commonly found in systemic sclerosis."&lt;SEP&gt;"Anti-topoisomerase I antibodies are indicative of certain autoimmune conditions."&lt;SEP&gt;"Anti-topoisomerase I is an autoantibody often associated with certain autoimmune conditions."&lt;SEP&gt;"Anti-topoisomerase I is an autoantibody present in systemic sclerosis."&lt;SEP&gt;"Autoantibodies against topoisomerase I, often found in patients with certain forms of systemic sclerosis."</data>
  <data key="d2">chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8&lt;SEP&gt;chunk-3184335b83c100772059d085ae00b750</data>
</node>
<node id="&quot;ANTI-RNA POLYMERASE III&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-RNA polymerase III antibodies are markers used in diagnosing specific autoimmune diseases."&lt;SEP&gt;"Anti-RNA polymerase III antibodies target RNA polymerase III enzyme and are linked to systemic sclerosis."&lt;SEP&gt;"Anti-RNA polymerase III is an autoantibody involved in systemic sclerosis."&lt;SEP&gt;"Anti-RNA polymerase III is an autoantibody that may be associated with specific autoimmune diseases."&lt;SEP&gt;"Autoantibodies targeting the RNA polymerase III enzyme, associated with systemic sclerosis."</data>
  <data key="d2">chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8&lt;SEP&gt;chunk-3184335b83c100772059d085ae00b750</data>
</node>
<node id="&quot;ANTI-CENTROMERE ANTIBODIES&quot;">
  <data key="d0">"PROTIEN"</data>
  <data key="d1">"Anti-centromere antibodies are autoantibodies commonly found in patients with systemic sclerosis, particularly associated with the limited form."&lt;SEP&gt;"Anti-centromere antibodies are proteins often present in patients with limited systemic sclerosis."</data>
  <data key="d2">chunk-96fee34b88b939b7834b2cdcf98d7366&lt;SEP&gt;chunk-c9c83616fb0c96ebed93b26d5ad94820</data>
</node>
<node id="&quot;ANTI-TOPOISOMERASE I ANTIBODIES&quot;">
  <data key="d0">"PROTIEN"</data>
  <data key="d1">"Anti-topoisomerase I antibodies are autoantibodies often found in patients with diffuse systemic sclerosis, associated with more severe disease features."&lt;SEP&gt;"Anti-topoisomerase I antibodies, also known as Scl-70, are specific proteins found in many patients with diffuse systemic sclerosis."</data>
  <data key="d2">chunk-96fee34b88b939b7834b2cdcf98d7366&lt;SEP&gt;chunk-c9c83616fb0c96ebed93b26d5ad94820</data>
</node>
<node id="&quot;ANTI-RNA POLYMERASE III ANTIBODIES&quot;">
  <data key="d0">"PROTIEN"</data>
  <data key="d1">"Anti-RNA polymerase III antibodies are autoantibodies linked to systemic sclerosis, often associated with certain clinical features such as renal crisis."</data>
  <data key="d2">chunk-96fee34b88b939b7834b2cdcf98d7366</data>
</node>
<node id="&quot;ANTI-BODIES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Antibodies that are involved in the immune response against specific antigens."</data>
  <data key="d2">chunk-ed94dfc6eac64c9c719dd45723718c39</data>
</node>
<node id="&quot;LABORATORY TESTS&quot;">
  <data key="d0">"PROCEDURE"</data>
  <data key="d1">"Various laboratory tests conducted to measure antibody levels and genetic markers."</data>
  <data key="d2">chunk-ed94dfc6eac64c9c719dd45723718c39</data>
</node>
<node id="&quot;LSSC&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Limited cutaneous systemic sclerosis (lSSc), a subset of systemic sclerosis."&lt;SEP&gt;"Limited systemic sclerosis affects the skin and in some cases, internal organs."&lt;SEP&gt;"Limited systemic sclerosis, a form of systemic sclerosis involving the skin and sometimes internal organs."&lt;SEP&gt;"Limited systemic sclerosis, a subtype of systemic sclerosis with more restricted skin involvement compared to diffuse systemic sclerosis."</data>
  <data key="d2">chunk-d76b2781d29c6f7d7c381b50337a12a0&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7</data>
</node>
<node id="&quot;DSSC&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Diffuse cutaneous systemic sclerosis (dSSc), a subset of systemic sclerosis."&lt;SEP&gt;"Diffuse systemic sclerosis involves widespread skin and organ symptoms."&lt;SEP&gt;"Diffuse systemic sclerosis is a form of systemic sclerosis with widespread skin and organ involvement."&lt;SEP&gt;"Diffuse systemic sclerosis, a subtype of systemic sclerosis characterized by widespread skin and organ involvement."</data>
  <data key="d2">chunk-d76b2781d29c6f7d7c381b50337a12a0&lt;SEP&gt;chunk-a44fd8cb1d2240f0d748b7587fa41030&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7</data>
</node>
<node id="&quot;PULMONARY FIBROSIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A disease characterized by progressive scarring of lung tissue, affecting breathing."&lt;SEP&gt;"Pulmonary fibrosis is a condition of excessive tissue scarring in the lungs, associated with systemic sclerosis."</data>
  <data key="d2">chunk-d76b2781d29c6f7d7c381b50337a12a0&lt;SEP&gt;chunk-5d3273222cddef8cb212284d98ad6ea3</data>
</node>
<node id="&quot;PULMONARY HYPERTENSION&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Increased blood pressure in the pulmonary arteries, which can be associated with systemic sclerosis."</data>
  <data key="d2">chunk-d76b2781d29c6f7d7c381b50337a12a0</data>
</node>
<node id="&quot;RS855648&quot;">
  <data key="d0">"SNP"</data>
  <data key="d1">"Single nucleotide polymorphism rs855648 associated with systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs855648 interacts with rs2205960 in TNFSF4 and is associated with systemic sclerosis."&lt;SEP&gt;"rs855648 is a single nucleotide polymorphism in the TNFSF4 gene, linked with increased SSc risk in specific genotypes."</data>
  <data key="d2">chunk-72875ba549df0c7c1e9bd9550ffbe3a8&lt;SEP&gt;chunk-22c95d151784bab494732266d8aaf873&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</node>
<node id="&quot;FEMALE&quot;">
  <data key="d0">"CATEGORY"</data>
  <data key="d1">"Gender identified as a significant factor influencing the risk of systemic sclerosis in genetic studies."</data>
  <data key="d2">chunk-72875ba549df0c7c1e9bd9550ffbe3a8</data>
</node>
<node id="&quot;TT/GT GENOTYPE&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"TT/GT genotype is a variant of SNP rs2205960 in the TNFSF4 gene associated with increased risk of systemic sclerosis in females."</data>
  <data key="d2">chunk-72875ba549df0c7c1e9bd9550ffbe3a8</data>
</node>
<node id="&quot;GG GENOTYPE&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"GG genotype is the wild-type genotype of SNP rs2205960 in the TNFSF4 gene, used for comparison in genetic risk analysis."</data>
  <data key="d2">chunk-72875ba549df0c7c1e9bd9550ffbe3a8</data>
</node>
<node id="&quot;AA GENOTYPE&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"AA genotype of the TNFSF4 variant rs855648 is associated with a higher risk of systemic sclerosis compared to AG/GG genotypes."</data>
  <data key="d2">chunk-72875ba549df0c7c1e9bd9550ffbe3a8</data>
</node>
<node id="&quot;RS944648&quot;">
  <data key="d0">"SNP"</data>
  <data key="d1">"Single nucleotide polymorphism rs944648 associated with systemic sclerosis."</data>
  <data key="d2">chunk-22c95d151784bab494732266d8aaf873</data>
</node>
<node id="&quot;WOMEN&quot;">
  <data key="d0">"SPECIES_OR_MODEL"</data>
  <data key="d1">"Female humans, specifically referencing individuals with systemic sclerosis in the study."</data>
  <data key="d2">chunk-22c95d151784bab494732266d8aaf873</data>
</node>
<node id="&quot;DENDRITIC CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Dendritic cells express OX40 ligand, acting as a costimulatory signal for Th-2 cell priming and memory induction."&lt;SEP&gt;"Dendritic cells express OX40L and are key regulators in immune response."&lt;SEP&gt;"Dendritic cells express OX40L and are part of the immune system."</data>
  <data key="d2">chunk-076b3b9ec096111e268d9d6a571decfd&lt;SEP&gt;chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</node>
<node id="&quot;MACROPHAGE&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Macrophages are immune cells expressing OX40L."&lt;SEP&gt;"Macrophages express OX40L and are involved in the immune response."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</node>
<node id="&quot;B CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"B cells express OX40L and are associated with antibody production."&lt;SEP&gt;"B cells express OX40L and are involved in differentiation and antibody production."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</node>
<node id="&quot;NK CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Natural Killer cells express OX40L, playing a role in immune responses."&lt;SEP&gt;"Natural killer cells express OX40L and play a role in the body's defense against tumors and virally infected cells."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</node>
<node id="&quot;ENDOTHELIAL CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Endothelial cells are non-immune cells that express OX40L."&lt;SEP&gt;"Endothelial cells, which make up the lining of blood vessels, express OX40L."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</node>
<node id="&quot;SMOOTH MUSCLE CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Smooth muscle cells express OX40L and are found in various organs."&lt;SEP&gt;"Smooth muscle cells, although non-immune, express OX40L."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</node>
<node id="&quot;CD4+ T CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"CD4+ T cells express OX40, which interacts with OX40 ligand for immune signaling."&lt;SEP&gt;"CD4+ T cells, where OX40 is highly expressed, receive costimulatory signals."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</node>
<node id="&quot;CD8+ T CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"CD8+ T cells express OX40 and are involved in immune responses."&lt;SEP&gt;"CD8+ T cells express OX40, which interacts with OX40 ligand for immune signaling."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</node>
<node id="&quot;OX40&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"OX40 is a T-cell receptor involved in immune response regulation with its ligand OX40L."&lt;SEP&gt;"OX40 is a co-stimulatory T-cell receptor crucial for generating TH2 memory cells in atopic dermatitis."&lt;SEP&gt;"OX40 is a co-stimulatory T-cell receptor expressed on CD4+ and CD8+ T cells."&lt;SEP&gt;"OX40 is a co-stimulatory T-cell receptor involved in T-cell immune responses, particularly in conditions like atopic dermatitis."&lt;SEP&gt;"OX40 is a co-stimulatory T-cell receptor involved in immune response modulation and is particularly significant in asthma models."&lt;SEP&gt;"OX40 is a co-stimulatory T-cell receptor."&lt;SEP&gt;"OX40 is a co-stimulatory molecule expressed on skin-homing T cells, important for upregulation in inflammatory processes in AD."&lt;SEP&gt;"OX40 is a co-stimulatory molecule expressed predominantly on skin-homing memory-prone CLA+ T cells in AD patients."&lt;SEP&gt;"OX40 is a co-stimulatory receptor expressed on T cells, associated with immune responses in atopic dermatitis."&lt;SEP&gt;"OX40 is a co-stimulatory receptor involved in T-cell activation and a key player in immune response."&lt;SEP&gt;"OX40 is a costimulatory T-cell receptor important for Th2 memory cell generation and involved in the inflammatory reaction of atopic dermatitis."&lt;SEP&gt;"OX40 is a costimulatory molecule involved in T cell activation and interaction with OX40L."&lt;SEP&gt;"OX40 is a costimulatory receptor that promotes Bcl-xL and Bcl-2 expression and is essential for CD4 T cell survival."&lt;SEP&gt;"OX40 is a gene associated with T-cell costimulatory pathways and plays a role in these immune responses."&lt;SEP&gt;"OX40 is a gene encoding a member of the TNF receptor superfamily, important for T-cell co-stimulation and survival."&lt;SEP&gt;"OX40 is a gene encoding a protein that is part of the co-stimulatory pathways and plays a role in T cell activation, particularly in the skin."&lt;SEP&gt;"OX40 is a gene encoding a receptor, involved in OX40/OX40L interactions, important for T-cell function."&lt;SEP&gt;"OX40 is a gene expressed primarily in CD4+CD45RO+CLA+ T cells, and its expression is higher in AD patients."&lt;SEP&gt;"OX40 is a gene involved in T cell costimulation and immune response regulation."&lt;SEP&gt;"OX40 is a gene involved in T-cell costimulatory signals."&lt;SEP&gt;"OX40 is a gene involved in T-cell receptor signaling."&lt;SEP&gt;"OX40 is a gene involved in the regulation of immune responses, particularly in atopic dermatitis."&lt;SEP&gt;"OX40 is a gene involved in the regulation of the immune system, playing a role in skin conditions like AD."&lt;SEP&gt;"OX40 is a gene that plays a role in T-cell mediated responses, particularly in the context of autoimmune diseases like AD."&lt;SEP&gt;"OX40 is a gene that plays a role in the co-stimulatory signaling process, particularly in relation to T-cell activity and atopic dermatitis."&lt;SEP&gt;"OX40 is a member of the tumour necrosis factor superfamily involved in immune response regulation and long-term memory response."&lt;SEP&gt;"OX40 is a protein targeted by antibodies in the context of atopic dermatitis."&lt;SEP&gt;"OX40 is involved in T cell proliferation and has roles in asthma and T cell interactions with mast cells."&lt;SEP&gt;"OX40 is involved in T cell-B cell interaction, necessary for the T cell-dependent humoral immune response."&lt;SEP&gt;"OX40 is involved in immune response modulation and has a role in atopic dermatitis treatment."&lt;SEP&gt;"OX40 is involved in the T-cell receptor pathway, crucial for immune response regulation."&lt;SEP&gt;"OX40 is involved in the interaction with its ligand OX40L, playing a role in immune cells interaction."&lt;SEP&gt;"OX40 is involved in the regulation of IL-17 production and T-cell costimulation."&lt;SEP&gt;"OX40, also known as CD134, is a member of the TNF-receptor superfamily and acts as a costimulatory receptor that contributes to T-cell survival."&lt;SEP&gt;"OX40, also known as CD134, is involved in T-cell-mediated immunity and immunopathology. It is a member of the TNF receptor superfamily and plays a crucial role in T-cell costimulation."</data>
  <data key="d2">chunk-9c36c2978a0bf868f306a82e42a345a9&lt;SEP&gt;chunk-725c3e7fa459b4b8ee95682739cfe06e&lt;SEP&gt;chunk-afdd4c61cd0aee9cfa4fdd53c26ad339&lt;SEP&gt;chunk-a1e55c0d3e82798ca6e2849fe54d23ff&lt;SEP&gt;chunk-1d58826a27e5d4fa79e478dc1995650f&lt;SEP&gt;chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-0901633e83241bf8c1296a2bb24a3099&lt;SEP&gt;chunk-4684629b8113b2d7e0d8498ef744b84f&lt;SEP&gt;chunk-ac36f1e468a863c1ae0527829717bfcf&lt;SEP&gt;chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-ad6451630cadf61d3fe3c4b59f09d5c2&lt;SEP&gt;chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae&lt;SEP&gt;chunk-6ef6d5065a278b01d19708d678d3b3e2&lt;SEP&gt;chunk-0727a0b1079f66832280de80d4cf2c98&lt;SEP&gt;chunk-9ff7b47e334d062c5c0cc9daeae082d7&lt;SEP&gt;chunk-e6d4cc75e3f259d8ad15f49ab499fddf&lt;SEP&gt;chunk-fe3d25355367e23fa84b7e96578f9aeb&lt;SEP&gt;chunk-dd1abca19a92c3ea17e849ebfe392af1&lt;SEP&gt;chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b&lt;SEP&gt;chunk-3c10f775faa2c2d2c39dc1cd18158a80&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-4486b79fa295f4486ae8f31f789db642&lt;SEP&gt;chunk-8a79a32d7c9115e6aa8a38cfe7e0fb8d&lt;SEP&gt;chunk-108cd1073705362b3d684cc095446c30&lt;SEP&gt;chunk-e9209ae4bd253b98ba9d5d0f58659c20&lt;SEP&gt;chunk-535005279394e36a8c0e64ebe74fff88&lt;SEP&gt;chunk-4cc60d46174dbafbe3376fe5793a500f&lt;SEP&gt;chunk-7c5f5c049c4de2e225436b011b91505b&lt;SEP&gt;chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808&lt;SEP&gt;chunk-801108ac3e166907ed4b5f552b259a53</data>
</node>
<node id="&quot;INTERLEUKIN 17&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Interleukin 17 production may be negatively regulated by the OX40-OX40L interaction."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</node>
<node id="&quot;FOXP3+ REGULATORY T CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"FOXP3+ regulatory T cells' formation is inhibited by OX40-OX40L interaction."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</node>
<node id="&quot;C57/BL6 MOUSE&quot;">
  <data key="d0">"SPECIES_OR_MODEL"</data>
  <data key="d1">"OX40L transgenic mice developing organ-specific inflammation."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</node>
<node id="&quot;NON-OBESE DIABETIC MOUSE&quot;">
  <data key="d0">"SPECIES_OR_MODEL"</data>
  <data key="d1">"Model organism for studying diabetes, where targeting OX40-OX40L pathway shows therapeutic effect."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</node>
<node id="&quot;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A model for multiple sclerosis affected by the OX40-OX40L pathway."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</node>
<node id="&quot;MULTIPLE SCLEROSIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A disease model suggested to be influenced by OX40-OX40L interactions."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</node>
<node id="&quot;T HELPER CELL (TH2)&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"T helper cells (Th2) increase cytokine production when influenced by OX40-OX40L interaction."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</node>
<node id="&quot;TH1 RESPONSE&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Th1 response is induced by OX40L with type I interferon."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</node>
<node id="&quot;TH2 RESPONSE&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Th2 response is induced by OX40L alone."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</node>
<node id="&quot;PLASMACYTOID DENDRITIC CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Plasmacytoid dendritic cells regulate T helper responses by balancing OX40L and type I interferon expression."</data>
  <data key="d2">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</node>
<node id="&quot;FOXP3&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Foxp3 is a gene associated with the regulation of immune responses."&lt;SEP&gt;"Foxp3 is implicated in the induction of regulatory T-cells and memory T-cell expansion."</data>
  <data key="d2">chunk-1d58826a27e5d4fa79e478dc1995650f&lt;SEP&gt;chunk-0901633e83241bf8c1296a2bb24a3099</data>
</node>
<node id="&quot;MOUSE&quot;">
  <data key="d0">"SPECIES"</data>
  <data key="d1">"Mouse is a common model organism used in biomedical research."&lt;SEP&gt;"Mouse is commonly used as an experimental model in biological research."&lt;SEP&gt;"Mouse is used as a model organism in the experiment."</data>
  <data key="d2">chunk-1d58826a27e5d4fa79e478dc1995650f&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808&lt;SEP&gt;chunk-ac36f1e468a863c1ae0527829717bfcf</data>
</node>
<node id="&quot;IMMUNE RESPONSE&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"A biological process involving the activity of the immune system in defending against disease."&lt;SEP&gt;"The immune response is the body's defensive reaction to foreign substances or pathogens."</data>
  <data key="d2">chunk-1d58826a27e5d4fa79e478dc1995650f&lt;SEP&gt;chunk-b267f7459d573ed53adff3f27835bd72</data>
</node>
<node id="&quot;SPECIES&quot;">
  <data key="d0">"SPECIES_OR_MODEL"</data>
  <data key="d1">"Species represents the taxonomic category of organisms in biological classification."</data>
  <data key="d2">chunk-1d58826a27e5d4fa79e478dc1995650f</data>
</node>
<node id="&quot;IMMUNE REGULATION&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Immune regulation refers to the mechanisms and processes that maintain immune system balance and prevent autoimmune diseases."</data>
  <data key="d2">chunk-1d58826a27e5d4fa79e478dc1995650f</data>
</node>
<node id="&quot;AIF1&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"AIF1 is a gene identified in the analysis with its specific role not mentioned in the text."&lt;SEP&gt;"AIF1 is an allograft inflammatory factor 1 gene associated with systemic sclerosis when anti-centromere antibodies are present."&lt;SEP&gt;"Allograft inflammatory factor 1 is associated with anti-centromere antibody-positive systemic sclerosis."</data>
  <data key="d2">chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-076b3b9ec096111e268d9d6a571decfd&lt;SEP&gt;chunk-ca51be81b7248c4c4ca5fd0218eb755d</data>
</node>
<node id="&quot;SNPS&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Single nucleotide polymorphisms, specifically in the TNFSF4 promoter region, are associated with SSc pathogenesis."</data>
  <data key="d2">chunk-6bbb8cd576c317bbe3ed9df3629a08e0</data>
</node>
<node id="&quot;SNP&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Single nucleotide polymorphisms (SNPs) within TNFSF4 are involved in systemic sclerosis pathogenesis."</data>
  <data key="d2">chunk-d3f80deee592fd8d98f9795daf2b98ca</data>
</node>
<node id="&quot;HUMAN&quot;">
  <data key="d0">"SPECIES"</data>
  <data key="d1">"Humans are the species being studied for genetic variation and susceptibility to systemic sclerosis."</data>
  <data key="d2">chunk-d3f80deee592fd8d98f9795daf2b98ca</data>
</node>
<node id="&quot;GENETIC STRUCTURE&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Variation in genetic structure indicates differences in genetic composition across populations in SSc studies."</data>
  <data key="d2">chunk-d3f80deee592fd8d98f9795daf2b98ca</data>
</node>
<node id="&quot;PATHOGENESIS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Pathogenesis refers to the development of disease, relevant to autoimmune diseases like SSc."</data>
  <data key="d2">chunk-d3f80deee592fd8d98f9795daf2b98ca</data>
</node>
<node id="&quot;CTLA4&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"CTLA4 is a gene involved in T-cell regulation and associated with autoimmune diseases like rheumatoid arthritis."</data>
  <data key="d2">chunk-fba739fd54b7c4be7dcfb724ce517bfc</data>
</node>
<node id="&quot;PADI4&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"PADI4 is a gene that influences susceptibility to rheumatoid arthritis through the regulation of citrullination."</data>
  <data key="d2">chunk-fba739fd54b7c4be7dcfb724ce517bfc</data>
</node>
<node id="&quot;RHEUMATOID ARTHRITIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"An autoimmune disease associated with PTPN22 gene polymorphism and STAT4 gene."&lt;SEP&gt;"Rheumatoid Arthritis is an autoimmune disease in which soluble OX40L is associated with the presence of autoantibodies."&lt;SEP&gt;"Rheumatoid arthritis is an autoimmune disease characterized by chronic inflammation of joints."</data>
  <data key="d2">chunk-fba739fd54b7c4be7dcfb724ce517bfc&lt;SEP&gt;chunk-dbadb4d9b74b89122cd7868a0008eea7&lt;SEP&gt;chunk-a1e55c0d3e82798ca6e2849fe54d23ff</data>
</node>
<node id="&quot;TYPE 1A DIABETES&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Type 1A diabetes is an autoimmune disease where the immune system attacks the insulin-producing beta cells in the pancreas."</data>
  <data key="d2">chunk-fba739fd54b7c4be7dcfb724ce517bfc</data>
</node>
<node id="&quot;PROTEIN TYROSINE PHOSPHATASE&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Protein tyrosine phosphatases are enzymes involved in removing phosphate groups from proteins, associated with signaling pathways."</data>
  <data key="d2">chunk-fba739fd54b7c4be7dcfb724ce517bfc</data>
</node>
<node id="&quot;NUCLEOTIDE POLYMORPHISM&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Nucleotide polymorphism refers to variations in the DNA sequence, which can influence susceptibility to diseases."</data>
  <data key="d2">chunk-fba739fd54b7c4be7dcfb724ce517bfc</data>
</node>
<node id="&quot;1858C/T&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"A functional polymorphism in the PTPN22 gene linked with autoimmune diseases such as type I diabetes."</data>
  <data key="d2">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</node>
<node id="&quot;TYPE I DIABETES&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"An autoimmune disease associated with the PTPN22 gene polymorphism."</data>
  <data key="d2">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</node>
<node id="&quot;LYMPHOID PROTEIN PHOSPHATASE&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Protein encoded by the PTPN22 gene, involved in regulating immune response."</data>
  <data key="d2">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</node>
<node id="&quot;GENETIC PREDISPOSITION&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"The increased likelihood of developing a particular disease based on a person's genetic makeup."</data>
  <data key="d2">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</node>
<node id="&quot;MULTIPLEX FAMILIES&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Families with multiple members affected by genetic diseases, used to study genetic links."</data>
  <data key="d2">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</node>
<node id="&quot;ATHEROTHROMBOSIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Atherothrombosis is a condition involving arterial thrombosis influenced by genetic factors such as TNFSF4."</data>
  <data key="d2">chunk-4e90f51a9fd956d75a15a68bb461dbf0</data>
</node>
<node id="&quot;VENOUS THROMBOEMBOLISM&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Venous thromboembolism is a condition where blood clots form in the vein, associated with TNFSF4 genetic variants."</data>
  <data key="d2">chunk-4e90f51a9fd956d75a15a68bb461dbf0</data>
</node>
<node id="&quot;BANK1&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"BANK1 is a gene associated with B-cell receptor signaling and has been linked to systemic lupus erythematosus in specific populations."</data>
  <data key="d2">chunk-4e90f51a9fd956d75a15a68bb461dbf0</data>
</node>
<node id="&quot;CAROTID ARTERY DISEASE&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Carotid artery disease is associated with genetic variants of TNFSF4."</data>
  <data key="d2">chunk-b267f7459d573ed53adff3f27835bd72</data>
</node>
<node id="&quot;STROKE&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Stroke risk is associated with genetic variants of TNFSF4."</data>
  <data key="d2">chunk-b267f7459d573ed53adff3f27835bd72</data>
</node>
<node id="&quot;GENETIC SUSCEPTIBILITY&quot;">
  <data key="d0">"CONCEPT"</data>
  <data key="d1">"A condition where specific genetic compositions increase the likelihood of developing certain diseases."</data>
  <data key="d2">chunk-b267f7459d573ed53adff3f27835bd72</data>
</node>
<node id="&quot;INFLAMMATORY GENE EXPRESSION&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Inflammatory gene expression indicates the upregulation of pro-inflammatory responses within cells, relevant in autoimmune conditions."</data>
  <data key="d2">chunk-5d3273222cddef8cb212284d98ad6ea3</data>
</node>
<node id="&quot;INTERFERON-INDUCIBLE GENE&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Genes that are activated in response to interferon signaling, playing a crucial role in the immune response in autoimmune diseases."</data>
  <data key="d2">chunk-5d3273222cddef8cb212284d98ad6ea3</data>
</node>
<node id="&quot;RNA BINDING PROTEINS&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Proteins involved in RNA processing that, when targeted by autoantibodies, are associated with systemic lupus erythematosus (SLE)."</data>
  <data key="d2">chunk-5d3273222cddef8cb212284d98ad6ea3</data>
</node>
<node id="&quot;ANTI-RNA BINDING PROTEIN AUTOANTIBODIES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Autoantibodies targeting RNA binding proteins, associated with the pathology of systemic lupus erythematosus."</data>
  <data key="d2">chunk-5d3273222cddef8cb212284d98ad6ea3</data>
</node>
<node id="&quot;VARIANT RS2004640&quot;">
  <data key="d0">"SNP"</data>
  <data key="d1">"A single nucleotide polymorphism in the IRF5 gene associated with systemic sclerosis and pulmonary fibrosis risk."</data>
  <data key="d2">chunk-5d3273222cddef8cb212284d98ad6ea3</data>
</node>
<node id="&quot;R620W&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"R620W is a polymorphism in the PTPN22 gene associated with systemic sclerosis."</data>
  <data key="d2">chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</node>
<node id="&quot;-670G&gt;A&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"-670G&gt;A is a polymorphism in the FAS gene promoter region that influences systemic sclerosis susceptibility."</data>
  <data key="d2">chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</node>
<node id="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Systemic lupus erythematosus is associated with polymorphisms in the FAS gene."</data>
  <data key="d2">chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</node>
<node id="&quot;SNP RS2004640&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"rs2004640 is a single nucleotide polymorphism associated with genomic research."</data>
  <data key="d2">chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</node>
<node id="&quot;F5&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"F5 is a gene mentioned in the article, possibly involved in genetic study context."</data>
  <data key="d2">chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</node>
<node id="&quot;ANTI-TOPOISOMERASE I ANTIBODY&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Antibody associated with systemic sclerosis indicating an autoimmune response."</data>
  <data key="d2">chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</node>
<node id="&quot;ANTI-CENTROMERE ANTIBODY&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Anti-centromere antibodies are associated with systemic sclerosis in the context of AIF1 SNPs."&lt;SEP&gt;"Antibody linked to systemic sclerosis, indicating a distinct autoimmune response."</data>
  <data key="d2">chunk-076b3b9ec096111e268d9d6a571decfd&lt;SEP&gt;chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</node>
<node id="&quot;ANTI-RNP ANTIBODIES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Antibodies that are often found in autoimmune diseases such as SLE"</data>
  <data key="d2">chunk-bc41401afd8fbd1a0e1739441ffe8577</data>
</node>
<node id="&quot;SCLERODERMA&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Also known as progressive systemic sclerosis, characterized by skin thickening and fibrosis."&lt;SEP&gt;"Scleroderma, another name for systemic sclerosis, characterized by skin hardening and tightening"</data>
  <data key="d2">chunk-7c5f5c049c4de2e225436b011b91505b&lt;SEP&gt;chunk-bc41401afd8fbd1a0e1739441ffe8577</data>
</node>
<node id="&quot;FIBRILLARIN&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"An autoantigen targeted by autoantibodies in systemic sclerosis"</data>
  <data key="d2">chunk-bc41401afd8fbd1a0e1739441ffe8577</data>
</node>
<node id="&quot;ANGIOGENESIS&quot;">
  <data key="d0">"PROCESS"</data>
  <data key="d1">"The formation of new blood vessels, which can be altered in scleroderma"</data>
  <data key="d2">chunk-bc41401afd8fbd1a0e1739441ffe8577</data>
</node>
<node id="&quot;CREST SYNDROME&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A distinct subtype of systemic sclerosis associated with anticentromere antibodies."</data>
  <data key="d2">chunk-ca51be81b7248c4c4ca5fd0218eb755d</data>
</node>
<node id="&quot;ANTICENTROMERE ANTIBODIES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Antibodies targeting centromere proteins, associated with CREST syndrome and systemic sclerosis."</data>
  <data key="d2">chunk-ca51be81b7248c4c4ca5fd0218eb755d</data>
</node>
<node id="&quot;AIF1 SNP&quot;">
  <data key="d0">"SNP"</data>
  <data key="d1">"Single nucleotide polymorphism in the AIF1 gene associated with systemic sclerosis."</data>
  <data key="d2">chunk-ca51be81b7248c4c4ca5fd0218eb755d</data>
</node>
<node id="&quot;TH-2 CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Th-2 cells are associated with the immune response and are influenced by signals from the OX40 ligand."</data>
  <data key="d2">chunk-076b3b9ec096111e268d9d6a571decfd</data>
</node>
<node id="&quot;BLADDER CANCER&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Bladder cancer is a condition related to DNA-repair and cell-cycle-control genes."</data>
  <data key="d2">chunk-076b3b9ec096111e268d9d6a571decfd</data>
</node>
<node id="&quot;TNF SUPERFAMILY&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Members of the TNF superfamily are involved in T-cell function and various diseases."</data>
  <data key="d2">chunk-076b3b9ec096111e268d9d6a571decfd</data>
</node>
<node id="&quot;ASTHMA&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A chronic inflammatory disease of the airways often associated with allergic reactions."&lt;SEP&gt;"A respiratory condition associated with AD, involving episodes of wheezing and breathlessness."&lt;SEP&gt;"A respiratory condition often involving allergic reactions, linked to elevated sOX40L and IgE expression."&lt;SEP&gt;"Asthma is a chronic inflammatory disease of the airways causing respiratory symptoms like wheezing and shortness of breath."&lt;SEP&gt;"Asthma is a chronic inflammatory disease of the airways, characterized by episodes of airflow obstruction."&lt;SEP&gt;"Asthma is a chronic inflammatory disease of the airways."&lt;SEP&gt;"Asthma is a chronic respiratory condition characterized by airway inflammation and bronchoconstriction."&lt;SEP&gt;"Asthma is a chronic respiratory condition often associated with allergic reactions, such as those seen in AD."&lt;SEP&gt;"Asthma is a chronic respiratory disease that is often associated with conditions like AD."&lt;SEP&gt;"Asthma is a common comorbidity associated with atopic dermatitis and involves chronic respiratory inflammation."&lt;SEP&gt;"Asthma is a respiratory condition associated with atopic dermatitis."&lt;SEP&gt;"Asthma is a respiratory condition, used in murine models to study the role of OX40 ligand in Th-2 cell development."&lt;SEP&gt;"Asthma, a condition often associated with atopic dermatitis."&lt;SEP&gt;"Asthma, specifically bronchial asthma, is characterized by inflammation of the airways and is associated with the OX40-OX40L pathway."</data>
  <data key="d2">chunk-076b3b9ec096111e268d9d6a571decfd&lt;SEP&gt;chunk-5523421a7f3eaa630cb13416842f81a5&lt;SEP&gt;chunk-725c3e7fa459b4b8ee95682739cfe06e&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-4cc60d46174dbafbe3376fe5793a500f&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae&lt;SEP&gt;chunk-a1e55c0d3e82798ca6e2849fe54d23ff&lt;SEP&gt;chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b&lt;SEP&gt;chunk-bf0a9d6fcaf06c245c2b80667c7f3261&lt;SEP&gt;chunk-4486b79fa295f4486ae8f31f789db642&lt;SEP&gt;chunk-108cd1073705362b3d684cc095446c30</data>
</node>
<node id="&quot;DNA-REPAIR GENES&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Genes involved in DNA repair play a role in bladder cancer predisposition."</data>
  <data key="d2">chunk-076b3b9ec096111e268d9d6a571decfd</data>
</node>
<node id="&quot;CELL-CYCLE-CONTROL GENES&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Genes involved in cell cycle control are associated with bladder cancer predisposition."</data>
  <data key="d2">chunk-076b3b9ec096111e268d9d6a571decfd</data>
</node>
<node id="&quot;REGULATORY T-CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"T-cells that are regulated by OX40/OX40L interactions, influencing immune response."</data>
  <data key="d2">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</node>
<node id="&quot;MEMORY T-CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"T-cells expanded by OX40/OX40L costimulation, important for immune memory."</data>
  <data key="d2">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</node>
<node id="&quot;B CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"B cells are involved in the immune response, expressing OX40L in conditions like asthma."&lt;SEP&gt;"B cells are involved in the immune response, where they proliferate and differentiate due to OX40 ligand stimulation."&lt;SEP&gt;"Cells influenced by OX40L in persistent alloantibody production."</data>
  <data key="d2">chunk-e6d4cc75e3f259d8ad15f49ab499fddf&lt;SEP&gt;chunk-0901633e83241bf8c1296a2bb24a3099&lt;SEP&gt;chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</node>
<node id="&quot;IL-17&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"IL-17 is a cytokine involved in immune response modulation, negatively regulated by OX40/OX40L interaction."</data>
  <data key="d2">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</node>
<node id="&quot;TNF/NGF CYTOKINE FAMILY&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"A family of cytokines that includes OX40L, involved in immune cell interactions."</data>
  <data key="d2">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</node>
<node id="&quot;SPLENIC B CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"B cells located in the spleen, influenced by cytokines like OX40L for immune response."</data>
  <data key="d2">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</node>
<node id="&quot;ALLOANTIBODY&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Antibodies produced in response to alloantigen exposure, impacted by OX40L on B cells."</data>
  <data key="d2">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</node>
<node id="&quot;PLASMACYTOID DENDRITIC CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"These cells regulate Th cell responses through OX40 ligand and type I IFNs."</data>
  <data key="d2">chunk-e6d4cc75e3f259d8ad15f49ab499fddf</data>
</node>
<node id="&quot;TH CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Th (T helper) cells are regulated by plasmacytoid dendritic cells through interactions with OX40 ligand and type I IFNs."</data>
  <data key="d2">chunk-e6d4cc75e3f259d8ad15f49ab499fddf</data>
</node>
<node id="&quot;AUTOIMMUNE-LIKE DISEASES&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Diseases resembling autoimmune conditions, which may be induced by constitutive OX40/OX40 ligand interaction."</data>
  <data key="d2">chunk-e6d4cc75e3f259d8ad15f49ab499fddf</data>
</node>
<node id="&quot;NOD MICE&quot;">
  <data key="d0">"SPECIES_OR_MODEL"</data>
  <data key="d1">"NOD mice are a model organism used to study diabetes and autoimmune diseases like encephalomyelitis."</data>
  <data key="d2">chunk-7c5f5c049c4de2e225436b011b91505b</data>
</node>
<node id="&quot;DIABETES&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Diabetes is a chronic disease characterized by high blood sugar levels due to poor insulin production."</data>
  <data key="d2">chunk-7c5f5c049c4de2e225436b011b91505b</data>
</node>
<node id="&quot;EAE&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Experimental autoimmune encephalomyelitis is an animal model of brain inflammation and multiple sclerosis."</data>
  <data key="d2">chunk-7c5f5c049c4de2e225436b011b91505b</data>
</node>
<node id="&quot;HLA-DQB1&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"HLA-DQB1 is a gene associated with immune response and linked to anti-topoisomerase I autoantibody response in scleroderma."&lt;SEP&gt;"HLA-DQB1 is a gene known for its association with autoimmune responses and is implicated in diseases like scleroderma."</data>
  <data key="d2">chunk-7c5f5c049c4de2e225436b011b91505b&lt;SEP&gt;chunk-4a79520712d3df44b8051f092fcea618</data>
</node>
<node id="&quot;ANTI-TOPOISOMERASE I AUTOANTIBODY&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"An autoantibody against topoisomerase I, commonly found in scleroderma patients, indicating an autoimmune process."&lt;SEP&gt;"Autoantibodies targeting topoisomerase I, associated with scleroderma, suggesting an autoimmune response."</data>
  <data key="d2">chunk-7c5f5c049c4de2e225436b011b91505b&lt;SEP&gt;chunk-4a79520712d3df44b8051f092fcea618</data>
</node>
<node id="&quot;PROGRESSIVE SYSTEMIC SCLEROSIS (SCLERODERMA)&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Progressive systemic sclerosis, also known as scleroderma, is a connective tissue disease characterized by skin thickening and fibrosis."</data>
  <data key="d2">chunk-4a79520712d3df44b8051f092fcea618</data>
</node>
<node id="&quot;GENE 7292&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"A gene associated with diseases like systemic sclerosis and lupus, relevant for encoding immune-related proteins."</data>
  <data key="d2">chunk-4a79520712d3df44b8051f092fcea618</data>
</node>
<node id="&quot;GENE 100506023&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"A gene associated with systemic sclerosis, contributing to disease pathogenesis and susceptibility."</data>
  <data key="d2">chunk-4a79520712d3df44b8051f092fcea618</data>
</node>
<node id="&quot;AD&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Atopic Dermatitis (AD), characterized by decreased levels of serum sOX40."&lt;SEP&gt;"Atopic Dermatitis, also known as AD, is a chronic inflammatory skin disease."&lt;SEP&gt;"Atopic dermatitis (AD) is a chronic inflammatory skin disease often associated with heightened immune responses."&lt;SEP&gt;"Atopic dermatitis (AD) is a type of eczema and a chronic inflammatory skin condition."&lt;SEP&gt;"Atopic dermatitis (AD) is an inflammatory skin disease."&lt;SEP&gt;"Atopic dermatitis is a chronic inflammatory skin condition affecting adult patients, associated with asthmatic and allergic responses."&lt;SEP&gt;"Atopic dermatitis is a chronic inflammatory skin condition associated with allergic rhinitis and asthma."&lt;SEP&gt;"Atopic dermatitis is a chronic inflammatory skin disease characterized by eczema, intense pruritus, and dry skin."&lt;SEP&gt;"Atopic dermatitis is a chronic inflammatory skin disease, compared with healthy controls in terms of OX40 expression."&lt;SEP&gt;"Atopic dermatitis is a chronic inflammatory skin disease."&lt;SEP&gt;"Atopic dermatitis is a chronic, inflammatory skin condition often linked with increased IgE levels."&lt;SEP&gt;"Atopic dermatitis is a chronic, relapsing inflammatory skin disease associated with asthma and allergic rhinitis."&lt;SEP&gt;"Atopic dermatitis, a chronic inflammatory skin disease associated with atopic comorbidities and characterized by altered OX40 system activity."&lt;SEP&gt;"Atopic dermatitis, a chronic inflammatory skin disease associated with elevated IgE levels."&lt;SEP&gt;"Atopic dermatitis, abbreviated as AD, is a chronic inflammatory skin disease associated with asthma and allergic rhinitis."&lt;SEP&gt;"Atopic dermatitis, abbreviated as AD, is a chronic inflammatory skin disorder."&lt;SEP&gt;"Atopic dermatitis, also referred as AD, is a chronic, relapsing inflammatory skin disease."&lt;SEP&gt;"Atopic dermatitis, also referred to as AD, is a chronic inflammatory skin disease known to be associated with asthma and allergic rhinitis."&lt;SEP&gt;"Atopic dermatitis, also referred to as AD, is a chronic inflammatory skin disease."&lt;SEP&gt;"Atopic dermatitis, also referred to as AD, is a chronic, relapsing inflammatory skin disease associated with asthma and allergic rhinitis."&lt;SEP&gt;"Atopic dermatitis, also referred to as AD, is a skin condition involving inflammation and associated with asthma."&lt;SEP&gt;"Atopic dermatitis, also referred to as AD, is an inflammatory skin disease diagnosed in both children and adults, characterized by decreased serum levels of sOX40."&lt;SEP&gt;"Atopic dermatitis, or AD, is a chronic inflammatory skin condition characterized by heightened inflammatory responses."&lt;SEP&gt;"Atopic dermatitis, referred to as AD, is a chronic, relapsing inflammatory skin disease."</data>
  <data key="d2">chunk-9c36c2978a0bf868f306a82e42a345a9&lt;SEP&gt;chunk-5523421a7f3eaa630cb13416842f81a5&lt;SEP&gt;chunk-afdd4c61cd0aee9cfa4fdd53c26ad339&lt;SEP&gt;chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae&lt;SEP&gt;chunk-6ef6d5065a278b01d19708d678d3b3e2&lt;SEP&gt;chunk-fe3d25355367e23fa84b7e96578f9aeb&lt;SEP&gt;chunk-90301ff694034070e60e3a68b15a982a&lt;SEP&gt;chunk-f17f68c620d56dddb447652de4fee94c&lt;SEP&gt;chunk-dd1abca19a92c3ea17e849ebfe392af1&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-bf0a9d6fcaf06c245c2b80667c7f3261&lt;SEP&gt;chunk-4486b79fa295f4486ae8f31f789db642&lt;SEP&gt;chunk-8a79a32d7c9115e6aa8a38cfe7e0fb8d&lt;SEP&gt;chunk-535005279394e36a8c0e64ebe74fff88&lt;SEP&gt;chunk-108cd1073705362b3d684cc095446c30&lt;SEP&gt;chunk-e9209ae4bd253b98ba9d5d0f58659c20&lt;SEP&gt;chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808</data>
</node>
<node id="&quot;TH2 CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A subset of T-cells that are involved in the immune response, especially in allergic reactions."&lt;SEP&gt;"TH2 cells are a subtype of T cells involved in the adaptive immune response, particularly in conditions like atopic dermatitis."&lt;SEP&gt;"Th2 cells are a type of T helper cell involved in the immune response, implicated in asthma."&lt;SEP&gt;"Th2 cells are a type of T-helper cell dominating atopic dermatitis, with OX40 and OX40L critical for their memory cell generation."&lt;SEP&gt;"Th2 cells dominate in atopic dermatitis, playing a significant role in its pathogenesis."</data>
  <data key="d2">chunk-4cc60d46174dbafbe3376fe5793a500f&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae&lt;SEP&gt;chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-0727a0b1079f66832280de80d4cf2c98&lt;SEP&gt;chunk-3c10f775faa2c2d2c39dc1cd18158a80</data>
</node>
<node id="&quot;CD4+ T CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Activated skin-homing CD4+ T cells express increased levels of OX40 in atopic dermatitis."&lt;SEP&gt;"CD4+ T cells are immune cells whose activation is analyzed in blood samples from patients with AD."&lt;SEP&gt;"CD4+ T cells, particularly those expressing CD45RO and CLA markers, display increased OX40 expression in patients with atopic dermatitis."</data>
  <data key="d2">chunk-801108ac3e166907ed4b5f552b259a53&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae</data>
</node>
<node id="&quot;SOX40&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Soluble OX40, a form of OX40 found in serum, assessed in relation to AD."&lt;SEP&gt;"Soluble OX40, a form of the OX40 receptor detectable in plasma."&lt;SEP&gt;"Soluble OX40, analyzed using an ELISA kit for detecting its levels in serum."&lt;SEP&gt;"Soluble OX40, whose serum levels are altered in atopic dermatitis patients and associated with disease activity."&lt;SEP&gt;"Soluble form of OX40 with anti-inflammatory effects when binding with membrane-bound OX40L."&lt;SEP&gt;"sOX40 is a soluble form of the co-stimulatory T-cell receptor molecule OX40, with decreased serum levels in both adult and child patients with atopic dermatitis."&lt;SEP&gt;"sOX40 is the soluble form of OX40 observed with altered serum levels in AD patients."&lt;SEP&gt;"sOX40 is the soluble form of OX40 with decreased serum levels observed in atopic dermatitis patients."&lt;SEP&gt;"sOX40 is the soluble form of OX40, and its reduced serum levels are associated with AD."&lt;SEP&gt;"sOX40 is the soluble form of the OX40 protein, with decreased serum levels noted in AD patients."&lt;SEP&gt;"sOX40 is the soluble form of the OX40 protein, with observed decreased serum levels in patients with atopic dermatitis."&lt;SEP&gt;"sOX40, or soluble OX40, is a form of the OX40 gene product measured in serum samples."</data>
  <data key="d2">chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-90301ff694034070e60e3a68b15a982a&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae&lt;SEP&gt;chunk-f17f68c620d56dddb447652de4fee94c&lt;SEP&gt;chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-535005279394e36a8c0e64ebe74fff88&lt;SEP&gt;chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</node>
<node id="&quot;DERMIS&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"The dermis is a skin layer where OX40 and OX40L are co-localized in AD patients."&lt;SEP&gt;"The dermis is a skin layer where OX40 and OX40L cells are co-located, indicating local activity in atopic dermatitis."</data>
  <data key="d2">chunk-afdd4c61cd0aee9cfa4fdd53c26ad339&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae</data>
</node>
<node id="&quot;ALLERGIC RHINITIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Allergic rhinitis is an allergic reaction that causes sneezing, runny nose, and other symptoms affecting the nose."&lt;SEP&gt;"Allergic rhinitis is often associated with atopic dermatitis and involves nasal inflammation caused by allergens."&lt;SEP&gt;"Allergic rhinitis, also known as hay fever, is commonly associated with atopic dermatitis."</data>
  <data key="d2">chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae</data>
</node>
<node id="&quot;BLOOD&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"A bodily fluid used to analyze PBMCs and plasma in patients with AD."&lt;SEP&gt;"Blood samples were used to measure soluble OX40 levels and analyze immune cells in atopic dermatitis."</data>
  <data key="d2">chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae</data>
</node>
<node id="&quot;IGE&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"IgE is an antibody measured in the sera of patients, used as a marker in allergy and immunology-related studies."&lt;SEP&gt;"IgE is an immunoglobulin associated with allergic reactions and elevated in certain skin conditions."&lt;SEP&gt;"IgE is an immunoglobulin involved in allergic responses, measured in serum levels for AD patients."&lt;SEP&gt;"IgE is an immunoglobulin linked to allergic responses and is examined in the context of AD."&lt;SEP&gt;"IgE is an immunoglobulin that activates mast cells, playing a role in immediate hypersensitivity reactions and interacting with OX40L."&lt;SEP&gt;"IgE is an immunoglobulin that plays a crucial role in allergic reactions and is often elevated in atopic conditions."&lt;SEP&gt;"IgE is associated with allergic reactions, and its levels correlate with OX40L expression in asthma."&lt;SEP&gt;"IgE levels are elevated in up to 80% of patients with atopic dermatitis (AD), an indicator of allergic response."&lt;SEP&gt;"Immunoglobulin E, abbreviated as IgE, is an antibody associated with allergic conditions and plays a role in allergic reactions."&lt;SEP&gt;"Immunoglobulin E, an antibody involved in allergic reactions and elevated in conditions like atopic dermatitis."</data>
  <data key="d2">chunk-bf0a9d6fcaf06c245c2b80667c7f3261&lt;SEP&gt;chunk-5523421a7f3eaa630cb13416842f81a5&lt;SEP&gt;chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b&lt;SEP&gt;chunk-3c10f775faa2c2d2c39dc1cd18158a80&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-801108ac3e166907ed4b5f552b259a53&lt;SEP&gt;chunk-108cd1073705362b3d684cc095446c30</data>
</node>
<node id="&quot;INFLAMMATORY SKIN DISEASE&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"An inflammatory skin disease that includes symptoms such as pruritus, dry skin, eczema, and skin inflammation."&lt;SEP&gt;"Inflammatory skin disease, such as AD, involves skin inflammation and epidermal barrier dysfunction."&lt;SEP&gt;"Inflammatory skin diseases include conditions like atopic dermatitis, characterized by skin inflammation and hypersensitivity."</data>
  <data key="d2">chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b&lt;SEP&gt;chunk-3c10f775faa2c2d2c39dc1cd18158a80</data>
</node>
<node id="&quot;CHRONIC INFLAMMATION&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Chronic inflammation is a persistent inflammatory response seen in diseases like AD and other atopic conditions."</data>
  <data key="d2">chunk-7b918eaccb40d1d7ef77196819ed077b</data>
</node>
<node id="&quot;ECZEMA&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A condition that makes the skin red, inflamed, and itchy."&lt;SEP&gt;"Eczema is a condition that causes inflamed, itchy, cracked, and rough skin, often associated with AD."&lt;SEP&gt;"Eczema is a significant symptom of atopic dermatitis, leading to itchy, inflamed, and red skin."&lt;SEP&gt;"Eczema is a skin condition linked to atopic dermatitis, characterized by itchy and inflamed patches."&lt;SEP&gt;"Eczema is a skin disease characterized by inflammation and irritation, closely associated with AD."</data>
  <data key="d2">chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-dd1abca19a92c3ea17e849ebfe392af1&lt;SEP&gt;chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b&lt;SEP&gt;chunk-8a79a32d7c9115e6aa8a38cfe7e0fb8d</data>
</node>
<node id="&quot;PRURITUS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"An uncomfortable sensation on the skin that provokes the urge to scratch."&lt;SEP&gt;"Pruritus is an intense itching sensation commonly experienced in patients with atopic dermatitis."</data>
  <data key="d2">chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b</data>
</node>
<node id="&quot;DRY SKIN&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"A condition of skin characterized by a lack of moisture."&lt;SEP&gt;"Dry skin is a frequent symptom in AD patients, exacerbating issues with the epidermal barrier."</data>
  <data key="d2">chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b</data>
</node>
<node id="&quot;T CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Memory T cells are central to the chronicity of AD due to their role in maintaining immune memory and contributing to continued inflammation."&lt;SEP&gt;"T cells are a type of immune cell that interacts with OX40 and mast cells."&lt;SEP&gt;"T cells interact with mast cells through OX40L, participating in the immune response related to AD."&lt;SEP&gt;"T cells, specifically skin-homing types, express OX40 and OX40L in atopic dermatitis."</data>
  <data key="d2">chunk-90301ff694034070e60e3a68b15a982a&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b&lt;SEP&gt;chunk-3c10f775faa2c2d2c39dc1cd18158a80&lt;SEP&gt;chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</node>
<node id="&quot;EPIDERMAL BARRIER DYSFUNCTION&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Epidermal barrier dysfunction is a critical factor in AD, leading to increased skin permeability and sensitivity."</data>
  <data key="d2">chunk-7b918eaccb40d1d7ef77196819ed077b</data>
</node>
<node id="&quot;MEMORY T CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Memory T cells are crucial for the persistence of inflammation in AD, as they retain information about previous immune responses."</data>
  <data key="d2">chunk-7b918eaccb40d1d7ef77196819ed077b</data>
</node>
<node id="&quot;SKIN INFLAMMATION&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Inflammation occurring in the skin, often presenting as redness and swelling."</data>
  <data key="d2">chunk-2785ff077980c1b6099f6312917ba06c</data>
</node>
<node id="&quot;AUTOIMMUNE AND INFLAMMATORY CONDITIONS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Conditions characterized by abnormal immune responses resulting in inflammation."</data>
  <data key="d2">chunk-2785ff077980c1b6099f6312917ba06c</data>
</node>
<node id="&quot;APC&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Antigen-presenting cells, which express OX40L after antigen activation."</data>
  <data key="d2">chunk-2785ff077980c1b6099f6312917ba06c</data>
</node>
<node id="&quot;MAST CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Cells that express OX40L and are involved in the inflammatory response."&lt;SEP&gt;"Cells that play a key role in immune responses, particularly involved in allergic reactions and inflammation in the skin."&lt;SEP&gt;"Mast cells are involved in T cell activation and produce interleukin-25."&lt;SEP&gt;"Mast cells are involved in hypersensitivity reactions and produce TH2 driving cytokines, central to AD pathogenesis."&lt;SEP&gt;"Mast cells play a crucial role in mediating inflammatory responses in the skin of AD patients, interacting with OX40-expressing T cells."</data>
  <data key="d2">chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-4cc60d46174dbafbe3376fe5793a500f&lt;SEP&gt;chunk-3c10f775faa2c2d2c39dc1cd18158a80&lt;SEP&gt;chunk-dd1abca19a92c3ea17e849ebfe392af1</data>
</node>
<node id="&quot;T-CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A type of lymphocyte that plays a central role in cell-mediated immunity and expresses OX40."&lt;SEP&gt;"T-cells are a type of lymphocyte that play a central role in cell-mediated immunity."</data>
  <data key="d2">chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808</data>
</node>
<node id="&quot;ALLERGIC ASTHMA&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A type of asthma triggered by allergens and linked to the OX40-OX40L axis."</data>
  <data key="d2">chunk-2785ff077980c1b6099f6312917ba06c</data>
</node>
<node id="&quot;REGULATORY T-CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A type of T-cell involved in suppressing immune response, which can be mimicked by sOX40."</data>
  <data key="d2">chunk-2785ff077980c1b6099f6312917ba06c</data>
</node>
<node id="&quot;INFLAMMATORY SKIN DISEASES&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Inflammatory skin diseases are characterized by chronic, relapsing skin inflammation with a significant role in atopic dermatitis."</data>
  <data key="d2">chunk-0727a0b1079f66832280de80d4cf2c98</data>
</node>
<node id="&quot;ATOPIC DERMATITIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A chronic inflammatory skin disease improved by anti-OX40 treatment."&lt;SEP&gt;"Atopic dermatitis is a chronic inflammatory skin disease dominated by Th2 cells, with a central role for OX40 and OX40L in its pathogenesis."&lt;SEP&gt;"Atopic dermatitis is an inflammatory skin disease."&lt;SEP&gt;"Atopic dermatitis, abbreviated as AD, is an inflammatory skin disease characterized by chronic or chronically relapsing conditions, often associated with asthma and allergic rhinitis."</data>
  <data key="d2">chunk-801108ac3e166907ed4b5f552b259a53&lt;SEP&gt;chunk-9ff7b47e334d062c5c0cc9daeae082d7&lt;SEP&gt;chunk-4684629b8113b2d7e0d8498ef744b84f&lt;SEP&gt;chunk-0727a0b1079f66832280de80d4cf2c98</data>
</node>
<node id="&quot;MODULE&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"The skin is a tissue where OX40 and OX40L colocalize, crucial for the inflammatory response in atopic dermatitis."</data>
  <data key="d2">chunk-0727a0b1079f66832280de80d4cf2c98</data>
</node>
<node id="&quot;INFLAMMATORY&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Inflammatory reactions occurring in skin conditions like atopic dermatitis, characterized by increased expression of OX40."</data>
  <data key="d2">chunk-0727a0b1079f66832280de80d4cf2c98</data>
</node>
<node id="&quot;TH2 MEMORY CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Memory cells of the Th2 type are critical in the chronicity and pathogenesis of atopic dermatitis, influenced by OX40 and OX40L interactions."</data>
  <data key="d2">chunk-0727a0b1079f66832280de80d4cf2c98</data>
</node>
<node id="&quot;ATOPIC DERMATITIS (AD)&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Atopic Dermatitis is an inflammatory skin disease associated with hypersensitivity and T-cell mediated pathogenesis."</data>
  <data key="d2">chunk-3c10f775faa2c2d2c39dc1cd18158a80</data>
</node>
<node id="&quot;IL-25&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"IL-25 is a cytokine produced by mast cells, driving TH2 responses and influencing AD pathogenesis."</data>
  <data key="d2">chunk-3c10f775faa2c2d2c39dc1cd18158a80</data>
</node>
<node id="&quot;IL-4&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"IL-4 is a cytokine involved in TH2 driving responses in the immune system and AD pathogenesis."</data>
  <data key="d2">chunk-3c10f775faa2c2d2c39dc1cd18158a80</data>
</node>
<node id="&quot;HYPERSENSITIVITY&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Hypersensitivity refers to exaggerated immune responses, including mast cell involvement seen in AD."</data>
  <data key="d2">chunk-3c10f775faa2c2d2c39dc1cd18158a80</data>
</node>
<node id="&quot;TH2 DRIVING CYTOKINES&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"TH2 driving cytokines promote the differentiation and function of TH2 cells, involved in allergic responses and conditions like AD."</data>
  <data key="d2">chunk-3c10f775faa2c2d2c39dc1cd18158a80</data>
</node>
<node id="&quot;SERUM LEVELS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Refers to the concentration of specific proteins, such as sOX40, in the blood serum, which can indicate disease links."&lt;SEP&gt;"Serum levels may indicate the presence and progression of diseases like AD through biomarkers such as soluble OX40."</data>
  <data key="d2">chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-3c10f775faa2c2d2c39dc1cd18158a80</data>
</node>
<node id="&quot;DISEASE-SPECIFIC MARKERS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Disease-specific markers are biomarkers used to diagnose or monitor conditions like AD."</data>
  <data key="d2">chunk-3c10f775faa2c2d2c39dc1cd18158a80</data>
</node>
<node id="&quot;DERMATITIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Dermatitis is a group of diseases that result in inflammation of the skin."</data>
  <data key="d2">chunk-108cd1073705362b3d684cc095446c30</data>
</node>
<node id="&quot;PATIENT&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"Refers to the human biological samples collected for clinical assessment and research in the study."</data>
  <data key="d2">chunk-108cd1073705362b3d684cc095446c30</data>
</node>
<node id="&quot;RHINITIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Allergic reaction causing nasal inflammation, commonly associated with atopic dermatitis and asthma."&lt;SEP&gt;"Rhinitis, also known as rhinitis, is characterized by the inflammation of the nasal membranes."&lt;SEP&gt;"Rhinitis, commonly linked with asthma and atopic dermatitis."</data>
  <data key="d2">chunk-5523421a7f3eaa630cb13416842f81a5&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-108cd1073705362b3d684cc095446c30</data>
</node>
<node id="&quot;SCORAD&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"SCORAD (SCORing Atopic Dermatitis) is a clinical tool used to assess the severity of atopic dermatitis."&lt;SEP&gt;"SCORAD is a clinical tool used to assess the severity of atopic dermatitis based on extent and intensity of symptoms."&lt;SEP&gt;"SCORing Atopic Dermatitis index, a clinical tool used to assess the severity of atopic dermatitis."&lt;SEP&gt;"Scoring Atopic Dermatitis index used to assess the severity of atopic dermatitis symptoms."</data>
  <data key="d2">chunk-5523421a7f3eaa630cb13416842f81a5&lt;SEP&gt;chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-108cd1073705362b3d684cc095446c30&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0</data>
</node>
<node id="&quot;HEALTHY CONTROL (HC)&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Control group consisting of healthy individuals used for comparison in atopic dermatitis studies."&lt;SEP&gt;"Refers to individuals without a history of atopic dermatitis or other systemic inflammatory diseases, used as a comparison group in the study."</data>
  <data key="d2">chunk-535005279394e36a8c0e64ebe74fff88&lt;SEP&gt;chunk-108cd1073705362b3d684cc095446c30</data>
</node>
<node id="&quot;SYSTEMIC INFLAMMATORY DISEASES&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A group of diseases characterized by systemic inflammation."&lt;SEP&gt;"Wider category of diseases comprising conditions like atopic dermatitis."</data>
  <data key="d2">chunk-5523421a7f3eaa630cb13416842f81a5&lt;SEP&gt;chunk-e0a177dbb0ea12fd8552823bfb451b34</data>
</node>
<node id="&quot;TISSUE&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"Affected regions in individuals with atopic dermatitis, typically including skin."</data>
  <data key="d2">chunk-5523421a7f3eaa630cb13416842f81a5</data>
</node>
<node id="&quot;SERUM&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"Serum, a component of blood, is used in biochemical measurements such as sOX40 level determination."</data>
  <data key="d2">chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07</data>
</node>
<node id="&quot;PBMCS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Peripheral Blood Mononuclear Cells analyzed for OX40 and OX40L expression."&lt;SEP&gt;"Peripheral blood mononuclear cells used to examine OX40 and OX40L expression in atopic dermatitis research."&lt;SEP&gt;"Peripheral blood mononuclear cells, used for analyzing immune responses."</data>
  <data key="d2">chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-90301ff694034070e60e3a68b15a982a&lt;SEP&gt;chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</node>
<node id="&quot;ATOPIC DISEASES&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A group of immunological disorders including allergies."&lt;SEP&gt;"Atopic diseases are a group of diseases characterized by atopic sensitization and include conditions like atopic dermatitis."</data>
  <data key="d2">chunk-8a79a32d7c9115e6aa8a38cfe7e0fb8d&lt;SEP&gt;chunk-e0a177dbb0ea12fd8552823bfb451b34</data>
</node>
<node id="&quot;PLASMA&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"Plasma is the liquid component of blood that can contain various proteins and antibodies."&lt;SEP&gt;"The liquid component of blood, analyzed for soluble proteins like sOX40."</data>
  <data key="d2">chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-725c3e7fa459b4b8ee95682739cfe06e</data>
</node>
<node id="&quot;FICOLL-PAQUE&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"A reagent used for density gradient centrifugation to isolate PBMCs."</data>
  <data key="d2">chunk-e0a177dbb0ea12fd8552823bfb451b34</data>
</node>
<node id="&quot;SOX40L&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Soluble OX40L, the soluble form of the OX40L ligand found in plasma."&lt;SEP&gt;"Soluble OX40L, with its detection and quantification performed through ELISA."&lt;SEP&gt;"sOX40L is a soluble form of OX40 that has elevated levels in patients with allergic asthma."&lt;SEP&gt;"sOX40L is a soluble form of OX40L, measured in patients but not differing significantly between patient groups."&lt;SEP&gt;"sOX40L is the soluble form of OX40L, measured alongside sOX40 in the context of AD."</data>
  <data key="d2">chunk-bf0a9d6fcaf06c245c2b80667c7f3261&lt;SEP&gt;chunk-f17f68c620d56dddb447652de4fee94c&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</node>
<node id="&quot;HC&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"HC is potentially referring to a control group or healthy subjects in the study context."&lt;SEP&gt;"HC, or Healthy Controls, refers to individuals without the disease being studied, used for comparison."&lt;SEP&gt;"Healthy adult volunteers used as a control group in atopic dermatitis studies."&lt;SEP&gt;"Healthy control subjects for comparative studies with AD."&lt;SEP&gt;"Healthy controls (HC) used for comparison in atopic dermatitis studies."&lt;SEP&gt;"Healthy controls, individuals without atopic dermatitis used for comparison in clinical studies."</data>
  <data key="d2">chunk-9c36c2978a0bf868f306a82e42a345a9&lt;SEP&gt;chunk-f17f68c620d56dddb447652de4fee94c&lt;SEP&gt;chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808&lt;SEP&gt;chunk-fe3d25355367e23fa84b7e96578f9aeb&lt;SEP&gt;chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</node>
<node id="&quot;BIOPSIES&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"Tissue samples collected from AD and control subjects for analysis."</data>
  <data key="d2">chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</node>
<node id="&quot;PARAFFIN&quot;">
  <data key="d0">"CHEMICAL"</data>
  <data key="d1">"Paraffin used for embedding biopsies collected from patients with AD."</data>
  <data key="d2">chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</node>
<node id="&quot;ELISA&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Enzyme-linked immunosorbent assay used to detect and quantify soluble proteins sOX40 and sOX40L."</data>
  <data key="d2">chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</node>
<node id="&quot;FLOW CYTOMETRY&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"A technique used to analyze the expression of proteins OX40 and OX40L on cell surfaces."</data>
  <data key="d2">chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</node>
<node id="&quot;CD4&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"CD4 is a gene expressed on T cells, involved in immune signaling and response."&lt;SEP&gt;"CD4 is a gene that plays a crucial role in the immune system, specifically in the development and function of T cells."&lt;SEP&gt;"CD4 is a glycoprotein expressed on the surface of immune cells like T helper cells, monocytes, macrophages, and dendritic cells. It plays a significant role in T-cell activation."&lt;SEP&gt;"CD4 is a glycoprotein expressed on the surface of immune cells such as T-helper cells, playing a role in AD."&lt;SEP&gt;"CD4 is a glycoprotein expressed on the surface of immune cells, particularly marked in subsets of T cells involved in immune response."&lt;SEP&gt;"CD4 is a glycoprotein found on the surface of immune cells, playing a role in immune signaling."&lt;SEP&gt;"CD4 is a molecule expressed on T-lymphocytes that assists in the immune response."&lt;SEP&gt;"CD4 is a molecule on T cells involved in immune signaling and is upregulated in skin-homing T cells in patients with AD."</data>
  <data key="d2">chunk-4684629b8113b2d7e0d8498ef744b84f&lt;SEP&gt;chunk-dd1abca19a92c3ea17e849ebfe392af1&lt;SEP&gt;chunk-a1e55c0d3e82798ca6e2849fe54d23ff&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-6ef6d5065a278b01d19708d678d3b3e2&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-fe3d25355367e23fa84b7e96578f9aeb</data>
</node>
<node id="&quot;CD8&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"CD8 is a co-receptor on T cells, primarily known for its role in recognizing antigens presented by MHC class I molecules."&lt;SEP&gt;"CD8 is a gene encoding a protein found on cytotoxic T cells and is involved in immune responses."&lt;SEP&gt;"CD8 is a gene expressed on a subset of T cells, important for cellular immune responses."&lt;SEP&gt;"CD8 is a molecule present on cytotoxic T cells that aids in the immune response."&lt;SEP&gt;"CD8 is a protein found on the surface of immune cells, involved in destroying infected or cancerous cells."</data>
  <data key="d2">chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-6ef6d5065a278b01d19708d678d3b3e2&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0</data>
</node>
<node id="&quot;CD14&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"CD14 is a co-receptor for the detection of bacterial lipopolysaccharide."</data>
  <data key="d2">chunk-97051cd2977e518296858a149f2a7808</data>
</node>
<node id="&quot;CD45RO&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"CD45RO is a gene encoding a memory isoform of the leukocyte common antigen, involved in T-cell activation."&lt;SEP&gt;"CD45RO is a marker on T cells indicative of memory cell status and is associated with increased expression in atopic dermatitis."&lt;SEP&gt;"CD45RO is an isoform of CD45, involved in the activation of T-cell receptor signaling pathways."&lt;SEP&gt;"CD45RO is an isoform of the CD45 gene, involved in the regulation of T-cell and other immune cell functions."&lt;SEP&gt;"CD45RO is an isoform of the CD45 protein expressed on memory T cells and is involved in the immune response."&lt;SEP&gt;"CD45RO is an isoform of the CD45 protein found on the surface of memory T cells."&lt;SEP&gt;"CD45RO is an isoform of the CD45 protein, typically expressed on memory T cells."&lt;SEP&gt;"CD45RO is an isoform of the protein tyrosine phosphatase receptor type C, expressed on memory T cells and involved in signaling."</data>
  <data key="d2">chunk-ad6451630cadf61d3fe3c4b59f09d5c2&lt;SEP&gt;chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-6ef6d5065a278b01d19708d678d3b3e2&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-801108ac3e166907ed4b5f552b259a53&lt;SEP&gt;chunk-fe3d25355367e23fa84b7e96578f9aeb</data>
</node>
<node id="&quot;CD56&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"CD56 is a gene encoding a neural cell adhesion molecule, important for cell adhesion processes."&lt;SEP&gt;"CD56 is a marker for natural killer (NK) cells and is used in identifying specific immune cell populations."</data>
  <data key="d2">chunk-ad6451630cadf61d3fe3c4b59f09d5c2&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808</data>
</node>
<node id="&quot;CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Cells were stained and analyzed in experiments using flow cytometry."</data>
  <data key="d2">chunk-97051cd2977e518296858a149f2a7808</data>
</node>
<node id="&quot;BSA&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Bovine serum albumin is used in laboratory experiments as a stabilizing agent or protein concentration standard."</data>
  <data key="d2">chunk-97051cd2977e518296858a149f2a7808</data>
</node>
<node id="&quot;CLA&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"CLA is a cutaneous lymphocyte antigen present on T cells, involved in skin homing."&lt;SEP&gt;"CLA is a marker for skin-homing T cells and helps in understanding T-cell migration to skin."&lt;SEP&gt;"CLA or Cutaneous Lymphocyte-associated Antigen is a homing receptor found on T cells, guiding them to skin tissues."&lt;SEP&gt;"CLA refers to cutaneous lymphocyte antigen, involved in the homing of T cells to the skin."&lt;SEP&gt;"CLA refers to cutaneous lymphocyte-associated antigen, involved in skin homing of T-cells."&lt;SEP&gt;"Cutaneous Lymphocyte-associated Antigen, or CLA, is a molecule expressed on T cells facilitating skin-homing in inflammation like atopic dermatitis."&lt;SEP&gt;"Cutaneous lymphocyte-associated antigen, a protein expressed on T cells involved in skin-homing activities."</data>
  <data key="d2">chunk-ad6451630cadf61d3fe3c4b59f09d5c2&lt;SEP&gt;chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808&lt;SEP&gt;chunk-6ef6d5065a278b01d19708d678d3b3e2&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-801108ac3e166907ed4b5f552b259a53&lt;SEP&gt;chunk-fe3d25355367e23fa84b7e96578f9aeb</data>
</node>
<node id="&quot;PBS&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"PBS (Phosphate Buffered Saline) is a buffer solution used in biological research."&lt;SEP&gt;"Phosphate-buffered saline is a buffer solution used in biological research."</data>
  <data key="d2">chunk-ad6451630cadf61d3fe3c4b59f09d5c2&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808</data>
</node>
<node id="&quot;FORMALDEHYDE&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Formaldehyde is used to fix cells in preparation for analysis in flow cytometry."</data>
  <data key="d2">chunk-97051cd2977e518296858a149f2a7808</data>
</node>
<node id="&quot;IGG&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"IgG antibodies are immune proteins that can interfere with assay results in arthritis patients by causing false positives."&lt;SEP&gt;"Immunoglobulin G is an antibody used experimentally to block unspecific binding."</data>
  <data key="d2">chunk-725c3e7fa459b4b8ee95682739cfe06e&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808</data>
</node>
<node id="&quot;FLOWJO SOFTWARE&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"FlowJo Software is used for analysis of flow cytometry data."</data>
  <data key="d2">chunk-97051cd2977e518296858a149f2a7808</data>
</node>
<node id="&quot;LSR FORTESSA&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"LSR Fortessa is a type of flow cytometer used for analyzing cell characteristics."</data>
  <data key="d2">chunk-97051cd2977e518296858a149f2a7808</data>
</node>
<node id="&quot;UCHL1&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"UCHL1 (Ubiquitin C-terminal Hydrolase L1) is a gene encoding a protein playing a crucial role in ubiquitin-mediated protein degradation."</data>
  <data key="d2">chunk-ad6451630cadf61d3fe3c4b59f09d5c2</data>
</node>
<node id="&quot;CAT&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Cat refers to a gene associated with the homology 55514, mentioned multiple times."</data>
  <data key="d2">chunk-ad6451630cadf61d3fe3c4b59f09d5c2</data>
</node>
<node id="&quot;CY7&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Cy7 is a near-infrared fluorescent dye used in molecular imaging techniques."</data>
  <data key="d2">chunk-ad6451630cadf61d3fe3c4b59f09d5c2</data>
</node>
<node id="&quot;BV510&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"BV510 is a fluorescent dye used in flow cytometry assays."</data>
  <data key="d2">chunk-ad6451630cadf61d3fe3c4b59f09d5c2</data>
</node>
<node id="&quot;TRYPTASE&quot;">
  <data key="d0">"PROTIEN"</data>
  <data key="d1">"Tryptase is a marker used to confirm the presence of mast cells in immunofluorescence studies."&lt;SEP&gt;"Tryptase is a protease enzyme involved in immune and inflammatory processes, targeted by antibodies in studies."&lt;SEP&gt;"Tryptase is a protein specifically targeted by monoclonal rabbit antibodies in the setup."&lt;SEP&gt;"Tryptase is an enzyme found in mast cells and can be used to identify these cells in skin tissue."</data>
  <data key="d2">chunk-4486b79fa295f4486ae8f31f789db642&lt;SEP&gt;chunk-9c36c2978a0bf868f306a82e42a345a9&lt;SEP&gt;chunk-afdd4c61cd0aee9cfa4fdd53c26ad339&lt;SEP&gt;chunk-ac36f1e468a863c1ae0527829717bfcf</data>
</node>
<node id="&quot;DONKEY SERUM&quot;">
  <data key="d0">"PROTIEN"</data>
  <data key="d1">"A blocking agent used in immunological assays."</data>
  <data key="d2">chunk-9c36c2978a0bf868f306a82e42a345a9</data>
</node>
<node id="&quot;DAPI&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"DAPI is a fluorescent stain that binds strongly to A-T rich regions in DNA, used for cell imaging."</data>
  <data key="d2">chunk-ac36f1e468a863c1ae0527829717bfcf</data>
</node>
<node id="&quot;ALEXA 488&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Alexa 488 is a fluorescent dye used for labeling proteins, commonly used in microscopy."</data>
  <data key="d2">chunk-ac36f1e468a863c1ae0527829717bfcf</data>
</node>
<node id="&quot;ALEXA 647&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Alexa 647 is a fluorescent dye used to label antibodies for visualization in microscopy."</data>
  <data key="d2">chunk-ac36f1e468a863c1ae0527829717bfcf</data>
</node>
<node id="&quot;MOUSE IGG1&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Mouse IgG1 is an isotype control antibody used in experiments to ensure specificity of antibody binding."</data>
  <data key="d2">chunk-ac36f1e468a863c1ae0527829717bfcf</data>
</node>
<node id="&quot;MOUNTING MEDIUM&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Mounting Medium is a substance used to affix histological sections to slides for microscopic examination."</data>
  <data key="d2">chunk-ac36f1e468a863c1ae0527829717bfcf</data>
</node>
<node id="&quot;OXL40&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"OXL40 is the ligand for the OX40 T-cell receptor, involved in T-cell costimulation and immune modulation."</data>
  <data key="d2">chunk-f17f68c620d56dddb447652de4fee94c</data>
</node>
<node id="&quot;ASHTMA&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A respiratory condition often comorbid with AD, characterized by airway inflammation and difficulty breathing."</data>
  <data key="d2">chunk-90301ff694034070e60e3a68b15a982a</data>
</node>
<node id="&quot;ATOPIC DISEASE&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Atopic disease encompasses conditions like AD and asthma, characterized by hypersensitive reactions."</data>
  <data key="d2">chunk-90301ff694034070e60e3a68b15a982a</data>
</node>
<node id="&quot;CLA+ T CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Memory-prone skin-homing T cells that express OX40 in atopic dermatitis patients."</data>
  <data key="d2">chunk-90301ff694034070e60e3a68b15a982a</data>
</node>
<node id="&quot;CD4+CD45RO+CLA+ T CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A subset of T cells in AD patients that predominantly express OX40, involved in immune response regulation."</data>
  <data key="d2">chunk-fe3d25355367e23fa84b7e96578f9aeb</data>
</node>
<node id="&quot;CD4+CD45RO+CLA- T CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A subset of T cells in AD patients with lower OX40 expression."</data>
  <data key="d2">chunk-fe3d25355367e23fa84b7e96578f9aeb</data>
</node>
<node id="&quot;CD8+CD45RO+CLA+ T CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A subset of T cells in AD patients with less pronounced OX40 expression compared to CD4+ counterparts."</data>
  <data key="d2">chunk-fe3d25355367e23fa84b7e96578f9aeb</data>
</node>
<node id="&quot;CD8+CD45RO+CLA- T CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A subset of T cells in AD patients characterized by minimal OX40 expression."</data>
  <data key="d2">chunk-fe3d25355367e23fa84b7e96578f9aeb</data>
</node>
<node id="&quot;MONOCYTES&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Monocytes are a type of immune cell that express high levels of OX40L, involved in mediating immune responses."&lt;SEP&gt;"Monocytes are a type of white blood cell that expresses OX40L, important in immune response."&lt;SEP&gt;"Monocytes are immune cells expressing OX40L, involved in presenting antigens and inflammatory reactions."</data>
  <data key="d2">chunk-801108ac3e166907ed4b5f552b259a53&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0</data>
</node>
<node id="&quot;CD8+ T CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"CD8+ T cells engage in cytotoxic activity and also show variable levels of OX40 expression in atopic dermatitis."</data>
  <data key="d2">chunk-801108ac3e166907ed4b5f552b259a53</data>
</node>
<node id="&quot;MEDIAN FLUORESCENCE INTENSITY&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Median Fluorescence Intensity (MFI) is a metric used to quantify protein expression levels, such as OX40 on T cells, in flow cytometry."</data>
  <data key="d2">chunk-801108ac3e166907ed4b5f552b259a53</data>
</node>
<node id="&quot;MFI&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Mean Fluorescence Intensity, used as an indicator of protein expression levels in cells."</data>
  <data key="d2">chunk-6fc49187b0de760cbc909d68cc6a21f0</data>
</node>
<node id="&quot;CD4+ CD45RO+ CLA+ T CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A subset of T cells characterized by the expression of OX40, associated with atopic dermatitis."</data>
  <data key="d2">chunk-535005279394e36a8c0e64ebe74fff88</data>
</node>
<node id="&quot;MONOCYTE&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A type of white blood cell that expresses OX40L and plays a role in immune response."&lt;SEP&gt;"Monocytes primarily express the OX40 ligand (OX40L) in patients with atopic dermatitis."</data>
  <data key="d2">chunk-6ef6d5065a278b01d19708d678d3b3e2&lt;SEP&gt;chunk-535005279394e36a8c0e64ebe74fff88</data>
</node>
<node id="&quot;CD4+CD45RO+ T CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A subset of T cells expressing CD4 and the CD45RO isoform."</data>
  <data key="d2">chunk-6ef6d5065a278b01d19708d678d3b3e2</data>
</node>
<node id="&quot;CD8+CD45RO+ T CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"A subset of T cells expressing CD8 and the CD45RO isoform."</data>
  <data key="d2">chunk-6ef6d5065a278b01d19708d678d3b3e2</data>
</node>
<node id="&quot;MAST CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Mast cells are a type of immune cell identified by co-expression of OX40L and tryptase in the dermis of AD patients."&lt;SEP&gt;"Mast cells in the skin express OX40L and have been confirmed by tryptase staining."&lt;SEP&gt;"The mast cells are immune cells in the dermis that are identified in AD by OX40L and tryptase co-expression."</data>
  <data key="d2">chunk-4486b79fa295f4486ae8f31f789db642&lt;SEP&gt;chunk-afdd4c61cd0aee9cfa4fdd53c26ad339</data>
</node>
<node id="&quot;ATOPIC COMORBIDITIES&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Atopic comorbidities refer to diseases that commonly co-occur with atopic dermatitis, such as allergic rhinitis and asthma."</data>
  <data key="d2">chunk-e4a9d1698278391ab0182f138d50f659</data>
</node>
<node id="&quot;CHILDREN&quot;">
  <data key="d0">"SPECIES_OR_MODEL"</data>
  <data key="d1">"Refers to young humans involved in the study of serum levels of sOX40 and AD."</data>
  <data key="d2">chunk-e4a9d1698278391ab0182f138d50f659</data>
</node>
<node id="&quot;ADULTS&quot;">
  <data key="d0">"SPECIES_OR_MODEL"</data>
  <data key="d1">"Refers to mature humans involved in the study of serum levels of sOX40 and AD."</data>
  <data key="d2">chunk-e4a9d1698278391ab0182f138d50f659</data>
</node>
<node id="&quot;TNF&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"TNF (Tumor Necrosis Factor) is a gene involved in inflammatory and immune responses."&lt;SEP&gt;"TNF is a part of the TNF-super family that includes OX40 proteins and is involved in immune signaling."</data>
  <data key="d2">chunk-4684629b8113b2d7e0d8498ef744b84f&lt;SEP&gt;chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</node>
<node id="&quot;ALLERGIC REACTION&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"A response triggered by elevated OX40L and IgE in conditions such as asthma."</data>
  <data key="d2">chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</node>
<node id="&quot;LUNG&quot;">
  <data key="d0">"TISSUE"</data>
  <data key="d1">"The lung tissue is involved in the immune response during allergic reactions in asthma models."</data>
  <data key="d2">chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</node>
<node id="&quot;HEALTHY VOLUNTEERS&quot;">
  <data key="d0">"SPECIES"</data>
  <data key="d1">"Control group in research studies used for comparison with AD and asthma patients."</data>
  <data key="d2">chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</node>
<node id="&quot;AD WITH ASTHMA&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A condition where individuals have both atopic dermatitis and asthma, often showing altered levels of serum proteins."</data>
  <data key="d2">chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</node>
<node id="&quot;EASI&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"The Eczema Area and Severity Index (EASI) score is used to measure the severity of eczema, a symptom relevant to AD."</data>
  <data key="d2">chunk-dd1abca19a92c3ea17e849ebfe392af1</data>
</node>
<node id="&quot;BIOMARKERS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Biomarkers in AD include proteins and other molecules that indicate disease activity and response to treatment."</data>
  <data key="d2">chunk-dd1abca19a92c3ea17e849ebfe392af1</data>
</node>
<node id="&quot;SKIN THICKNESS&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Increased skin thickness is a symptom of AD, often linked to inflammation and fibrosis."</data>
  <data key="d2">chunk-dd1abca19a92c3ea17e849ebfe392af1</data>
</node>
<node id="&quot;INFLAMMATORY REACTION&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Inflammatory reactions in the skin often occur in conditions such as atopic dermatitis."</data>
  <data key="d2">chunk-8a79a32d7c9115e6aa8a38cfe7e0fb8d</data>
</node>
<node id="&quot;BCL-XL&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Bcl-xL is a protein that is promoted by OX40 and plays a role in cell survival."</data>
  <data key="d2">chunk-4684629b8113b2d7e0d8498ef744b84f</data>
</node>
<node id="&quot;BCL-2&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Bcl-2 is a protein whose expression is promoted by OX40, contributing to cell survival."</data>
  <data key="d2">chunk-4684629b8113b2d7e0d8498ef744b84f</data>
</node>
<node id="&quot;CD4 T CELL&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"CD4 T cells are a type of immune cell that are essential for adaptive immunity and are affected by OX40."</data>
  <data key="d2">chunk-4684629b8113b2d7e0d8498ef744b84f</data>
</node>
<node id="&quot;LDL RECEPTOR&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"The LDL receptor is involved in the regulation of cholesterol levels by mediating the endocytosis of cholesterol-rich LDLs."</data>
  <data key="d2">chunk-a1e55c0d3e82798ca6e2849fe54d23ff</data>
</node>
<node id="&quot;TNFR&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"TNFR, or tumor necrosis factor receptor, is a receptor that binds tumor necrosis factors and plays a role in signaling pathways related to inflammation and apoptosis."</data>
  <data key="d2">chunk-a1e55c0d3e82798ca6e2849fe54d23ff</data>
</node>
<node id="&quot;SOLUBLE OX40L&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Soluble OX40L is a form of OX40 ligand that can be measured to assess the presence of autoantibodies in diseases like rheumatoid arthritis."</data>
  <data key="d2">chunk-a1e55c0d3e82798ca6e2849fe54d23ff</data>
</node>
<node id="&quot;INTERLEUKIN-25&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"Interleukin-25 is produced by mast cells upon activation."</data>
  <data key="d2">chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</node>
<node id="&quot;FC EPSILON RECEPTOR I (FCRI)&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"FcRI is a high-affinity receptor for the Fc region of immunoglobulin E, important for activating mast cells."</data>
  <data key="d2">chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</node>
<node id="&quot;HUMAN TONSILLAR MAST CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Human tonsillar mast cells are a type of mast cell found in the tonsils, used for comparative studies on gene expression."</data>
  <data key="d2">chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</node>
<node id="&quot;LUNG-CULTURED MAST CELLS&quot;">
  <data key="d0">"CELL"</data>
  <data key="d1">"Lung-cultured mast cells are derived from human lung tissues and used for studying the interaction of mast cells with T cells."</data>
  <data key="d2">chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</node>
<node id="&quot;ARTHRITIS&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"Arthritis is an inflammatory disease affecting joints, leading to pain and stiffness."</data>
  <data key="d2">chunk-725c3e7fa459b4b8ee95682739cfe06e</data>
</node>
<node id="&quot;GBR 830&quot;">
  <data key="d0">"PROTEIN"</data>
  <data key="d1">"An anti-OX40 protein that improves skin gene signatures and clinical scores in patients with atopic dermatitis."</data>
  <data key="d2">chunk-9ff7b47e334d062c5c0cc9daeae082d7</data>
</node>
<node id="&quot;J ALLERGY CLIN IMMUNOL&quot;">
  <data key="d0">"SOURCE"</data>
  <data key="d1">"A scientific journal where the study on GBR 830 and atopic dermatitis was published."</data>
  <data key="d2">chunk-9ff7b47e334d062c5c0cc9daeae082d7</data>
</node>
<node id="&quot;CLINICAL SCORES&quot;">
  <data key="d0">"SYMPTOM"</data>
  <data key="d1">"Indicators of disease severity in atopic dermatitis, improved by GBR 830."</data>
  <data key="d2">chunk-9ff7b47e334d062c5c0cc9daeae082d7</data>
</node>
<node id="&quot;GENE SIGNATURES&quot;">
  <data key="d0">"GENE"</data>
  <data key="d1">"Markers of gene expression profiles in the skin of atopic dermatitis patients, enhanced by GBR 830 treatment."</data>
  <data key="d2">chunk-9ff7b47e334d062c5c0cc9daeae082d7</data>
</node>
<node id="&quot;INN&quot;">
  <data key="d0">"DISEASE"</data>
  <data key="d1">"A vein within the document metadata, indicating details or references."</data>
  <data key="d2">chunk-9ff7b47e334d062c5c0cc9daeae082d7</data>
</node>
<node id="&quot;GENDER AND CONTROLS&quot;">
  <data key="d2">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
  <data key="d1">"N is used to specify the number of samples or individuals in gender and control groups within research data."</data>
  <data key="d0">"UNKNOWN"</data>
</node>
<node id="&quot;CUTANOUS INVOLVEMENT&quot;">
  <data key="d2">chunk-e785e8a37b35cb99202b04012deed634</data>
  <data key="d1">"Cutaneous involvement is a defining characteristic of systemic sclerosis."</data>
  <data key="d0">"UNKNOWN"</data>
</node>
<node id="&quot;RS1234214&quot;">
  <data key="d2">chunk-210e345ac292a0c3ccf4c2c84f6ad8b3</data>
  <data key="d1">"SNP rs1234214 is significantly associated with ACA-positive and ATA-positive SSc patients"</data>
  <data key="d0">"UNKNOWN"</data>
</node>
<node id="&quot;RS2004640&quot;">
  <data key="d2">chunk-5d3273222cddef8cb212284d98ad6ea3</data>
  <data key="d1">"IRF5 gene polymorphism rs2004640 is associated with systemic sclerosis and pulmonary fibrosis."</data>
  <data key="d0">"UNKNOWN"</data>
</node>
<node id="&quot;OX40/OX40L&quot;">
  <data key="d2">chunk-0901633e83241bf8c1296a2bb24a3099</data>
  <data key="d1">"IL-17 production is negatively regulated by the interaction between OX40 and OX40L."</data>
  <data key="d0">"UNKNOWN"</data>
</node>
<node id="&quot;OX40/OX40 LIGAND&quot;">
  <data key="d2">chunk-e6d4cc75e3f259d8ad15f49ab499fddf</data>
  <data key="d1">"Constitutive interaction between OX40 and OX40 ligand can induce autoimmune-like diseases."</data>
  <data key="d0">"UNKNOWN"</data>
</node>
<node id="&quot;OX40-OX40L AXIS&quot;">
  <data key="d2">chunk-2785ff077980c1b6099f6312917ba06c</data>
  <data key="d1">"The OX40-OX40L axis is implicated in the development of allergic asthma."</data>
  <data key="d0">"UNKNOWN"</data>
</node>
<node id="&quot;CD4+CD45RO+OX40+ T CELLS&quot;">
  <data key="d2">chunk-6fc49187b0de760cbc909d68cc6a21f0</data>
  <data key="d1">"The percentage of CD4+CD45RO+OX40+ T cells inversely correlates with SCORAD, indicating disease activity in AD"</data>
  <data key="d0">"UNKNOWN"</data>
</node>
<node id="&quot;CLA T CELLS&quot;">
  <data key="d2">chunk-6fc49187b0de760cbc909d68cc6a21f0</data>
  <data key="d1">"CLA T cells' expression correlates with SCORAD, indicating disease activity in AD"</data>
  <data key="d0">"UNKNOWN"</data>
</node>
<node id="&quot;OX40-OX40L&quot;">
  <data key="d2">chunk-dd1abca19a92c3ea17e849ebfe392af1</data>
  <data key="d1">"Interaction of OX40 with its ligand OX40L plays a role in the inflammatory skin condition AD."</data>
  <data key="d0">"UNKNOWN"</data>
</node>
<edge source="&quot;TNFSF4/OX40L&quot;" target="&quot;SYSTEMIC SCLEROSIS (SSC)&quot;">
  <data key="d3">18.0</data>
  <data key="d4">"TNFSF4/OX40L polymorphisms are associated with susceptibility to systemic sclerosis."</data>
  <data key="d5">"genetic susceptibility, association, polymorphisms"</data>
  <data key="d6">chunk-cd1ab204b4a907f594ee95c28910787a</data>
</edge>
<edge source="&quot;TNFSF4/OX40L&quot;" target="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"TNFSF4/OX40L is identified as a susceptibility gene for the development of systemic lupus erythematosus."</data>
  <data key="d5">"genetic susceptibility, SLE association"</data>
  <data key="d6">chunk-cd1ab204b4a907f594ee95c28910787a</data>
</edge>
<edge source="&quot;TNFSF4/OX40L&quot;" target="&quot;T CELL&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"TNFSF4/OX40L encodes the OX40 ligand, which is a T cell costimulatory molecule, indicating its role in T cell activation and proliferation."</data>
  <data key="d5">"T cell costimulation, immune response"</data>
  <data key="d6">chunk-cd1ab204b4a907f594ee95c28910787a</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS (SSC)&quot;" target="&quot;FIBROSIS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Systemic sclerosis leads to the development of cutaneous and visceral fibrosis as a key pathogenic feature."</data>
  <data key="d5">"fibrosis development, pathogenesis, autoimmune condition"</data>
  <data key="d6">chunk-cd1ab204b4a907f594ee95c28910787a</data>
</edge>
<edge source="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)&quot;" target="&quot;PTPN22&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"PTPN22 polymorphism is associated with systemic lupus erythematosus."</data>
  <data key="d5">"autoimmune association"</data>
  <data key="d6">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</edge>
<edge source="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)&quot;" target="&quot;STAT4&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"STAT4 gene is associated with systemic lupus erythematosus risk."</data>
  <data key="d5">"genetic risk"</data>
  <data key="d6">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</edge>
<edge source="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)&quot;" target="&quot;AUTOIMMUNE DISEASES&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"SLE is a type of autoimmune disease where the immune system attacks its tissues."</data>
  <data key="d5">"disease classification"</data>
  <data key="d6">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</edge>
<edge source="&quot;FIBROSIS&quot;" target="&quot;SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">18.0</data>
  <data key="d4">"Systemic sclerosis causes fibrosis of skin and internal organs."&lt;SEP&gt;"Systemic sclerosis is characterized by fibrosis of the skin and internal organs."</data>
  <data key="d5">"disease characteristic"&lt;SEP&gt;"disease symptom"</data>
  <data key="d6">chunk-ca51be81b7248c4c4ca5fd0218eb755d&lt;SEP&gt;chunk-b267f7459d573ed53adff3f27835bd72</data>
</edge>
<edge source="&quot;T CELL&quot;" target="&quot;OX40L&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"OX40L provides a costimulatory signal on T cells resulting in proliferation and cytokine production."</data>
  <data key="d5">9</data>
  <data key="d6">chunk-8cc4d94318a6e7beedefc58596376892</data>
</edge>
<edge source="&quot;AUTOIMMUNE DISEASES&quot;" target="&quot;TNFSF4&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"TNFSF4 is considered a shared gene among multiple autoimmune diseases, including SSc and SLE."&lt;SEP&gt;"TNFSF4 may confer risk to multiple autoimmune diseases, suggesting a broader genetic susceptibility."</data>
  <data key="d5">"broad genetic risk factor"&lt;SEP&gt;"shared genetics, immune response"</data>
  <data key="d6">chunk-d3f80deee592fd8d98f9795daf2b98ca&lt;SEP&gt;chunk-f40d75c218dbbd371d3444666f5fa395</data>
</edge>
<edge source="&quot;AUTOIMMUNE DISEASES&quot;" target="&quot;PTPN22&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"PTPN22 is linked to multiple autoimmune diseases, indicating shared genetic risk factors."</data>
  <data key="d5">"shared genetic risk"</data>
  <data key="d6">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</edge>
<edge source="&quot;AUTOIMMUNE DISEASES&quot;" target="&quot;STAT4&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"STAT4 is a susceptibility gene implicated in autoimmune diseases like SLE and RA, showing common pathways and risk factors."</data>
  <data key="d5">"genetic susceptibility"</data>
  <data key="d6">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</edge>
<edge source="&quot;AUTOIMMUNE DISEASES&quot;" target="&quot;POLYMORPHISMS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Genetic polymorphisms contribute to the susceptibility and development of various autoimmune diseases."</data>
  <data key="d5">"genetic risk factor"</data>
  <data key="d6">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</edge>
<edge source="&quot;AUTOIMMUNE DISEASES&quot;" target="&quot;SSC&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Systemic sclerosis is one of multiple autoimmune diseases with complex immunopathogenesis."</data>
  <data key="d5">"immunopathogenesis, disease group"</data>
  <data key="d6">chunk-d3f80deee592fd8d98f9795daf2b98ca</data>
</edge>
<edge source="&quot;AUTOIMMUNE DISEASES&quot;" target="&quot;SLE&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"SLE is an autoimmune disease that might share genes with other diseases like systemic sclerosis."</data>
  <data key="d5">"shared genetics, disease association"</data>
  <data key="d6">chunk-d3f80deee592fd8d98f9795daf2b98ca</data>
</edge>
<edge source="&quot;AUTOIMMUNE DISEASES&quot;" target="&quot;1858C/T&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"The 1858C/T polymorphism in PTPN22 contributes to several autoimmune diseases."</data>
  <data key="d5">"genetic variant contribution"</data>
  <data key="d6">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;TNFSF4&quot;">
  <data key="d3">17.0</data>
  <data key="d4">"OX40L is encoded by the TNFSF4 gene."&lt;SEP&gt;"TNFSF4 gene encodes the OX40L protein."</data>
  <data key="d5">"gene encoding"&lt;SEP&gt;8</data>
  <data key="d6">chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;DENDRITIC CELL&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40L is expressed on dendritic cells as part of the immune response."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-8cc4d94318a6e7beedefc58596376892</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;MACROPHAGE&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40L is expressed on macrophages as part of the immune response."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-8cc4d94318a6e7beedefc58596376892</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;B CELL&quot;">
  <data key="d3">15.0</data>
  <data key="d4">"OX40L interactions are critical in B cell differentiation and antibody production."&lt;SEP&gt;"OX40L is expressed on B cells which are involved in antibody production."</data>
  <data key="d5">"differentiation, antibody production"&lt;SEP&gt;7</data>
  <data key="d6">chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;NK CELL&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40L is expressed on natural killer cells, which play a role in immunity."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-8cc4d94318a6e7beedefc58596376892</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;ENDOTHELIAL CELL&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40L is expressed on endothelial cells which make up the lining of blood vessels."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-8cc4d94318a6e7beedefc58596376892</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;SMOOTH MUSCLE CELL&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40L is expressed on smooth muscle cells found in various organs."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-8cc4d94318a6e7beedefc58596376892</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;OX40&quot;">
  <data key="d3">165.0</data>
  <data key="d4">"OX40 and OX40L are co-localized and interact within the skin of atopic dermatitis patients, playing a central role in disease pathogenesis."&lt;SEP&gt;"OX40 and OX40L are proteins targeted for staining in the study using monoclonal antibodies."&lt;SEP&gt;"OX40 and OX40L engage in interaction pivotal for T cell costimulation, especially relevant in AD."&lt;SEP&gt;"OX40 and OX40L interact as a T-cell receptor and ligand pair, crucial for Th2 memory cell generation in atopic dermatitis."&lt;SEP&gt;"OX40 and OX40L interact in costimulatory pathways to promote T-cell proliferation in models of asthma."&lt;SEP&gt;"OX40 and OX40L interact in immune response mechanisms involving T-cells."&lt;SEP&gt;"OX40 and OX40L interact to mediate T-cell costimulation in atopic dermatitis."&lt;SEP&gt;"OX40 and OX40L interaction mediates co-stimulatory signals essential for T-cell response modulation."&lt;SEP&gt;"OX40 binds with its ligand OX40L to regulate immune response and facilitate T-cell activation."&lt;SEP&gt;"OX40 interacts with OX40L to mediate immune cell interplay, crucial in AD pathogenesis."&lt;SEP&gt;"OX40 interacts with OX40L to regulate IL-17 production and T-cell responses."&lt;SEP&gt;"OX40 interacts with its ligand OX40L to enhance T-cell activation and survival."&lt;SEP&gt;"OX40 is the receptor on T cells for the OX40 ligand, facilitating immune signaling."&lt;SEP&gt;"OX40L interacts with OX40 as part of the T-cell receptor-ligand pair crucial for immunological studies."&lt;SEP&gt;"OX40L is the ligand for OX40 and plays a crucial role in T-cell activation and survival in AD."&lt;SEP&gt;"OX40L is the ligand for OX40, providing a costimulatory signal to T cells."&lt;SEP&gt;"OX40L serves as the ligand for the OX40 receptor, mediating immune cell interactions."&lt;SEP&gt;"The interaction between OX40 and OX40 ligand is crucial for T-cell-mediated immunity, affecting various diseases and conditions such as rheumatoid arthritis and bronchial asthma."</data>
  <data key="d5">"Costimulation"&lt;SEP&gt;"T-cell costimulation"&lt;SEP&gt;"T-cell costimulation, pathogenesis, OX40 system"&lt;SEP&gt;"T-cell interaction, immune response, co-stimulation"&lt;SEP&gt;"binding, immune regulation"&lt;SEP&gt;"co-localization, T-cell costimulation"&lt;SEP&gt;"costimulation, T-cell activation"&lt;SEP&gt;"costimulation, immune regulation"&lt;SEP&gt;"costimulatory interaction, T-cell proliferation, asthma"&lt;SEP&gt;"immune interaction, AD pathway"&lt;SEP&gt;"immune response modulation, inflammatory mediation"&lt;SEP&gt;"immune response, T-cell interaction, costimulatory pathways"&lt;SEP&gt;"immune response, receptor-ligand interaction"&lt;SEP&gt;"immune signaling"&lt;SEP&gt;"ligand-receptor interaction, immune response"&lt;SEP&gt;7&lt;SEP&gt;8</data>
  <data key="d6">chunk-9c36c2978a0bf868f306a82e42a345a9&lt;SEP&gt;chunk-ac36f1e468a863c1ae0527829717bfcf&lt;SEP&gt;chunk-ad6451630cadf61d3fe3c4b59f09d5c2&lt;SEP&gt;chunk-afdd4c61cd0aee9cfa4fdd53c26ad339&lt;SEP&gt;chunk-725c3e7fa459b4b8ee95682739cfe06e&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae&lt;SEP&gt;chunk-a1e55c0d3e82798ca6e2849fe54d23ff&lt;SEP&gt;chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-97051cd2977e518296858a149f2a7808&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-0727a0b1079f66832280de80d4cf2c98&lt;SEP&gt;chunk-3c10f775faa2c2d2c39dc1cd18158a80&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892&lt;SEP&gt;chunk-801108ac3e166907ed4b5f552b259a53&lt;SEP&gt;chunk-1d58826a27e5d4fa79e478dc1995650f&lt;SEP&gt;chunk-65c249408dc8af0e13c451e05d8d1d7a&lt;SEP&gt;chunk-0901633e83241bf8c1296a2bb24a3099</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;INTERLEUKIN 17&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"OX40-OX40L interaction may negatively regulate interleukin 17 production."</data>
  <data key="d5">"immune modulation"</data>
  <data key="d6">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;FOXP3+ REGULATORY T CELL&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40-OX40L interaction inhibits the formation of these regulatory T cells."</data>
  <data key="d5">"regulation, inhibition"</data>
  <data key="d6">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;TYPE I INTERFERON&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40L with type I interferon induces a Th1 response."</data>
  <data key="d5">"immune modulation"</data>
  <data key="d6">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;FOXP3&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"OX40L may be involved in immune regulation pathways where Foxp3 is also a key player."</data>
  <data key="d5">"immune regulation, interaction, pathway involvement"</data>
  <data key="d6">chunk-1d58826a27e5d4fa79e478dc1995650f</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;B CELLS&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"B cells express OX40L, a crucial component in allergic asthma and immune response."&lt;SEP&gt;"OX40L influences proliferation and differentiation in murine splenic B cells."</data>
  <data key="d5">"Proliferation, differentiation"&lt;SEP&gt;8</data>
  <data key="d6">chunk-0901633e83241bf8c1296a2bb24a3099&lt;SEP&gt;chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;TNF/NGF CYTOKINE FAMILY&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40L is a member of the TNF/NGF cytokine family, influencing immune cell functions."</data>
  <data key="d5">"Cytokine family member"</data>
  <data key="d6">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;SPLENIC B CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40L induces proliferation and differentiation in splenic B cells."</data>
  <data key="d5">"B cell activation"</data>
  <data key="d6">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;ALLOANTIBODY&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40L on B cells supports persistent alloantibody production after alloimmunisation."</data>
  <data key="d5">"Antibody production"</data>
  <data key="d6">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;APC&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40L is expressed by antigen-presenting cells after antigen activation."</data>
  <data key="d5">"expression, antigen activation"</data>
  <data key="d6">chunk-2785ff077980c1b6099f6312917ba06c</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;MAST CELLS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40L is also expressed by mast cells, playing a role in the inflammatory response."</data>
  <data key="d5">"expression, inflammation"</data>
  <data key="d6">chunk-2785ff077980c1b6099f6312917ba06c</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;SOX40&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"sOX40 binds to membrane-bound OX40L mimicking regulatory T-cell function and inhibiting mast cell degranulation."</data>
  <data key="d5">"binding, regulation"</data>
  <data key="d6">chunk-2785ff077980c1b6099f6312917ba06c</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;REGULATORY T-CELL&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"sOX40 mimics regulatory T-cell function when binding to membrane-bound OX40L, showing anti-inflammatory effects."</data>
  <data key="d5">"regulation, mimicry"</data>
  <data key="d6">chunk-2785ff077980c1b6099f6312917ba06c</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;T-CELL&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40L on antigen-presenting cells and mast cells interacts with T-cells via OX40."</data>
  <data key="d5">"interaction, signaling"</data>
  <data key="d6">chunk-2785ff077980c1b6099f6312917ba06c</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;ATOPIC DERMATITIS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40L plays a central role in the pathogenesis and chronicity of atopic dermatitis, involved in the inflammatory response."</data>
  <data key="d5">"disease pathogenesis, costimulatory role"</data>
  <data key="d6">chunk-0727a0b1079f66832280de80d4cf2c98</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;IGE&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"IgE-activated mast cells interact with T cells through OX40L, indicating complex immune cell interplay in AD."&lt;SEP&gt;"Increased OX40L expression on B cells is associated with the level of total IgE in allergic asthma."</data>
  <data key="d5">"immune mediation, cellular interaction"&lt;SEP&gt;8</data>
  <data key="d6">chunk-3c10f775faa2c2d2c39dc1cd18158a80&lt;SEP&gt;chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;AD&quot;">
  <data key="d3">32.0</data>
  <data key="d4">"OX40L is expressed in PBMCs from AD patients, indicating its involvement in disease pathogenesis."&lt;SEP&gt;"OX40L is expressed in the skin of patients with atopic dermatitis, highlighting its role in the disease progression."&lt;SEP&gt;"OX40L-positive cells are found in AD-affected skin, suggesting its involvement in the disease process."</data>
  <data key="d5">"T-cell costimulation, immune pathway"&lt;SEP&gt;"disease progression, pathogenesis"&lt;SEP&gt;"immune response"</data>
  <data key="d6">chunk-4486b79fa295f4486ae8f31f789db642&lt;SEP&gt;chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-afdd4c61cd0aee9cfa4fdd53c26ad339</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;SOX40L&quot;">
  <data key="d3">14.0</data>
  <data key="d4">"sOX40L is the detectable soluble form of OX40L present in serum."&lt;SEP&gt;"sOX40L is the soluble form of OX40L present in plasma."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;FLOW CYTOMETRY&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Flow cytometry was used to evaluate the surface expression of OX40L on PBMCs."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;TRYPTASE&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"The study setup included antibodies targeting tryptase and OX40L for comparative studies."</data>
  <data key="d5">6</data>
  <data key="d6">chunk-9c36c2978a0bf868f306a82e42a345a9</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;T CELLS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"OX40L expression is involved in the immunological mechanisms of atopic dermatitis through its interaction with T cells."</data>
  <data key="d5">"immunological pathways, protein interaction"</data>
  <data key="d6">chunk-90301ff694034070e60e3a68b15a982a</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;MONOCYTES&quot;">
  <data key="d3">20.0</data>
  <data key="d4">"Monocytes express OX40L, contributing to T-cell costimulation and involvement in AD pathology"&lt;SEP&gt;"Monocytes express high levels of OX40L, suggesting their involvement in immunological interactions and responses."</data>
  <data key="d5">"immune cell involvement, OX40L expression"&lt;SEP&gt;6</data>
  <data key="d6">chunk-801108ac3e166907ed4b5f552b259a53&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;MONOCYTE&quot;">
  <data key="d3">14.0</data>
  <data key="d4">"OX40L is expressed on monocytes but shows no difference in levels between AD patients and healthy controls."&lt;SEP&gt;"OX40L is expressed primarily by monocytes in patients with atopic dermatitis."</data>
  <data key="d5">"expressions, immune signal, disease comparison"&lt;SEP&gt;8</data>
  <data key="d6">chunk-6ef6d5065a278b01d19708d678d3b3e2&lt;SEP&gt;chunk-535005279394e36a8c0e64ebe74fff88</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;SKIN&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40L expression is observed in the skin of AD patients, indicating its contribution to the disease."</data>
  <data key="d5">"cellular expression"</data>
  <data key="d6">chunk-afdd4c61cd0aee9cfa4fdd53c26ad339</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;TNF&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"TNF proteins, including OX40L, play a role in immune response and inflammation in conditions like asthma."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;MAST CELL&quot;">
  <data key="d3">14.0</data>
  <data key="d4">"OX40L co-expressed with tryptase identifies mast cells in the dermis of AD patients."</data>
  <data key="d5">"cell activation"</data>
  <data key="d6">chunk-4486b79fa295f4486ae8f31f789db642</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;ASTHMA&quot;">
  <data key="d3">15.0</data>
  <data key="d4">"OX40L acts as an inflammatory mediator in bronchial asthma, indicating its role in exacerbating airway inflammation."&lt;SEP&gt;"OX40L levels could be a biomarker for the severity and persistence of asthma, reflecting the immune status of patients."</data>
  <data key="d5">"biomarker, immune status, chronic inflammation"&lt;SEP&gt;"inflammatory pathway, airway inflammation"</data>
  <data key="d6">chunk-725c3e7fa459b4b8ee95682739cfe06e&lt;SEP&gt;chunk-a1e55c0d3e82798ca6e2849fe54d23ff</data>
</edge>
<edge source="&quot;OX40L&quot;" target="&quot;RHEUMATOID ARTHRITIS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Soluble OX40L is associated with the presence of autoantibodies in early rheumatoid arthritis, suggesting its involvement in disease progression."</data>
  <data key="d5">"autoantibody presence, disease progression"</data>
  <data key="d6">chunk-a1e55c0d3e82798ca6e2849fe54d23ff</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;SLE&quot;">
  <data key="d3">49.0</data>
  <data key="d4">"Polymorphisms in the TNFSF4 gene confer susceptibility to systemic lupus erythematosus."&lt;SEP&gt;"TNFSF4 SNPs previously shown association with SLE susceptibility."&lt;SEP&gt;"TNFSF4 has been associated with SLE in previous studies."&lt;SEP&gt;"TNFSF4 is identified as a susceptibility gene for systemic lupus erythematosus."&lt;SEP&gt;"TNFSF4 polymorphisms are linked to susceptibility in systemic lupus erythematosus."_ |_"genetic association, susceptibility"&lt;SEP&gt;"The TNFSF4 gene is associated with susceptibility to systemic lupus erythematosus."</data>
  <data key="d5">"gene-disease association"&lt;SEP&gt;"genetic association, susceptibility"&lt;SEP&gt;"genetic linkage, disease pattern"&lt;SEP&gt;"genetic susceptibility"&lt;SEP&gt;8&lt;SEP&gt;9</data>
  <data key="d6">chunk-ff6038a6a2d79f1e763ca1f367a21f51&lt;SEP&gt;chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-4e90f51a9fd956d75a15a68bb461dbf0&lt;SEP&gt;chunk-dfad4826c0b7e6a17d2e0d647d8df903&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;SSC&quot;">
  <data key="d3">105.0</data>
  <data key="d4">"Polymorphisms in TNFSF4 are associated with systemic sclerosis susceptibility."_ |_"genetic association, susceptibility"&lt;SEP&gt;"Polymorphisms in TNFSF4 gene region are associated with systemic sclerosis susceptibility."&lt;SEP&gt;"Polymorphisms in the TNFSF4 gene region are associated with susceptibility to systemic sclerosis."&lt;SEP&gt;"Polymorphisms in the TNFSF4 gene region are associated with systemic sclerosis susceptibility."&lt;SEP&gt;"TNFSF4 SNPs are used as predictors in statistical models for systemic sclerosis outcomes."&lt;SEP&gt;"TNFSF4 genetic polymorphisms are associated with systemic sclerosis and its clinical subsets."&lt;SEP&gt;"TNFSF4 has been associated with susceptibility to systemic sclerosis."&lt;SEP&gt;"TNFSF4 is a gene associated with susceptibility to systemic sclerosis."&lt;SEP&gt;"TNFSF4 polymorphisms are associated with systemic sclerosis and its clinical subsets"&lt;SEP&gt;"TNFSF4 polymorphisms show a significant association with susceptibility to systemic sclerosis."&lt;SEP&gt;"TNFSF4 polymorphisms show a significant association with systemic sclerosis susceptibility."&lt;SEP&gt;"The TNFSF4 gene and its SNPs are linked to systemic sclerosis susceptibility."&lt;SEP&gt;"The TNFSF4 gene region demonstrates an association with SSc susceptibility."</data>
  <data key="d5">"association, disease linkage, polymorphism"&lt;SEP&gt;"gene-disease association"&lt;SEP&gt;"genetic association"&lt;SEP&gt;"genetic association, autoimmune disease"&lt;SEP&gt;"genetic association, susceptibility"&lt;SEP&gt;"genetic susceptibility, disease association"&lt;SEP&gt;"susceptibility, pathogenesis"&lt;SEP&gt;7&lt;SEP&gt;8</data>
  <data key="d6">chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-e785e8a37b35cb99202b04012deed634&lt;SEP&gt;chunk-6bbb8cd576c317bbe3ed9df3629a08e0&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-d3f80deee592fd8d98f9795daf2b98ca&lt;SEP&gt;chunk-f40d75c218dbbd371d3444666f5fa395&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892&lt;SEP&gt;chunk-88b78ed0abef17d11ffa6aefaa201bcd&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-dfad4826c0b7e6a17d2e0d647d8df903&lt;SEP&gt;chunk-eeb39a2fa5676c3abaaa455a6c7075ba&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;RS2205960&quot;">
  <data key="d3">82.0</data>
  <data key="d4">"SNP in TNFSF4 gene linked to systemic sclerosis susceptibility."&lt;SEP&gt;"SNP rs2205960 is a minor allele of the TNFSF4 gene observed in limited systemic sclerosis."&lt;SEP&gt;"TNFSF4 and snp rs2205960 are linked in the susceptibility of systemic sclerosis."&lt;SEP&gt;"TNFSF4 gene region contains the snp rs2205960 linked to SSc."&lt;SEP&gt;"The TNFSF4 gene is associated with single nucleotide polymorphism rs2205960, which is linked to systemic sclerosis."&lt;SEP&gt;"The interaction between TNFSF4 gene region and SNP rs2205960 increases susceptibility to systemic sclerosis, particularly in women with certain genotypes."&lt;SEP&gt;"rs2205960 is a SNP within the TNFSF4 gene region associated with SSc susceptibility."&lt;SEP&gt;"rs2205960 is a SNP within the TNFSF4 gene, associated with systemic sclerosis susceptibility."&lt;SEP&gt;"rs2205960 is another minor allele of the TNFSF4 gene connected to limited systemic sclerosis."</data>
  <data key="d5">"SNP association, systemic sclerosis"&lt;SEP&gt;"genetic association"&lt;SEP&gt;"genetic association, SNP interaction"&lt;SEP&gt;"genetic association, SNP"&lt;SEP&gt;"genetic association, autoimmune disease"&lt;SEP&gt;"genetic susceptibility, autoimmune condition"&lt;SEP&gt;"genetic variation, disease association"&lt;SEP&gt;8</data>
  <data key="d6">chunk-22c95d151784bab494732266d8aaf873&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892&lt;SEP&gt;chunk-c2823bcad3d01b2fb4bdef5f8aa96865&lt;SEP&gt;chunk-72875ba549df0c7c1e9bd9550ffbe3a8&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7&lt;SEP&gt;chunk-dfad4826c0b7e6a17d2e0d647d8df903&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7&lt;SEP&gt;chunk-eeb39a2fa5676c3abaaa455a6c7075ba</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;RS844648&quot;">
  <data key="d3">23.0</data>
  <data key="d4">"A SNP in TNFSF4 showing an association with systemic sclerosis susceptibility."&lt;SEP&gt;"TNFSF4 and snp rs844648 are linked in the susceptibility of systemic sclerosis."&lt;SEP&gt;"The SNP rs844648 in the TNFSF4 gene region is part of the analysis for systemic sclerosis risk."</data>
  <data key="d5">"gene association, SNP analysis"&lt;SEP&gt;"genetic association"&lt;SEP&gt;"genetic association, SNP"</data>
  <data key="d6">chunk-c6704e5262862d28c2ad0880a79393a7&lt;SEP&gt;chunk-72875ba549df0c7c1e9bd9550ffbe3a8&lt;SEP&gt;chunk-eeb39a2fa5676c3abaaa455a6c7075ba</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;RS1234314&quot;">
  <data key="d3">46.0</data>
  <data key="d4">"SNP rs1234314 is a minor allele of the TNFSF4 gene associated with limited systemic sclerosis."&lt;SEP&gt;"TNFSF4 gene comprises SNPs such as rs1234314 implicated in SSc."&lt;SEP&gt;"rs1234314 is a SNP within the TNFSF4 gene, potentially affecting genetic susceptibility."&lt;SEP&gt;"rs1234314 is a minor allele of the TNFSF4 gene, linked to limited systemic sclerosis."&lt;SEP&gt;"rs1234314 is associated with the TNFSF4 gene region in relation to SSc susceptibility."</data>
  <data key="d5">"SNP association, genetic susceptibility"&lt;SEP&gt;"genetic association"&lt;SEP&gt;"genetic association, autoimmune condition"&lt;SEP&gt;"genetic association, autoimmune disease"&lt;SEP&gt;"genetic susceptibility, SNP"</data>
  <data key="d6">chunk-c6704e5262862d28c2ad0880a79393a7&lt;SEP&gt;chunk-eeb39a2fa5676c3abaaa455a6c7075ba&lt;SEP&gt;chunk-c2823bcad3d01b2fb4bdef5f8aa96865&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;POLYMORPHISMS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Polymorphisms in the TNFSF4 gene region are associated with disease susceptibility."</data>
  <data key="d5">"genetic variation association"</data>
  <data key="d6">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;ATHEROSCLEROSIS&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"Polymorphisms in TNFSF4 are associated with atherosclerosis."&lt;SEP&gt;"Positional identification of TNFSF4 influences atherosclerosis susceptibility."</data>
  <data key="d5">"genetic risk"&lt;SEP&gt;8</data>
  <data key="d6">chunk-b267f7459d573ed53adff3f27835bd72&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS)&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Different SNPs in the TNFSF4 gene are studied for their role in autoimmune diseases like SLE."</data>
  <data key="d5">"genetic variation, autoimmune susceptibility"</data>
  <data key="d6">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;RS10912580&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"rs10912580 is a SNP within the TNFSF4 gene region studied for SSc susceptibility."</data>
  <data key="d5">"genetic variation, disease association"</data>
  <data key="d6">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;CAUCASIAN&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"The study involved Caucasian individuals to explore TNFSF4 genetic variations associated with SSc."</data>
  <data key="d5">"population study, genetic research"</data>
  <data key="d6">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;CANDIDATE GENE ASSOCIATION STUDY&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Conducted to explore the imprint of TNFSF4 variations in systemic sclerosis beyond previous ties to SLE."</data>
  <data key="d5">"genetic comparison, disease association"</data>
  <data key="d6">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;LD&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Linkage disequilibrium calculated for TNFSF4 SNPs in the study population."</data>
  <data key="d5">"genetic linkage, disease study"</data>
  <data key="d6">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;RS844665&quot;">
  <data key="d3">12.0</data>
  <data key="d4">"rs844665 is a SNP within the TNFSF4 gene, associated with the pathogenesis of systemic sclerosis."</data>
  <data key="d5">"SNP association, disease pathogenesis"</data>
  <data key="d6">chunk-c2823bcad3d01b2fb4bdef5f8aa96865</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;RS844644&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"SNP rs844644 is observed in studies on the TNFSF4 gene and systemic sclerosis."</data>
  <data key="d5">"genetic variation, autoimmune disease"</data>
  <data key="d6">chunk-1f1d798adb899eb19d8a9c24ad7f0bb7</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;RS855648&quot;">
  <data key="d3">23.0</data>
  <data key="d4">"SNP rs855648 in the TNFSF4 gene is associated with increased systemic sclerosis risk in specific genotypes."&lt;SEP&gt;"TNFSF4 gene region contains the snp rs855648 linked to SSc."&lt;SEP&gt;"The TNFSF4 gene is associated with single nucleotide polymorphism rs855648, which is linked to systemic sclerosis."</data>
  <data key="d5">"genetic association"&lt;SEP&gt;"genetic association, susceptibility"&lt;SEP&gt;8</data>
  <data key="d6">chunk-72875ba549df0c7c1e9bd9550ffbe3a8&lt;SEP&gt;chunk-22c95d151784bab494732266d8aaf873&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;RS944648&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"The TNFSF4 gene is associated with single nucleotide polymorphism rs944648, which is linked to systemic sclerosis."</data>
  <data key="d5">"genetic association"</data>
  <data key="d6">chunk-22c95d151784bab494732266d8aaf873</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;AUTOIMMUNE DISEASE&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"TNFSF4 gene is considered for its role across multiple autoimmune diseases including SLE and SSc."</data>
  <data key="d5">"genetic association, cross-disease"</data>
  <data key="d6">chunk-6bbb8cd576c317bbe3ed9df3629a08e0</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;SNP&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"SNPs within TNFSF4 are identified as factors in the pathogenesis of systemic sclerosis."</data>
  <data key="d5">"genetic variation, disease pathogenesis"</data>
  <data key="d6">chunk-d3f80deee592fd8d98f9795daf2b98ca</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;PATHOGENESIS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"TNFSF4 plays a role in the pathogenesis of systemic sclerosis and other autoimmune diseases."</data>
  <data key="d5">"disease development, gene involvement"</data>
  <data key="d6">chunk-d3f80deee592fd8d98f9795daf2b98ca</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;ATHEROTHROMBOSIS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Genetic variants of TNFSF4 increase the risk of atherothrombosis."</data>
  <data key="d5">"genetic risk"</data>
  <data key="d6">chunk-4e90f51a9fd956d75a15a68bb461dbf0</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;VENOUS THROMBOEMBOLISM&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"TNFSF4 genetic variants are linked to a higher risk of venous thromboembolism."</data>
  <data key="d5">"genetic risk"</data>
  <data key="d6">chunk-4e90f51a9fd956d75a15a68bb461dbf0</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;BANK1&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Both TNFSF4 and BANK1 have been associated with systemic lupus erythematosus, suggesting a potential interaction or co-involvement in the disease pathogenesis."</data>
  <data key="d5">"genetic association"</data>
  <data key="d6">chunk-4e90f51a9fd956d75a15a68bb461dbf0</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;STAT4&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Both TNFSF4 and STAT4 are genes implicated in autoimmune response regulation, potentially influencing susceptibility to conditions like SLE."</data>
  <data key="d5">"autoimmunity"</data>
  <data key="d6">chunk-4e90f51a9fd956d75a15a68bb461dbf0</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;OX40 LIGAND&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"TNFSF4 encodes the OX40 ligand, an important factor in immune response modulation."</data>
  <data key="d5">"gene-protein encoding"</data>
  <data key="d6">chunk-b267f7459d573ed53adff3f27835bd72</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;CAROTID ARTERY DISEASE&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Genetic variants of TNFSF4 are linked with increased risk for carotid artery disease."</data>
  <data key="d5">"genetic risk"</data>
  <data key="d6">chunk-b267f7459d573ed53adff3f27835bd72</data>
</edge>
<edge source="&quot;TNFSF4&quot;" target="&quot;STROKE&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Genetic variants of TNFSF4 are associated with an increased risk of stroke."</data>
  <data key="d5">"genetic risk"</data>
  <data key="d6">chunk-b267f7459d573ed53adff3f27835bd72</data>
</edge>
<edge source="&quot;SLE&quot;" target="&quot;PTPN22&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"PTPN22 is associated with the development of systemic lupus erythematosus."</data>
  <data key="d5">"gene-disease association"</data>
  <data key="d6">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</edge>
<edge source="&quot;SLE&quot;" target="&quot;STAT4&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"STAT4 is a susceptibility gene linked to systemic lupus erythematosus."</data>
  <data key="d5">"gene-disease association"</data>
  <data key="d6">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</edge>
<edge source="&quot;SLE&quot;" target="&quot;SSC&quot;">
  <data key="d3">31.0</data>
  <data key="d4">"Common alterations in immune function and related genes are present between SLE and SSc."_ |_"autoimmune relationship, immune function"&lt;SEP&gt;"Patients with systemic sclerosis were excluded if they met criteria for SLE, indicating separate autoimmune pathologies."&lt;SEP&gt;"SSC and SLE share common immune alterations and a pattern of upregulation of type I interferon associated gene transcripts."&lt;SEP&gt;"Systemic sclerosis and systemic lupus erythematosus share common immune alterations and genetic polymorphisms."</data>
  <data key="d5">"Differential diagnosis"&lt;SEP&gt;"immune alterations, type I interferon, gene polymorphisms"&lt;SEP&gt;7&lt;SEP&gt;9</data>
  <data key="d6">chunk-b8c59e84703c3508fdcaea1e0f1d798b&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-ff6038a6a2d79f1e763ca1f367a21f51&lt;SEP&gt;chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</edge>
<edge source="&quot;SLE&quot;" target="&quot;RNA POLYMERASE III&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"RNA polymerase III is a critical target for autoantibodies in the context of systemic sclerosis that may overlap in symptomatology with SLE."</data>
  <data key="d5">"autoimmune diseases, overlapping symptoms"</data>
  <data key="d6">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</edge>
<edge source="&quot;SLE&quot;" target="&quot;RS2205960&quot;">
  <data key="d3">5.0</data>
  <data key="d4">"SNP rs2205960 has potential associations with systemic lupus erythematosus."</data>
  <data key="d5">5</data>
  <data key="d6">chunk-d177121ee3e32d25172682ac2df0f91b</data>
</edge>
<edge source="&quot;SLE&quot;" target="&quot;IRF5&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"IRF5 gene exhibits functional variants that define risk and protective haplotypes for lupus."</data>
  <data key="d5">"genetic risk, haplotypes, autoimmune regulation"</data>
  <data key="d6">chunk-5d3273222cddef8cb212284d98ad6ea3</data>
</edge>
<edge source="&quot;SLE&quot;" target="&quot;PERIPHERAL BLOOD CELLS&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Interferon-inducible gene expression signature observed in peripheral blood cells of SLE patients."</data>
  <data key="d5">"immune response, gene expression signature"</data>
  <data key="d6">chunk-5d3273222cddef8cb212284d98ad6ea3</data>
</edge>
<edge source="&quot;SLE&quot;" target="&quot;FAS&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"The FAS gene promoter polymorphism is associated with anti-RNP antibodies in SLE"</data>
  <data key="d5">8</data>
  <data key="d6">chunk-bc41401afd8fbd1a0e1739441ffe8577</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;CUTANEOUS AND VISCERAL FIBROSIS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"SSc is characterized by fibrosis of the skin and internal organs."</data>
  <data key="d5">"disease symptom"</data>
  <data key="d6">chunk-d548e9ff6c14d77f5815c38f5bb0c54f</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RS1234314&quot;">
  <data key="d3">61.0</data>
  <data key="d4">"Rs1234314 is one of the SNPs analyzed for systemic sclerosis susceptibility."&lt;SEP&gt;"SNP RS1234314 is linked with altered genetic predisposition towards systemic sclerosis."&lt;SEP&gt;"SNP rs1234314 is linked to increased risk of systemic sclerosis."&lt;SEP&gt;"SNP rs1234314 is significantly associated with susceptibility to systemic sclerosis."&lt;SEP&gt;"SNP rs1234314 shows an association with systemic sclerosis, indicating a potential genetic contribution to the disease."&lt;SEP&gt;"The SNP rs1234314 shows a certain percentage presence among patients with systemic sclerosis compared to controls, indicating potential susceptibility or risk factor for the disease."&lt;SEP&gt;"The minor allele of SNP rs1234314 is associated with a higher risk of systemic sclerosis."&lt;SEP&gt;"rs1234314 is associated with systemic sclerosis"</data>
  <data key="d5">"SNP, systemic sclerosis, susceptibility"&lt;SEP&gt;"genetic predisposition"&lt;SEP&gt;"genetic risk, autoimmune disease"&lt;SEP&gt;"risk factor, genetic association"&lt;SEP&gt;"snp association, disease linkage"&lt;SEP&gt;"snp-disease association"&lt;SEP&gt;6&lt;SEP&gt;7</data>
  <data key="d6">chunk-457c8cc26a6098970ec760d84c398a2a&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-5603d604754b1f5919bd4f70c43da7c8&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-c3d25dc1bb5909ac0c6c506368f54f42&lt;SEP&gt;chunk-88b78ed0abef17d11ffa6aefaa201bcd&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RS2205960&quot;">
  <data key="d3">107.0</data>
  <data key="d4">"RS2205960 is associated with systemic sclerosis susceptibility."&lt;SEP&gt;"RS2205960 shows significant allele frequency differences in systemic sclerosis patients, indicating its potential involvement."&lt;SEP&gt;"Rs2205960 is one of the SNPs analyzed for systemic sclerosis susceptibility."&lt;SEP&gt;"SNP rs2205960 is linked with studies in systemic sclerosis."&lt;SEP&gt;"SNP rs2205960 is more frequent in ATA-positive SSc patients compared to controls"&lt;SEP&gt;"SNP rs2205960 is observed more frequently in systemic sclerosis patients."&lt;SEP&gt;"SNP rs2205960 is significantly associated with susceptibility to systemic sclerosis."&lt;SEP&gt;"Single nucleotide polymorphism rs2205960 is associated with systemic sclerosis susceptibility."&lt;SEP&gt;"The SNP rs2205960 is associated with an increased risk of systemic sclerosis."&lt;SEP&gt;"The minor allele of SNP rs2205960 is associated with a higher frequency in systemic sclerosis."&lt;SEP&gt;"The rs2205960 SNP in the TNFSF4 gene increases the risk for systemic sclerosis, confirmed by the interaction model."&lt;SEP&gt;"The single nucleotide polymorphism rs2205960 is associated with increased susceptibility to systemic sclerosis."&lt;SEP&gt;"rs2205960 SNP is linked to susceptibility to systemic sclerosis."|"SNP-disease association"&lt;SEP&gt;"rs2205960 is associated with systemic sclerosis susceptibility"</data>
  <data key="d5">"allele frequency difference"&lt;SEP&gt;"disease risk, SNP association"&lt;SEP&gt;"disease susceptibility, SNP association"&lt;SEP&gt;"genetic association"&lt;SEP&gt;"genetic risk, autoimmune disease"&lt;SEP&gt;"genetic susceptibility"&lt;SEP&gt;"snp association, disease linkage"&lt;SEP&gt;"snp-disease association"&lt;SEP&gt;6&lt;SEP&gt;7&lt;SEP&gt;8</data>
  <data key="d6">chunk-457c8cc26a6098970ec760d84c398a2a&lt;SEP&gt;chunk-210e345ac292a0c3ccf4c2c84f6ad8b3&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-22c95d151784bab494732266d8aaf873&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-c3d25dc1bb5909ac0c6c506368f54f42&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892&lt;SEP&gt;chunk-c2823bcad3d01b2fb4bdef5f8aa96865&lt;SEP&gt;chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-72875ba549df0c7c1e9bd9550ffbe3a8&lt;SEP&gt;chunk-88b78ed0abef17d11ffa6aefaa201bcd&lt;SEP&gt;chunk-d177121ee3e32d25172682ac2df0f91b&lt;SEP&gt;chunk-dfad4826c0b7e6a17d2e0d647d8df903&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RS844648&quot;">
  <data key="d3">67.0</data>
  <data key="d4">"RS844648 is associated with a significant odds ratio indicating a potential genetic linkage to systemic sclerosis susceptibility."&lt;SEP&gt;"RS844648 is associated with systemic sclerosis susceptibility."&lt;SEP&gt;"Rs844648 is one of the SNPs analyzed for systemic sclerosis susceptibility."&lt;SEP&gt;"SNP rs844648 is linked to increased risk of systemic sclerosis."&lt;SEP&gt;"SNP rs844648 is noted to be associated with ARA-positive SSc"&lt;SEP&gt;"SNP rs844648 is potentially related to systemic sclerosis."&lt;SEP&gt;"SNP rs844648 is related to systemic sclerosis."&lt;SEP&gt;"SNP rs844648 is significantly associated with susceptibility to systemic sclerosis, but the minor allele is protective."&lt;SEP&gt;"The minor allele of SNP rs844648 shows an association with systemic sclerosis, but its frequency is less common compared to controls."&lt;SEP&gt;"rs844648 is associated with systemic sclerosis"</data>
  <data key="d5">"genetic association"&lt;SEP&gt;"genetic association, autoimmune disease"&lt;SEP&gt;"genetic linkage"&lt;SEP&gt;"risk factor, genetic association"&lt;SEP&gt;"snp association, disease linkage"&lt;SEP&gt;"snp-disease association"&lt;SEP&gt;6&lt;SEP&gt;7</data>
  <data key="d6">chunk-457c8cc26a6098970ec760d84c398a2a&lt;SEP&gt;chunk-210e345ac292a0c3ccf4c2c84f6ad8b3&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-c3d25dc1bb5909ac0c6c506368f54f42&lt;SEP&gt;chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-88b78ed0abef17d11ffa6aefaa201bcd&lt;SEP&gt;chunk-d177121ee3e32d25172682ac2df0f91b&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RS844644&quot;">
  <data key="d3">59.0</data>
  <data key="d4">"RS844644 SNP demonstrates significant allelic differences between systemic sclerosis cases and controls, suggesting a role in disease susceptibility."&lt;SEP&gt;"RS844644 is associated with systemic sclerosis."&lt;SEP&gt;"Rs844644 is one of the SNPs analyzed for systemic sclerosis susceptibility."&lt;SEP&gt;"SNP rs844644 has a lower frequency in systemic sclerosis, suggesting a protective effect."&lt;SEP&gt;"SNP rs844644 is associated with increased risk of systemic sclerosis."&lt;SEP&gt;"SNP rs844644 is protective against systemic sclerosis."&lt;SEP&gt;"The minor allele of SNP rs844644 is protective against systemic sclerosis."&lt;SEP&gt;"rs844644 is a SNP considered during TNFSF4 studies in relation to systemic sclerosis."&lt;SEP&gt;"rs844644 is associated with systemic sclerosis"</data>
  <data key="d5">"disease susceptibility"&lt;SEP&gt;"genetic association"&lt;SEP&gt;"genetic linkage, systemic disease"&lt;SEP&gt;"genetic protection"&lt;SEP&gt;"risk factor, genetic association"&lt;SEP&gt;"snp association, disease linkage"&lt;SEP&gt;"snp-disease association"&lt;SEP&gt;6</data>
  <data key="d6">chunk-457c8cc26a6098970ec760d84c398a2a&lt;SEP&gt;chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-d548e9ff6c14d77f5815c38f5bb0c54f&lt;SEP&gt;chunk-c3d25dc1bb5909ac0c6c506368f54f42&lt;SEP&gt;chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7&lt;SEP&gt;chunk-eeb39a2fa5676c3abaaa455a6c7075ba</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;CLINICAL AND AUTOANTIBODY SUBSETS&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Systemic sclerosis is characterized by its clinical manifestations and specific autoantibody subsets."</data>
  <data key="d5">"disease characteristics"</data>
  <data key="d6">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;IRF5&quot;">
  <data key="d3">17.0</data>
  <data key="d4">"IRF5 gene polymorphisms are associated with SSC, suggesting its role in disease susceptibility."&lt;SEP&gt;"IRF5 is linked with differentially regulated interferon gene expression in peripheral blood cells of SSC patients."</data>
  <data key="d5">"gene expression, interferon regulation, autoimmune response"&lt;SEP&gt;"gene polymorphisms, disease susceptibility"</data>
  <data key="d6">chunk-5d3273222cddef8cb212284d98ad6ea3&lt;SEP&gt;chunk-b8c59e84703c3508fdcaea1e0f1d798b</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;STAT4&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"STAT4 gene polymorphisms are linked to systemic sclerosis, indicating a genetic influence on the disease."</data>
  <data key="d5">"genetic influence, disease linkage"</data>
  <data key="d6">chunk-b8c59e84703c3508fdcaea1e0f1d798b</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;PTPN22&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"PTPN22 gene polymorphisms are associated with systemic sclerosis, suggesting a role in immune regulation."</data>
  <data key="d5">"immune regulation, genetic association"</data>
  <data key="d6">chunk-b8c59e84703c3508fdcaea1e0f1d798b</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;FAS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"FAS gene polymorphisms contribute to systemic sclerosis susceptibility through apoptosis regulation."</data>
  <data key="d5">"apoptosis, disease susceptibility"</data>
  <data key="d6">chunk-b8c59e84703c3508fdcaea1e0f1d798b</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;PATIENTS&quot;">
  <data key="d3">20.0</data>
  <data key="d4">"Human patients are the subjects studied for systemic sclerosis characteristics and antibody presence."&lt;SEP&gt;"Patients are those affected by systemic sclerosis, included in the research for analysis."&lt;SEP&gt;"The study was conducted on North American Caucasian patients with systemic sclerosis."_ |_"study cohort, patient demographics"</data>
  <data key="d5">"clinical subjects, research cohort"&lt;SEP&gt;"disease association"&lt;SEP&gt;6</data>
  <data key="d6">chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-80df7c229ad2b2fcbbca5e31a05d5324&lt;SEP&gt;chunk-1f1d798adb899eb19d8a9c24ad7f0bb7</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;CALCINOSIS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Calcinosis is one of the symptoms observed in systemic sclerosis patients as part of the CREST syndrome."</data>
  <data key="d5">"Ssc symptoms"</data>
  <data key="d6">chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RAYNAUD'S PHENOMENON&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Raynaud's phenomenon is commonly observed in patients with SSC as part of the CREST syndrome."</data>
  <data key="d5">"Ssc symptoms"</data>
  <data key="d6">chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;ESOPHAGEAL DYSFUNCTION&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Esophageal dysfunction is part of the CREST syndrome observed in SSC."</data>
  <data key="d5">"Ssc symptoms"</data>
  <data key="d6">chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;SCLERODACTYLY&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Sclerodactyly is observed in the CREST syndrome found in SSC patients."</data>
  <data key="d5">"Ssc symptoms"</data>
  <data key="d6">chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;TELANGIECTASIAS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Telangiectasias are part of the CREST syndrome found in SSC patients."</data>
  <data key="d5">"Ssc symptoms"</data>
  <data key="d6">chunk-039888df49d04e1f7f17eea69b15a3a2</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RS1234315&quot;">
  <data key="d3">13.0</data>
  <data key="d4">"Rs1234315 is one of the SNPs analyzed for systemic sclerosis susceptibility."&lt;SEP&gt;"SNP rs1234315 is linked to systemic sclerosis in genetic studies."</data>
  <data key="d5">6&lt;SEP&gt;7</data>
  <data key="d6">chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-ece9281114fbd43ea91166a7803561b5</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RS844665&quot;">
  <data key="d3">39.0</data>
  <data key="d4">"RS844665 SNP contributes to the genetic factors that might influence systemic sclerosis, although with a less significant statistical impact."&lt;SEP&gt;"Rs844665 is one of the SNPs analyzed for systemic sclerosis susceptibility."&lt;SEP&gt;"SNP rs844665 is associated with increased risk of systemic sclerosis."&lt;SEP&gt;"rs844665 SNP is associated with systemic sclerosis susceptibility."|"SNP-disease association"&lt;SEP&gt;"rs844665 is associated with systemic sclerosis"</data>
  <data key="d5">"genetic contribution"&lt;SEP&gt;"risk factor, genetic association"&lt;SEP&gt;"snp association, disease linkage"&lt;SEP&gt;6&lt;SEP&gt;7</data>
  <data key="d6">chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-c3d25dc1bb5909ac0c6c506368f54f42&lt;SEP&gt;chunk-c2823bcad3d01b2fb4bdef5f8aa96865&lt;SEP&gt;chunk-15058ba27fe3301f047ae0d4c6f56534&lt;SEP&gt;chunk-c6704e5262862d28c2ad0880a79393a7</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RS12039904&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Rs12039904 is one of the SNPs analyzed for systemic sclerosis susceptibility."</data>
  <data key="d5">6</data>
  <data key="d6">chunk-bdac558c5112759cd5ed90781ac68e5b</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RS10912580&quot;">
  <data key="d3">13.0</data>
  <data key="d4">"Rs10912580 is one of the SNPs analyzed for systemic sclerosis susceptibility."&lt;SEP&gt;"The SNP rs10912580 is associated with systemic sclerosis."</data>
  <data key="d5">"SNP importance, disease link"&lt;SEP&gt;6</data>
  <data key="d6">chunk-bdac558c5112759cd5ed90781ac68e5b&lt;SEP&gt;chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;HEALTHY CONTROLS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Healthy controls were used to compare against SSc patients in the TNFSF4 association study."</data>
  <data key="d5">"control group comparison, disease study"</data>
  <data key="d6">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;SKIN&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Systemic sclerosis involves skin, leading to pathological changes."</data>
  <data key="d5">8</data>
  <data key="d6">chunk-ece9281114fbd43ea91166a7803561b5</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;ACA&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Presence of ACA is linked with distinct clinical subsets of systemic sclerosis."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-e785e8a37b35cb99202b04012deed634</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;ATA&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"ATA is associated with systemic sclerosis, particularly defining certain phenotypic subsets."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-e785e8a37b35cb99202b04012deed634</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;ARA&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"ARA is connected with systemic sclerosis, indicating autoantibody presence in the disease"</data>
  <data key="d5">7</data>
  <data key="d6">chunk-e785e8a37b35cb99202b04012deed634</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;CUTANOUS INVOLVEMENT&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Cutaneous involvement is a defining characteristic of systemic sclerosis."</data>
  <data key="d5">8</data>
  <data key="d6">chunk-e785e8a37b35cb99202b04012deed634</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;ANTI-CENTROMERE&quot;">
  <data key="d3">15.0</data>
  <data key="d4">"Anti-centromere antibodies are found in limited systemic sclerosis cases."&lt;SEP&gt;"Presence of anti-centromere antibodies is associated with systemic sclerosis, suggesting a potential biomarker."</data>
  <data key="d5">"autoantibody, biomarker"&lt;SEP&gt;"clinical marker"</data>
  <data key="d6">chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;ANTI-TOPOISOMERASE I&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"Anti-topoisomerase I antibodies are common in diffuse systemic sclerosis."&lt;SEP&gt;"Anti-topoisomerase I antibodies are commonly found in systemic sclerosis, indicating a strong association."</data>
  <data key="d5">"autoantibody, association"&lt;SEP&gt;"clinical marker"</data>
  <data key="d6">chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;ANTI-RNA POLYMERASE III&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"Anti-RNA polymerase III antibodies are linked to systemic sclerosis, acting as a potential biomarker."&lt;SEP&gt;"Anti-RNA polymerase III antibodies are observed in systemic sclerosis patients."</data>
  <data key="d5">"autoantibody, biomarker"&lt;SEP&gt;"clinical marker"</data>
  <data key="d6">chunk-ed94dfc6eac64c9c719dd45723718c39&lt;SEP&gt;chunk-1abbb69992e35027832da74675048aa8</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;LIMITED SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Limited systemic sclerosis is a subtype of systemic sclerosis with distinct features."</data>
  <data key="d5">"subtype, comparison"</data>
  <data key="d6">chunk-1abbb69992e35027832da74675048aa8</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;DIFFUSE SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Diffuse systemic sclerosis is a subtype of systemic sclerosis characterized by widespread skin involvement."</data>
  <data key="d5">"subtype, characteristic"</data>
  <data key="d6">chunk-1abbb69992e35027832da74675048aa8</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;LABORATORY TESTS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Laboratory tests are used to identify antibodies and genetic associations in systemic sclerosis."</data>
  <data key="d5">"diagnostic procedure"</data>
  <data key="d6">chunk-ed94dfc6eac64c9c719dd45723718c39</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RS1234214&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"SNP rs1234214 is significantly associated with ACA-positive and ATA-positive SSc patients"</data>
  <data key="d5">8</data>
  <data key="d6">chunk-210e345ac292a0c3ccf4c2c84f6ad8b3</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RS855648&quot;">
  <data key="d3">21.0</data>
  <data key="d4">"SNP rs855648 within the TNFSF4 gene region is linked to increased systemic sclerosis risk, particularly in certain genotypes."&lt;SEP&gt;"Single nucleotide polymorphism rs855648 is associated with systemic sclerosis susceptibility through interaction with rs2205960."&lt;SEP&gt;"The single nucleotide polymorphism rs855648 is associated with increased susceptibility to systemic sclerosis."</data>
  <data key="d5">"disease susceptibility, genetic association"&lt;SEP&gt;"genetic susceptibility"&lt;SEP&gt;7</data>
  <data key="d6">chunk-72875ba549df0c7c1e9bd9550ffbe3a8&lt;SEP&gt;chunk-22c95d151784bab494732266d8aaf873&lt;SEP&gt;chunk-8cc4d94318a6e7beedefc58596376892</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;FEMALE&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Female gender is identified as a factor influencing susceptibility to systemic sclerosis based on SNP interactions."</data>
  <data key="d5">"gender influence, disease risk"</data>
  <data key="d6">chunk-72875ba549df0c7c1e9bd9550ffbe3a8</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;RS944648&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"The single nucleotide polymorphism rs944648 is associated with increased susceptibility to systemic sclerosis."</data>
  <data key="d5">"genetic susceptibility"</data>
  <data key="d6">chunk-22c95d151784bab494732266d8aaf873</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;OX40&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Elevated serum levels of OX40 found in SSc patients suggest a role of the OX40 pathway."</data>
  <data key="d5">"disease association, biomarker"</data>
  <data key="d6">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;HUMAN&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Human species are the subjects being studied for susceptibility to systemic sclerosis."</data>
  <data key="d5">"species study, pathological analysis"</data>
  <data key="d6">chunk-d3f80deee592fd8d98f9795daf2b98ca</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;GENETIC STRUCTURE&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Variation in genetic structure is analyzed in the context of systemic sclerosis pathogenesis."</data>
  <data key="d5">"genetic analysis, disease correlation"</data>
  <data key="d6">chunk-d3f80deee592fd8d98f9795daf2b98ca</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;PERIPHERAL BLOOD CELLS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Differential interferon gene expression and vasculotrophism observed in peripheral blood cells of SSC patients."</data>
  <data key="d5">"immune modulation, vasculotrophism, gene regulation"</data>
  <data key="d6">chunk-5d3273222cddef8cb212284d98ad6ea3</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;PULMONARY FIBROSIS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Pulmonary fibrosis is connected to systemic sclerosis, notably influenced by IRF5 polymorphisms."</data>
  <data key="d5">"disease symptomatology, fibrosis, genetic influence"</data>
  <data key="d6">chunk-5d3273222cddef8cb212284d98ad6ea3</data>
</edge>
<edge source="&quot;SSC&quot;" target="&quot;FIBRILLARIN&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Autoantibodies to fibrillarin are found in systemic sclerosis patients"</data>
  <data key="d5">7</data>
  <data key="d6">chunk-bc41401afd8fbd1a0e1739441ffe8577</data>
</edge>
<edge source="&quot;RS1234314&quot;" target="&quot;RS2205960&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Both RS2205960 and RS1234314 SNPs are identified as significant within genetic studies related to expression and susceptibility."</data>
  <data key="d5">"genetic significance"</data>
  <data key="d6">chunk-c3d25dc1bb5909ac0c6c506368f54f42</data>
</edge>
<edge source="&quot;RS1234314&quot;" target="&quot;PATIENTS WITH SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"The RS1234314 polymorphism shows a significant association with systemic sclerosis, indicating a genetic susceptibility"</data>
  <data key="d5">"genetic association, susceptibility"</data>
  <data key="d6">chunk-1abbb69992e35027832da74675048aa8</data>
</edge>
<edge source="&quot;RS1234314&quot;" target="&quot;ANTI-CENTROMERE&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"The presence of anti-centromere antibodies in patients with the RS1234314 variant suggests a possible biomarker role for this SNP."</data>
  <data key="d5">"biomarker, correlation"</data>
  <data key="d6">chunk-1abbb69992e35027832da74675048aa8</data>
</edge>
<edge source="&quot;RS1234314&quot;" target="&quot;LSSC&quot;">
  <data key="d3">14.0</data>
  <data key="d4">"SNP rs1234314 is more common in limited systemic sclerosis compared to controls."&lt;SEP&gt;"rs1234314 appears more frequently in limited systemic sclerosis cases versus controls."</data>
  <data key="d5">"genetic risk, autoimmune disease"&lt;SEP&gt;"genetic susceptibility, autoimmune condition"</data>
  <data key="d6">chunk-1f1d798adb899eb19d8a9c24ad7f0bb7</data>
</edge>
<edge source="&quot;RS2205960&quot;" target="&quot;RS844648&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Potential interaction between rs2205960 and rs844648 SNPs in relation to SSc susceptibility."</data>
  <data key="d5">"genetic interaction"</data>
  <data key="d6">chunk-eeb39a2fa5676c3abaaa455a6c7075ba</data>
</edge>
<edge source="&quot;RS2205960&quot;" target="&quot;SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"SNP rs2205960 is associated with systemic sclerosis."</data>
  <data key="d5">"genetic marker, disease susceptibility"</data>
  <data key="d6">chunk-3184335b83c100772059d085ae00b750</data>
</edge>
<edge source="&quot;RS2205960&quot;" target="&quot;PATIENTS WITH SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"The RS2205960 polymorphism is linked to increased risk of systemic sclerosis, highlighting its role in disease susceptibility."</data>
  <data key="d5">"genetic association, susceptibility"</data>
  <data key="d6">chunk-1abbb69992e35027832da74675048aa8</data>
</edge>
<edge source="&quot;RS2205960&quot;" target="&quot;ANTI-RNA POLYMERASE III&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"The presence of anti-RNA polymerase III antibodies in patients carrying the RS2205960 variant is associated with systemic sclerosis."</data>
  <data key="d5">"biomarker, correlation"</data>
  <data key="d6">chunk-1abbb69992e35027832da74675048aa8</data>
</edge>
<edge source="&quot;RS2205960&quot;" target="&quot;LSSC&quot;">
  <data key="d3">14.0</data>
  <data key="d4">"SNP rs2205960 is more common in limited systemic sclerosis compared to controls."&lt;SEP&gt;"rs2205960 is more prevalent in lSSc cases when compared to control groups."</data>
  <data key="d5">"genetic risk, autoimmune disease"&lt;SEP&gt;"genetic susceptibility, autoimmune condition"</data>
  <data key="d6">chunk-1f1d798adb899eb19d8a9c24ad7f0bb7</data>
</edge>
<edge source="&quot;RS2205960&quot;" target="&quot;RS855648&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"The SNPs rs2205960 and rs855648 interact within the TNFSF4 gene region to influence systemic sclerosis risk, confirmed by the interaction model."</data>
  <data key="d5">"SNP interaction, genetic risk"</data>
  <data key="d6">chunk-72875ba549df0c7c1e9bd9550ffbe3a8</data>
</edge>
<edge source="&quot;RS2205960&quot;" target="&quot;TT/GT GENOTYPE&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"The TT/GT genotype of rs2205960 increases risk for systemic sclerosis compared to GG genotype in females."</data>
  <data key="d5">"genotype influence, disease risk"</data>
  <data key="d6">chunk-72875ba549df0c7c1e9bd9550ffbe3a8</data>
</edge>
<edge source="&quot;RS2205960&quot;" target="&quot;GG GENOTYPE&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"The GG genotype of rs2205960 serves as a baseline for comparison in assessing systemic sclerosis risk in females."</data>
  <data key="d5">"baseline genotype, risk comparison"</data>
  <data key="d6">chunk-72875ba549df0c7c1e9bd9550ffbe3a8</data>
</edge>
<edge source="&quot;RS844648&quot;" target="&quot;RS844644&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Both RS844644 and RS844648 are SNPs located within similar regions, suggesting possible shared gene regulatory roles."</data>
  <data key="d5">"genetic similarity"</data>
  <data key="d6">chunk-c3d25dc1bb5909ac0c6c506368f54f42</data>
</edge>
<edge source="&quot;RS844648&quot;" target="&quot;SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"The rs844648 SNP is studied in systemic sclerosis for potential genetic links."</data>
  <data key="d5">"genetic association"</data>
  <data key="d6">chunk-90b4d608c8fb7478d68e5b7eee350e40</data>
</edge>
<edge source="&quot;RS844644&quot;" target="&quot;RS844665&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"RS844644 and RS844665 are associated within a genetic framework, possibly influencing related genes."</data>
  <data key="d5">"genetic association"</data>
  <data key="d6">chunk-c3d25dc1bb5909ac0c6c506368f54f42</data>
</edge>
<edge source="&quot;RS844644&quot;" target="&quot;SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"RS844644 is a genetic variant examined for its potential association with systemic sclerosis."</data>
  <data key="d5">"genetic association"</data>
  <data key="d6">chunk-c9c83616fb0c96ebed93b26d5ad94820</data>
</edge>
<edge source="&quot;PATIENTS&quot;" target="&quot;AD&quot;">
  <data key="d3">12.0</data>
  <data key="d4">"Patients are diagnosed with atopic dermatitis, being assessed for disease severity and immune markers"&lt;SEP&gt;"Patients with AD are the focus of many clinical studies to evaluate treatment efficacy and disease progression"</data>
  <data key="d5">"clinical studies, human subjects"&lt;SEP&gt;6</data>
  <data key="d6">chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0</data>
</edge>
<edge source="&quot;PATIENTS&quot;" target="&quot;AD WITH ASTHMA&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Individuals with both AD and asthma exhibit distinct immune response markers."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</edge>
<edge source="&quot;PTPN22&quot;" target="&quot;TIDM&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"PTPN22 is associated with the development of type I diabetes mellitus."</data>
  <data key="d5">"gene-disease association"</data>
  <data key="d6">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</edge>
<edge source="&quot;PTPN22&quot;" target="&quot;RA&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"PTPN22 is associated with the development of rheumatoid arthritis."</data>
  <data key="d5">"gene-disease association"</data>
  <data key="d6">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</edge>
<edge source="&quot;PTPN22&quot;" target="&quot;1858C/T&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"The 1858C/T polymorphism is in the PTPN22 gene and is linked with autoimmune diseases."</data>
  <data key="d5">"gene mutation association"</data>
  <data key="d6">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</edge>
<edge source="&quot;PTPN22&quot;" target="&quot;TYPE I DIABETES&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"PTPN22 gene polymorphism is linked with type I diabetes in multiplex families."</data>
  <data key="d5">"autoimmune association"</data>
  <data key="d6">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</edge>
<edge source="&quot;PTPN22&quot;" target="&quot;RHEUMATOID ARTHRITIS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"PTPN22 polymorphism is associated with rheumatoid arthritis."</data>
  <data key="d5">"autoimmune association"</data>
  <data key="d6">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</edge>
<edge source="&quot;PTPN22&quot;" target="&quot;LYMPHOID PROTEIN PHOSPHATASE&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Lymphoid protein phosphatase is encoded by the PTPN22 gene."</data>
  <data key="d5">"protein encoding"</data>
  <data key="d6">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</edge>
<edge source="&quot;PTPN22&quot;" target="&quot;R620W&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"PTPN22 encompasses the R620W polymorphism linked to systemic sclerosis susceptibility."</data>
  <data key="d5">"gene polymorphism, systemic sclerosis"</data>
  <data key="d6">chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</edge>
<edge source="&quot;PTPN22&quot;" target="&quot;SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"PTPN22 R620W polymorphism is associated with anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis."</data>
  <data key="d5">"gene polymorphism, autoimmune response"</data>
  <data key="d6">chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</edge>
<edge source="&quot;STAT4&quot;" target="&quot;RA&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"STAT4 is a susceptibility gene linked to rheumatoid arthritis."</data>
  <data key="d5">"gene-disease association"</data>
  <data key="d6">chunk-f40d75c218dbbd371d3444666f5fa395</data>
</edge>
<edge source="&quot;STAT4&quot;" target="&quot;RHEUMATOID ARTHRITIS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"STAT4 gene increases the risk of rheumatoid arthritis."</data>
  <data key="d5">"genetic risk"</data>
  <data key="d6">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</edge>
<edge source="&quot;STAT4&quot;" target="&quot;SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"STAT4 gene influences genetic predisposition to systemic sclerosis phenotype."</data>
  <data key="d5">"genetic influence"</data>
  <data key="d6">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</edge>
<edge source="&quot;STAT4&quot;" target="&quot;GENETIC PREDISPOSITION&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"STAT4 gene influences genetic predisposition towards systemic sclerosis phenotype."</data>
  <data key="d5">"genetic risk factor"</data>
  <data key="d6">chunk-dbadb4d9b74b89122cd7868a0008eea7</data>
</edge>
<edge source="&quot;ATHEROSCLEROSIS&quot;" target="&quot;OX40 LIGAND&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40 ligand, encoded by TNFSF4, plays a role in atherosclerosis susceptibility."</data>
  <data key="d5">"protein-disease interaction"</data>
  <data key="d6">chunk-b267f7459d573ed53adff3f27835bd72</data>
</edge>
<edge source="&quot;ATHEROSCLEROSIS&quot;" target="&quot;OX40&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Interruption of the OX40-OX40L pathway in LDL receptor-deficient mice causes regression of atherosclerosis, indicating the pathway's role in this disease."</data>
  <data key="d5">"disease regression, pathway interruption"</data>
  <data key="d6">chunk-a1e55c0d3e82798ca6e2849fe54d23ff</data>
</edge>
<edge source="&quot;OX40 LIGAND&quot;" target="&quot;TH-2 CELL&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40 ligand acts as a costimulatory signal for the development of pathogenic Th-2 cells."</data>
  <data key="d5">"immune regulation"</data>
  <data key="d6">chunk-076b3b9ec096111e268d9d6a571decfd</data>
</edge>
<edge source="&quot;OX40 LIGAND&quot;" target="&quot;DENDRITIC CELL&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"OX40 ligand expressed by dendritic cells offers a costimulatory signal for Th-2 cells."</data>
  <data key="d5">"immune signaling"</data>
  <data key="d6">chunk-076b3b9ec096111e268d9d6a571decfd</data>
</edge>
<edge source="&quot;OX40 LIGAND&quot;" target="&quot;OX40&quot;">
  <data key="d3">18.0</data>
  <data key="d4">"OX40 and its ligand play crucial roles in the proliferation and regulation of T cells in asthma models."&lt;SEP&gt;"The T cell-B cell interaction via OX40-OX40L is essential for the T cell-dependent humoral immune response."</data>
  <data key="d5">"immune interaction, ligand-receptor, asthma"&lt;SEP&gt;"immune response, cell interaction"</data>
  <data key="d6">chunk-e6d4cc75e3f259d8ad15f49ab499fddf&lt;SEP&gt;chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</edge>
<edge source="&quot;OX40 LIGAND&quot;" target="&quot;PLASMACYTOID DENDRITIC CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand."</data>
  <data key="d5">"regulation, immune response"</data>
  <data key="d6">chunk-e6d4cc75e3f259d8ad15f49ab499fddf</data>
</edge>
<edge source="&quot;ANTINUCLEAR ANTIBODIES&quot;" target="&quot;HEP-2&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"HEp-2 cells are used as an antigen substrate for detecting antinuclear antibodies."</data>
  <data key="d5">"immunoassay, cell substrate"</data>
  <data key="d6">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</edge>
<edge source="&quot;INTERNAL ORGANS&quot;" target="&quot;SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Systemic sclerosis can cause fibrosis of the internal organs."</data>
  <data key="d5">"disease symptomatology"</data>
  <data key="d6">chunk-90b4d608c8fb7478d68e5b7eee350e40</data>
</edge>
<edge source="&quot;IRF5&quot;" target="&quot;RS2004640&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"IRF5 gene polymorphism rs2004640 is associated with systemic sclerosis and pulmonary fibrosis."</data>
  <data key="d5">"genetic polymorphism, disease association, immune response regulation"</data>
  <data key="d6">chunk-5d3273222cddef8cb212284d98ad6ea3</data>
</edge>
<edge source="&quot;FAS&quot;" target="&quot;-670G&gt;A&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"-670G&gt;A polymorphism in the FAS gene is related to systemic sclerosis susceptibility."</data>
  <data key="d5">"gene polymorphism, systemic sclerosis"</data>
  <data key="d6">chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</edge>
<edge source="&quot;FAS&quot;" target="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Functional polymorphism in FAS gene promoter associated with systemic lupus erythematosus."</data>
  <data key="d5">"gene polymorphism, systemic lupus erythematosus"</data>
  <data key="d6">chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</edge>
<edge source="&quot;RAYNAUD'S PHENOMENON&quot;" target="&quot;ESOPHAGEAL DYSFUNCTION&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Both are symptoms that may occur together as clinical features of systemic sclerosis."</data>
  <data key="d5">"systemic sclerosis symptoms"</data>
  <data key="d6">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</edge>
<edge source="&quot;SCLERODACTYLY&quot;" target="&quot;TELANGIECTASIAS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Both symptoms can be manifestations of systemic sclerosis, affecting the skin and blood vessels."</data>
  <data key="d5">"systemic sclerosis symptoms"</data>
  <data key="d6">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</edge>
<edge source="&quot;HEP-2&quot;" target="&quot;ANTI-CENTROMERE ANTIBODIES (ACA)&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"HEp-2 cells serve as a substrate to detect specific staining patterns of anti-centromere antibodies in immunofluorescence assays."</data>
  <data key="d5">"immunofluorescence assay, substrate use"</data>
  <data key="d6">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</edge>
<edge source="&quot;TOPOISOMERASE I&quot;" target="&quot;RNA POLYMERASE III&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Both are proteins targeted by specific autoantibodies in autoimmune diseases."</data>
  <data key="d5">"autoantibodies, target proteins"</data>
  <data key="d6">chunk-e19459917d5c48c6b875c4a30fdad3b1</data>
</edge>
<edge source="&quot;TOPOISOMERASE I&quot;" target="&quot;ANTI-TOPOISOMERASE I AUTOANTIBODY&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Topoisomerase I is the target protein for the autoantibodies present in scleroderma."</data>
  <data key="d5">"protein targeting, autoantibody response"</data>
  <data key="d6">chunk-4a79520712d3df44b8051f092fcea618</data>
</edge>
<edge source="&quot;D'&quot;" target="&quot;R2&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Both are statistical measures used in the study to evaluate genetic association among TNFSF4 SNPs."</data>
  <data key="d5">"statistical correlation, genetic analysis"</data>
  <data key="d6">chunk-dfad4826c0b7e6a17d2e0d647d8df903</data>
</edge>
<edge source="&quot;SKIN&quot;" target="&quot;INFLAMMATORY SKIN DISEASE&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Skin is the primary tissue affected in inflammatory skin diseases, showing signs like eczema and dryness."</data>
  <data key="d5">"affliction, symptoms"</data>
  <data key="d6">chunk-2785ff077980c1b6099f6312917ba06c</data>
</edge>
<edge source="&quot;SKIN&quot;" target="&quot;AD&quot;">
  <data key="d3">44.0</data>
  <data key="d4">"AD affects the skin tissue, leading to inflammation and changes in cellular makeup marked by gene expression variations."&lt;SEP&gt;"In atopic dermatitis, skin tissue is biopsied for inflammation studies."&lt;SEP&gt;"Skin is one of the target organs affected in atopic dermatitis, resulting in visible symptoms."&lt;SEP&gt;"The skin is the primary tissue affected in atopic dermatitis, showing symptoms like redness, itching, and swelling"</data>
  <data key="d5">"disease manifestation, inflammation"&lt;SEP&gt;"inflammation"&lt;SEP&gt;8&lt;SEP&gt;9</data>
  <data key="d6">chunk-4486b79fa295f4486ae8f31f789db642&lt;SEP&gt;chunk-9c36c2978a0bf868f306a82e42a345a9&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-15081dd238cde18547767c2656f6e80f</data>
</edge>
<edge source="&quot;SKIN&quot;" target="&quot;ECZEMA&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Eczema is a symptom occurring in the skin as a result of conditions like AD."</data>
  <data key="d5">8</data>
  <data key="d6">chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07</data>
</edge>
<edge source="&quot;SKIN&quot;" target="&quot;BIOPSIES&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Biopsies were collected from the skin of AD patients for research purposes."</data>
  <data key="d5">6</data>
  <data key="d6">chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</edge>
<edge source="&quot;SKIN&quot;" target="&quot;OX40&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40 expression is observed within the skin, particularly on cells expressing OX40L in AD patients."</data>
  <data key="d5">"cellular expression"</data>
  <data key="d6">chunk-afdd4c61cd0aee9cfa4fdd53c26ad339</data>
</edge>
<edge source="&quot;SKIN&quot;" target="&quot;GENE SIGNATURES&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Gene signatures are expressions in the skin tissue improved by GBR 830 treatment in atopic dermatitis."</data>
  <data key="d5">"tissue expression, marker improvement"</data>
  <data key="d6">chunk-9ff7b47e334d062c5c0cc9daeae082d7</data>
</edge>
<edge source="&quot;SKIN INVOLVEMENT&quot;" target="&quot;SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">1.0</data>
  <data key="d4">"Skin involvement is a symptom observed in patients with systemic sclerosis."</data>
  <data key="d5">"symptom association"|&lt;7</data>
  <data key="d6">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;LIMITED SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Limited systemic sclerosis is a milder subtype of systemic sclerosis."&lt;SEP&gt;"Limited systemic sclerosis is a subtype of systemic sclerosis characterized by milder symptoms."</data>
  <data key="d5">"disease subtype relation"&lt;SEP&gt;"subtype relationship"|&lt;7</data>
  <data key="d6">chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;DIFFUSE SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Diffuse systemic sclerosis is a more severe subtype of systemic sclerosis."&lt;SEP&gt;"Diffuse systemic sclerosis is a severe subtype of systemic sclerosis marked by widespread skin changes."</data>
  <data key="d5">"disease subtype relation"&lt;SEP&gt;"subtype relationship"|&lt;8</data>
  <data key="d6">chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;ANTI-CENTROMERE AUTOANTIBODIES&quot;">
  <data key="d3">1.0</data>
  <data key="d4">"Presence of anti-centromere autoantibodies is significant in diagnosis and classification of systemic sclerosis."</data>
  <data key="d5">"autoantibody association"|&lt;7</data>
  <data key="d6">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;ANTI-RNA POLYMERASE III AUTOANTIBODIES&quot;">
  <data key="d3">1.0</data>
  <data key="d4">"Anti-RNA polymerase III autoantibodies indicate a distinct clinical subset of systemic sclerosis."</data>
  <data key="d5">"autoantibody association"|&lt;7</data>
  <data key="d6">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;SSC-ASSOCIATED AUTOANTIBODIES&quot;">
  <data key="d3">1.0</data>
  <data key="d4">"SSc-associated autoantibodies are used as markers in diagnosing systemic sclerosis."</data>
  <data key="d5">"diagnostic marker"|&lt;7</data>
  <data key="d6">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;ANTI-CENTROMERE&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Anti-centromere antibodies are often found in patients with systemic sclerosis."</data>
  <data key="d5">"autoantibodies, disease association"</data>
  <data key="d6">chunk-3184335b83c100772059d085ae00b750</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;ANTI-TOPOISOMERASE I&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"Anti-topoisomerase I antibodies are associated with systemic sclerosis."&lt;SEP&gt;"Anti-topoisomerase I autoantibodies are commonly found in patients with systemic sclerosis."</data>
  <data key="d5">"autoantibodies, disease association"&lt;SEP&gt;"autoantibody association"</data>
  <data key="d6">chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-3184335b83c100772059d085ae00b750</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;ANTI-RNA POLYMERASE III&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"Anti-RNA polymerase III antibodies are linked to systemic sclerosis."&lt;SEP&gt;"Anti-RNA polymerase III autoantibodies are associated with systemic sclerosis patients."</data>
  <data key="d5">"autoantibodies, disease association"&lt;SEP&gt;"autoantibody association"</data>
  <data key="d6">chunk-90b4d608c8fb7478d68e5b7eee350e40&lt;SEP&gt;chunk-3184335b83c100772059d085ae00b750</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;ANTI-RNA POLYMERASE III ANTIBODIES&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Anti-RNA Polymerase III antibodies are linked to systemic sclerosis and can signal specific clinical manifestations."</data>
  <data key="d5">"antibody-disease link, clinical features"</data>
  <data key="d6">chunk-96fee34b88b939b7834b2cdcf98d7366</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;PATIENTS WITH SYSTEMIC SCLEROSIS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"The individuals diagnosed with systemic sclerosis are studied for disease characteristics."</data>
  <data key="d5">"disease diagnosis"</data>
  <data key="d6">chunk-90b4d608c8fb7478d68e5b7eee350e40</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;IMMUNE RESPONSE&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"SSC involves abnormal immune responses leading to fibrosis."</data>
  <data key="d5">"immune dysfunction"</data>
  <data key="d6">chunk-b267f7459d573ed53adff3f27835bd72</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;GENETIC SUSCEPTIBILITY&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Genetic predispositions are involved in the development of systemic sclerosis."</data>
  <data key="d5">"genetic predisposition"</data>
  <data key="d6">chunk-b267f7459d573ed53adff3f27835bd72</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;CREST SYNDROME&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"CREST syndrome is a distinct serologic subset of systemic sclerosis."</data>
  <data key="d5">"disease subset"</data>
  <data key="d6">chunk-ca51be81b7248c4c4ca5fd0218eb755d</data>
</edge>
<edge source="&quot;SYSTEMIC SCLEROSIS&quot;" target="&quot;AIF1&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"AIF1 gene SNPs are associated with anti-centromere antibody positive systemic sclerosis."&lt;SEP&gt;"AIF1 gene is associated with systemic sclerosis and the presence of anti-centromere antibodies."</data>
  <data key="d5">"genetic association"</data>
  <data key="d6">chunk-076b3b9ec096111e268d9d6a571decfd&lt;SEP&gt;chunk-ca51be81b7248c4c4ca5fd0218eb755d</data>
</edge>
<edge source="&quot;LIMITED SYSTEMIC SCLEROSIS&quot;" target="&quot;ANTI-CENTROMERE ANTIBODIES&quot;">
  <data key="d3">17.0</data>
  <data key="d4">"Anti-centromere antibodies are often associated with limited systemic sclerosis."&lt;SEP&gt;"Limited systemic sclerosis is often associated with the presence of anti-centromere antibodies."</data>
  <data key="d5">"antibody association"&lt;SEP&gt;"antibody association, disease subtype"</data>
  <data key="d6">chunk-96fee34b88b939b7834b2cdcf98d7366&lt;SEP&gt;chunk-c9c83616fb0c96ebed93b26d5ad94820</data>
</edge>
<edge source="&quot;DIFFUSE SYSTEMIC SCLEROSIS&quot;" target="&quot;ANTI-TOPOISOMERASE I AUTOANTIBODIES&quot;">
  <data key="d3">1.0</data>
  <data key="d4">"Anti-topoisomerase I autoantibodies are strongly associated with diffuse systemic sclerosis subtype of the disease."</data>
  <data key="d5">"autoantibody association"|&lt;8</data>
  <data key="d6">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</edge>
<edge source="&quot;DIFFUSE SYSTEMIC SCLEROSIS&quot;" target="&quot;ANTI-TOPOISOMERASE I ANTIBODIES&quot;">
  <data key="d3">17.0</data>
  <data key="d4">"Anti-topoisomerase I antibodies are typically found in patients with diffuse systemic sclerosis."&lt;SEP&gt;"Diffuse systemic sclerosis is associated with anti-topoisomerase I antibodies, indicating more severe involvement."</data>
  <data key="d5">"antibody association, disease severity"&lt;SEP&gt;"antibody subtype"</data>
  <data key="d6">chunk-96fee34b88b939b7834b2cdcf98d7366&lt;SEP&gt;chunk-c9c83616fb0c96ebed93b26d5ad94820</data>
</edge>
<edge source="&quot;N&quot;" target="&quot;GENDER AND CONTROLS&quot;">
  <data key="d3">1.0</data>
  <data key="d4">"N is used to specify the number of samples or individuals in gender and control groups within research data."</data>
  <data key="d5">"numeric significance"|&lt;5</data>
  <data key="d6">chunk-320d0b743f738f2697e6cc5d5e524a9e</data>
</edge>
<edge source="&quot;RS855648&quot;" target="&quot;AA GENOTYPE&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"The AA genotype of rs855648 is associated with increased systemic sclerosis risk compared to AG/GG genotypes."</data>
  <data key="d5">"risk association, genotype comparison"</data>
  <data key="d6">chunk-72875ba549df0c7c1e9bd9550ffbe3a8</data>
</edge>
<edge source="&quot;CD4+ T CELL&quot;" target="&quot;OX40&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40 is highly expressed on CD4+ T cells, providing costimulatory signals."</data>
  <data key="d5">"expression, costimulation"</data>
  <data key="d6">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</edge>
<edge source="&quot;CD8+ T CELL&quot;" target="&quot;OX40&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40 is highly expressed on CD8+ T cells, affecting costimulation."</data>
  <data key="d5">"expression, costimulation"</data>
  <data key="d6">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;REGULATORY T-CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40 impacts the induction of regulatory T-cells through costimulation."</data>
  <data key="d5">"Regulatory T-cells induction"</data>
  <data key="d6">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;MEMORY T-CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40 costimulation leads to memory T-cells expansion in vivo."</data>
  <data key="d5">"Memory T-cells expansion"</data>
  <data key="d6">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;PLASMACYTOID DENDRITIC CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40 ligand from plasmacytoid dendritic cells interacts with OX40 to regulate immune responses."</data>
  <data key="d5">"regulation, cell interaction"</data>
  <data key="d6">chunk-e6d4cc75e3f259d8ad15f49ab499fddf</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;SOX40&quot;">
  <data key="d3">39.0</data>
  <data key="d4">"OX40 and its soluble form sOX40 both are involved but sOX40 has anti-inflammatory effects"&lt;SEP&gt;"sOX40 is the serum form of OX40, both are part of the OX40 system."&lt;SEP&gt;"sOX40 is the soluble form of OX40 detected and measured in serum."&lt;SEP&gt;"sOX40 is the soluble form of OX40 found in plasma, reflecting its presence in the body."&lt;SEP&gt;"sOX40 represents the soluble form of OX40, both are structurally related but differ in form and circulation in serum"</data>
  <data key="d5">"equivalence, function"&lt;SEP&gt;"protein structure difference"&lt;SEP&gt;"serum levels, OX40 system"&lt;SEP&gt;7</data>
  <data key="d6">chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae&lt;SEP&gt;chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;CD4+ T CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Activated CD4+ T cells in the skin show increased OX40 expression in atopic dermatitis."</data>
  <data key="d5">"cell activation, OX40 expression"</data>
  <data key="d6">chunk-ef8863e5d4ffec4c87086ac24e9620ae</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;DERMIS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40 and OX40L cells are co-located within the dermis, indicating local activity in atopic dermatitis."</data>
  <data key="d5">"local activity, skin layer"</data>
  <data key="d6">chunk-ef8863e5d4ffec4c87086ac24e9620ae</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;AD&quot;">
  <data key="d3">65.0</data>
  <data key="d4">"OX40 expression inversely correlates with disease severity in atopic dermatitis"&lt;SEP&gt;"OX40 expression is significant in AD, particularly among skin-homing memory-prone T cells, indicating its role in disease pathogenesis."&lt;SEP&gt;"OX40 expression is significantly higher in patients with atopic dermatitis compared to healthy controls."&lt;SEP&gt;"OX40 is expressed in the skin of AD patients, indicating its involvement in the disease's pathogenesis."&lt;SEP&gt;"OX40 is implicated in the immune response and exacerbation of chronic inflammation observed in AD."&lt;SEP&gt;"OX40 levels are analyzed in peripheral blood mononuclear cells from AD patients to understand its role in pathogenesis."&lt;SEP&gt;"OX40-positive cells are present in the skin of patients with AD, indicating a role of this gene in the disease pathogenesis."</data>
  <data key="d5">"T-cell pathway, immune response, disease correlation"&lt;SEP&gt;"disease involvement"&lt;SEP&gt;"expression level, immune response, disease marker"&lt;SEP&gt;"immune response and inflammation"&lt;SEP&gt;"immunoregulation"&lt;SEP&gt;7&lt;SEP&gt;9</data>
  <data key="d6">chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-afdd4c61cd0aee9cfa4fdd53c26ad339&lt;SEP&gt;chunk-6ef6d5065a278b01d19708d678d3b3e2&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b&lt;SEP&gt;chunk-6fc49187b0de760cbc909d68cc6a21f0&lt;SEP&gt;chunk-4486b79fa295f4486ae8f31f789db642&lt;SEP&gt;chunk-fe3d25355367e23fa84b7e96578f9aeb</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;TH2 CELLS&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"OX40 is involved in the development of pathogenic Th2 cells in asthma."&lt;SEP&gt;"Signal through OX40 enhances clonal expansion and survival of TH2 cells."</data>
  <data key="d5">"cell differentiation, asthma regulation"&lt;SEP&gt;"enhancement, T-cell survival"</data>
  <data key="d6">chunk-2785ff077980c1b6099f6312917ba06c&lt;SEP&gt;chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;T-CELL&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"OX40 is expressed on T-cells after antigen activation, enhancing activation and clonal expansion."</data>
  <data key="d5">"expression, activation"</data>
  <data key="d6">chunk-2785ff077980c1b6099f6312917ba06c</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;MODULE&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40 expression is increased on skin-homing T cells, indicating its role in the skin-related inflammatory reactions of atopic dermatitis."</data>
  <data key="d5">"inflammation, T-cell expression"</data>
  <data key="d6">chunk-0727a0b1079f66832280de80d4cf2c98</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;FLOW CYTOMETRY&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Flow cytometry was employed to assess OX40 expression on PBMCs."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;T CELLS&quot;">
  <data key="d3">17.0</data>
  <data key="d4">"OX40 is highly expressed by skin-homing T cells in atopic dermatitis, contributing to disease pathology."&lt;SEP&gt;"OX40 on T cells is vital for proliferation and immune response regulation via interactions with mast cells."</data>
  <data key="d5">"cell surface expression, immune response"&lt;SEP&gt;"proliferation, immune response"</data>
  <data key="d6">chunk-90301ff694034070e60e3a68b15a982a&lt;SEP&gt;chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;PBMCS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40 expression is analyzed on the surface of PBMCs from AD patients."</data>
  <data key="d5">"cell surface expression, immune characterization"</data>
  <data key="d6">chunk-90301ff694034070e60e3a68b15a982a</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;CLA+ T CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40 is expressed by memory-prone CLA+ T cells in AD, contributing to disease pathology."</data>
  <data key="d5">"cell expression, memory response"</data>
  <data key="d6">chunk-90301ff694034070e60e3a68b15a982a</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;CD4+CD45RO+CLA+ T CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40 is prominently expressed on CD4+CD45RO+CLA+ T cells in AD patients, indicating a role in immune regulation."</data>
  <data key="d5">8</data>
  <data key="d6">chunk-fe3d25355367e23fa84b7e96578f9aeb</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;ATOPIC DERMATITIS&quot;">
  <data key="d3">27.0</data>
  <data key="d4">"In atopic dermatitis, CD4+ T cells express significant levels of OX40, contributing to the disease's pathogenesis."&lt;SEP&gt;"OX40 is involved in atopic dermatitis and targeted by GBR 830 for treatment."</data>
  <data key="d5">"T-cell co-stimulation, disease pathogenesis"&lt;SEP&gt;"disease involvement, therapy target"</data>
  <data key="d6">chunk-801108ac3e166907ed4b5f552b259a53&lt;SEP&gt;chunk-9ff7b47e334d062c5c0cc9daeae082d7</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;CD8+ T CELLS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"CD8+ T cells exhibit variable OX40 expression levels impacting cytotoxic activity in atopic dermatitis."</data>
  <data key="d5">"cytotoxic activity, OX40 expression"</data>
  <data key="d6">chunk-801108ac3e166907ed4b5f552b259a53</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;SCORAD&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40 expression levels inversely correlate with SCORAD scores in AD patients"</data>
  <data key="d5">7</data>
  <data key="d6">chunk-6fc49187b0de760cbc909d68cc6a21f0</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;CD4+ CD45RO+ CLA+ T CELL&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"OX40 is expressed at high levels by CD4+ CD45RO+ CLA+ T cell subsets in patients with atopic dermatitis."</data>
  <data key="d5">9</data>
  <data key="d6">chunk-535005279394e36a8c0e64ebe74fff88</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;CD4+CD45RO+ T CELL&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40 is expressed primarily by CD4+CD45RO+ T cells."</data>
  <data key="d5">"expression, immune markers, cell subset"</data>
  <data key="d6">chunk-6ef6d5065a278b01d19708d678d3b3e2</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;CD4&quot;">
  <data key="d3">17.0</data>
  <data key="d4">"OX40 expression is increased on skin-homing CD4+ T cells in AD, enhancing migration to sites of inflammation."&lt;SEP&gt;"OX40 regulates the development of CD4 memory by controlling primary clonal expansion."</data>
  <data key="d5">"co-stimulatory interaction, immune response"&lt;SEP&gt;"immune response, clonal expansion, memory development"</data>
  <data key="d6">chunk-4684629b8113b2d7e0d8498ef744b84f&lt;SEP&gt;chunk-dd1abca19a92c3ea17e849ebfe392af1</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;MAST CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40-expressing cells co-localize with mast cells in the skin of AD patients, indicating an interplay in the inflammatory response."</data>
  <data key="d5">"immune system interactions, inflammation"</data>
  <data key="d6">chunk-dd1abca19a92c3ea17e849ebfe392af1</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;GBR 830&quot;">
  <data key="d3">8.5</data>
  <data key="d4">"GBR 830 targets OX40 to improve skin gene signatures in atopic dermatitis."</data>
  <data key="d5">"treatment, target"</data>
  <data key="d6">chunk-9ff7b47e334d062c5c0cc9daeae082d7</data>
</edge>
<edge source="&quot;OX40&quot;" target="&quot;GENE SIGNATURES&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"OX40 is involved in the modulation of gene expressions linked to atopic dermatitis when targeted by GBR 830."</data>
  <data key="d5">"gene expression, modulation"</data>
  <data key="d6">chunk-9ff7b47e334d062c5c0cc9daeae082d7</data>
</edge>
<edge source="&quot;EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS&quot;" target="&quot;MULTIPLE SCLEROSIS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"The model is used to study multiple sclerosis, influenced by OX40-OX40L."</data>
  <data key="d5">"model, autoimmune study"</data>
  <data key="d6">chunk-65c249408dc8af0e13c451e05d8d1d7a</data>
</edge>
<edge source="&quot;FOXP3&quot;" target="&quot;REGULATORY T-CELLS&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Foxp3 is crucial for the regulation and function of T-cells including regulatory T-cells."</data>
  <data key="d5">"T-cell regulation"</data>
  <data key="d6">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</edge>
<edge source="&quot;MOUSE&quot;" target="&quot;TRYPTASE&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Studies using mice focus on tryptase-related immune responses, employing specific antibodies for detection."</data>
  <data key="d5">"experimental model, immune response"</data>
  <data key="d6">chunk-ac36f1e468a863c1ae0527829717bfcf</data>
</edge>
<edge source="&quot;F5&quot;" target="&quot;RS2004640&quot;">
  <data key="d3">5.0</data>
  <data key="d4">"SNP rs2004640 in relation to F5 gene might be a part of the genetic investigation context."</data>
  <data key="d5">"genetic research, SNPs"</data>
  <data key="d6">chunk-b4ff39770b5e8cbf3dedd6876a26cb9d</data>
</edge>
<edge source="&quot;SCLERODERMA&quot;" target="&quot;ANGIOGENESIS&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Regulators of angiogenesis show abnormalities in scleroderma"</data>
  <data key="d5">6</data>
  <data key="d6">chunk-bc41401afd8fbd1a0e1739441ffe8577</data>
</edge>
<edge source="&quot;CREST SYNDROME&quot;" target="&quot;ANTICENTROMERE ANTIBODIES&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"The presence of anticentromere antibodies is a marker for CREST syndrome."</data>
  <data key="d5">"immune response"</data>
  <data key="d6">chunk-ca51be81b7248c4c4ca5fd0218eb755d</data>
</edge>
<edge source="&quot;ANTICENTROMERE ANTIBODIES&quot;" target="&quot;AIF1 SNP&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"AIF1 SNP is associated with an increased prevalence of anticentromere antibodies in systemic sclerosis."</data>
  <data key="d5">"genetic marker"</data>
  <data key="d6">chunk-ca51be81b7248c4c4ca5fd0218eb755d</data>
</edge>
<edge source="&quot;ASTHMA&quot;" target="&quot;AD&quot;">
  <data key="d3">51.0</data>
  <data key="d4">"AD and asthma frequently co-occur due to shared immunological pathways and triggers."&lt;SEP&gt;"AD is associated with asthma as both are conditions linked to allergic reactions."&lt;SEP&gt;"AD is associated with asthma, indicating common immunological pathways between these conditions."&lt;SEP&gt;"AD is frequently associated with asthma, indicating a shared pathophysiological pathway."&lt;SEP&gt;"Asthma is a common comorbidity in patients with atopic dermatitis, influencing disease manifestations."&lt;SEP&gt;"Some AD patients also have asthma, indicating a common comorbid condition."</data>
  <data key="d5">"allergy, inflammation, chronic disease"&lt;SEP&gt;"comorbid association"&lt;SEP&gt;"comorbidity"&lt;SEP&gt;"comorbidity, inflammatory response"&lt;SEP&gt;"comorbidity, respiratory symptoms"&lt;SEP&gt;8</data>
  <data key="d6">chunk-5523421a7f3eaa630cb13416842f81a5&lt;SEP&gt;chunk-90301ff694034070e60e3a68b15a982a&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b&lt;SEP&gt;chunk-4486b79fa295f4486ae8f31f789db642</data>
</edge>
<edge source="&quot;ASTHMA&quot;" target="&quot;OX40-OX40L AXIS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"The OX40-OX40L axis is implicated in the development of allergic asthma."</data>
  <data key="d5">"involvement, allergic response"</data>
  <data key="d6">chunk-2785ff077980c1b6099f6312917ba06c</data>
</edge>
<edge source="&quot;ASTHMA&quot;" target="&quot;RHINITIS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Rhinitis and asthma are often comorbid, indicating a connection within allergic disorders."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07</data>
</edge>
<edge source="&quot;ASTHMA&quot;" target="&quot;SOX40L&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"sOX40L levels are elevated in allergic asthma, indicating its role in asthma pathogenesis."</data>
  <data key="d5">9</data>
  <data key="d6">chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</edge>
<edge source="&quot;ASTHMA&quot;" target="&quot;LUNG&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"The lung is a key organ affected during allergic reactions in asthma."</data>
  <data key="d5">9</data>
  <data key="d6">chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</edge>
<edge source="&quot;ASTHMA&quot;" target="&quot;TH2 CELLS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Th2 cells are implicated in asthma's immune and inflammatory responses."</data>
  <data key="d5">"disease mechanism, immune response"</data>
  <data key="d6">chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</edge>
<edge source="&quot;IL-17&quot;" target="&quot;OX40/OX40L&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"IL-17 production is negatively regulated by the interaction between OX40 and OX40L."</data>
  <data key="d5">"Regulation of cytokine production"</data>
  <data key="d6">chunk-0901633e83241bf8c1296a2bb24a3099</data>
</edge>
<edge source="&quot;AUTOIMMUNE-LIKE DISEASES&quot;" target="&quot;OX40/OX40 LIGAND&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Constitutive interaction between OX40 and OX40 ligand can induce autoimmune-like diseases."</data>
  <data key="d5">"induction, autoimmunity"</data>
  <data key="d6">chunk-e6d4cc75e3f259d8ad15f49ab499fddf</data>
</edge>
<edge source="&quot;HLA-DQB1&quot;" target="&quot;PROGRESSIVE SYSTEMIC SCLEROSIS (SCLERODERMA)&quot;">
  <data key="d3">18.0</data>
  <data key="d4">"HLA-DQB1 gene is associated with the autoimmune response in scleroderma, playing a potential role in disease susceptibility."</data>
  <data key="d5">"gene-disease association, autoimmune response"</data>
  <data key="d6">chunk-4a79520712d3df44b8051f092fcea618</data>
</edge>
<edge source="&quot;ANTI-TOPOISOMERASE I AUTOANTIBODY&quot;" target="&quot;PROGRESSIVE SYSTEMIC SCLEROSIS (SCLERODERMA)&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"The presence of anti-topoisomerase I autoantibodies indicates an autoimmune process specific to scleroderma."</data>
  <data key="d5">"autoimmunity, disease marker"</data>
  <data key="d6">chunk-4a79520712d3df44b8051f092fcea618</data>
</edge>
<edge source="&quot;PROGRESSIVE SYSTEMIC SCLEROSIS (SCLERODERMA)&quot;" target="&quot;GENE 7292&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Gene 7292 is associated with scleroderma susceptibility and autoimmunity."</data>
  <data key="d5">"autoimmune disease, gene-disease association"</data>
  <data key="d6">chunk-4a79520712d3df44b8051f092fcea618</data>
</edge>
<edge source="&quot;PROGRESSIVE SYSTEMIC SCLEROSIS (SCLERODERMA)&quot;" target="&quot;GENE 100506023&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Gene 100506023 is linked to scleroderma, indicating a role in its pathology."</data>
  <data key="d5">"gene-disease link, systemic sclerosis"</data>
  <data key="d6">chunk-4a79520712d3df44b8051f092fcea618</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;SOX40&quot;">
  <data key="d3">78.0</data>
  <data key="d4">"AD patients showed different serum levels of sOX40 compared to controls."&lt;SEP&gt;"Altered levels of sOX40 are associated with AD, indicating a role in pathogenesis dealing with immune responses in the disease"&lt;SEP&gt;"Atopic dermatitis is associated with decreased serum levels of sOX40, indicating altered OX40 system activity."&lt;SEP&gt;"Decreased levels of sOX40 are observed in individuals with AD, suggesting a link to disease mechanisms."&lt;SEP&gt;"Decreased serum levels of sOX40 are observed in AD patients, indicating a potential biomarker role."&lt;SEP&gt;"Decreased serum levels of sOX40 are observed in patients with atopic dermatitis compared to healthy controls."&lt;SEP&gt;"Reduced serum levels of sOX40 are observed in patients with AD, indicating an association between sOX40 levels and AD."&lt;SEP&gt;"Serum sOX40 levels are decreased in both adult and child patients with atopic dermatitis (AD)."&lt;SEP&gt;"Soluble OX40 levels in serum are evaluated for their association with AD severity and progression."&lt;SEP&gt;"sOX40 serum levels are associated with atopic dermatitis activity in both adults and children."</data>
  <data key="d5">"O X40 system alterations, serum levels"&lt;SEP&gt;"biomarker, serum level"&lt;SEP&gt;"decreased levels, inflammation, immune response"&lt;SEP&gt;"serum level, immune association"&lt;SEP&gt;"serum levels, disease activity"&lt;SEP&gt;"serum levels, disease association"&lt;SEP&gt;"serum levels, immune regulation"&lt;SEP&gt;8</data>
  <data key="d6">chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-90301ff694034070e60e3a68b15a982a&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-ef8863e5d4ffec4c87086ac24e9620ae&lt;SEP&gt;chunk-f17f68c620d56dddb447652de4fee94c&lt;SEP&gt;chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-535005279394e36a8c0e64ebe74fff88&lt;SEP&gt;chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;IGE&quot;">
  <data key="d3">32.0</data>
  <data key="d4">"Elevated IgE levels are often found in patients with AD, representing an underlying allergic component"&lt;SEP&gt;"Elevated levels of IgE are strongly associated with the severity and chronicity of AD."&lt;SEP&gt;"IgE levels are clinically relevant in the context of atopic dermatitis, influencing the disease pathology."&lt;SEP&gt;"IgE levels are measured in patients with AD to assess the allergic response."</data>
  <data key="d5">"allergic response association"&lt;SEP&gt;"allergic response, disease pathology"&lt;SEP&gt;"allergic response, serum biomarker"&lt;SEP&gt;8</data>
  <data key="d6">chunk-15081dd238cde18547767c2656f6e80f&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07&lt;SEP&gt;chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;CHRONIC INFLAMMATION&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"AD features chronic inflammation as a core factor of symptomatic flare-ups and long-term skin damage."</data>
  <data key="d5">"immune dysfunction"</data>
  <data key="d6">chunk-7b918eaccb40d1d7ef77196819ed077b</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;ECZEMA&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Eczema is a major clinical presentation of AD, characterized by red and itchy patches of skin."</data>
  <data key="d5">"symptom association"</data>
  <data key="d6">chunk-7b918eaccb40d1d7ef77196819ed077b</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;PRURITUS&quot;">
  <data key="d3">10.0</data>
  <data key="d4">"Pruritus is a hallmark symptom of AD, contributing significantly to patient discomfort."</data>
  <data key="d5">"symptom association"</data>
  <data key="d6">chunk-7b918eaccb40d1d7ef77196819ed077b</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;DRY SKIN&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Patients with AD frequently experience dry skin, worsening their condition by affecting the skin's barrier function."</data>
  <data key="d5">"symptomatic exacerbation"</data>
  <data key="d6">chunk-7b918eaccb40d1d7ef77196819ed077b</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;ALLERGIC RHINITIS&quot;">
  <data key="d3">14.0</data>
  <data key="d4">"AD is often concomitant with allergic rhinitis, drawing from a common allergic pathway."&lt;SEP&gt;"AD patients also exhibit symptoms of allergic rhinitis, suggesting a potential comorbidity between the conditions."</data>
  <data key="d5">"comorbid association"&lt;SEP&gt;"comorbidity, symptom overlap"</data>
  <data key="d6">chunk-e4a9d1698278391ab0182f138d50f659&lt;SEP&gt;chunk-7b918eaccb40d1d7ef77196819ed077b</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;RHINITIS&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"AD is associated with rhinitis, often co-existing due to similar immunological pathways."&lt;SEP&gt;"Patients with AD often exhibit symptoms of rhinitis due to a common underlying allergic mechanism."</data>
  <data key="d5">"allergy, inflammation, chronic disease"&lt;SEP&gt;7</data>
  <data key="d6">chunk-5523421a7f3eaa630cb13416842f81a5&lt;SEP&gt;chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;SYSTEMIC INFLAMMATORY DISEASES&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"AD is considered a systemic inflammatory disease, highlighting its broad implications on the immune system."</data>
  <data key="d5">"chronic inflammation, systemic impact"</data>
  <data key="d6">chunk-5523421a7f3eaa630cb13416842f81a5</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;SERUM&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Serum samples are analyzed in patients with AD to measure biomarkers like sOX40."</data>
  <data key="d5">7</data>
  <data key="d6">chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;CD4+ T CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"CD4+ T cells are activated in patients with AD, representing an immune response characteristic of the disease."</data>
  <data key="d5">8</data>
  <data key="d6">chunk-e3bf74c4f8c2ca2ce3d4ff2f2ca64f07</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;PBMCS&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"PBMCs are used to analyze the expression of OX40 and OX40L in relation to AD."&lt;SEP&gt;"PBMCs from AD patients were analyzed for expression of OX40 and OX40L."</data>
  <data key="d5">"immune cells, disease analysis"&lt;SEP&gt;9</data>
  <data key="d6">chunk-e0a177dbb0ea12fd8552823bfb451b34&lt;SEP&gt;chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;SOX40L&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"Although sOX40L levels are decreased in AD, its measurement is not appropriate for disease activity despite elevated levels in asthma."&lt;SEP&gt;"No significant difference in serum levels of sOX40L was observed in patients with atopic dermatitis (AD) when compared to healthy controls."&lt;SEP&gt;"sOX40L was measured in AD patients, though its levels did not show significant change."</data>
  <data key="d5">"immune response, costimulation"&lt;SEP&gt;"serum measurement, biomarker assessment"&lt;SEP&gt;6</data>
  <data key="d6">chunk-8e6b277a10c2bbae1b52446acca96138&lt;SEP&gt;chunk-bf0a9d6fcaf06c245c2b80667c7f3261&lt;SEP&gt;chunk-f17f68c620d56dddb447652de4fee94c</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;CLA&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"CLA mediates the homing of T cells to the skin, which is relevant in AD due to skin inflammation"</data>
  <data key="d5">"immune homing, skin targeting"</data>
  <data key="d6">chunk-15081dd238cde18547767c2656f6e80f</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;SCORAD&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"SCORAD is used to evaluate the clinical severity of AD in patients by analyzing symptoms and skin extent"</data>
  <data key="d5">"clinical assessment, severity scoring"</data>
  <data key="d6">chunk-15081dd238cde18547767c2656f6e80f</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;HEALTHY VOLUNTEERS&quot;">
  <data key="d3">5.0</data>
  <data key="d4">"Healthy volunteers serve as a control group to compare against patients with AD in research studies."</data>
  <data key="d5">5</data>
  <data key="d6">chunk-bf0a9d6fcaf06c245c2b80667c7f3261</data>
</edge>
<edge source="&quot;AD&quot;" target="&quot;OX40-OX40L&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Interaction of OX40 with its ligand OX40L plays a role in the inflammatory skin condition AD."</data>
  <data key="d5">"pathogenesis, treatment interaction"</data>
  <data key="d6">chunk-dd1abca19a92c3ea17e849ebfe392af1</data>
</edge>
<edge source="&quot;CD4+ T CELLS&quot;" target="&quot;ATOPIC DERMATITIS&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"CD4+ T cells expressing CD45RO and CLA have increased OX40 expression in atopic dermatitis."</data>
  <data key="d5">"T-cell activation, disease mechanism"</data>
  <data key="d6">chunk-801108ac3e166907ed4b5f552b259a53</data>
</edge>
<edge source="&quot;CD4+ T CELLS&quot;" target="&quot;CD45RO&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"CD4+ T cells expressing CD45RO indicates memory cell involvement in atopic dermatitis."</data>
  <data key="d5">"memory cell marker, T-cell activation"</data>
  <data key="d6">chunk-801108ac3e166907ed4b5f552b259a53</data>
</edge>
<edge source="&quot;CD4+ T CELLS&quot;" target="&quot;CLA&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"CD4+ T cells expressing CLA facilitate skin-homing, relevant in atopic dermatitis."</data>
  <data key="d5">"skin-homing, T-cell surface marker"</data>
  <data key="d6">chunk-801108ac3e166907ed4b5f552b259a53</data>
</edge>
<edge source="&quot;SOX40&quot;" target="&quot;PLASMA&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Plasma samples analyzed to measure levels of sOX40 in patients with AD."</data>
  <data key="d5">"protein quantification, blood analysis"</data>
  <data key="d6">chunk-e0a177dbb0ea12fd8552823bfb451b34</data>
</edge>
<edge source="&quot;SOX40&quot;" target="&quot;ELISA&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"ELISA was utilized for measuring the levels of sOX40 in serum samples."</data>
  <data key="d5">8</data>
  <data key="d6">chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</edge>
<edge source="&quot;DERMIS&quot;" target="&quot;MAST CELL&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"In the dermis, mast cells express OX40L, confirmed by specific protein staining."</data>
  <data key="d5">"co-localization, cell type confirmation"</data>
  <data key="d6">chunk-afdd4c61cd0aee9cfa4fdd53c26ad339</data>
</edge>
<edge source="&quot;BLOOD&quot;" target="&quot;PBMCS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Blood used to isolate PBMCs for studying immune cell activity in AD."</data>
  <data key="d5">"immune cells, blood analysis"</data>
  <data key="d6">chunk-e0a177dbb0ea12fd8552823bfb451b34</data>
</edge>
<edge source="&quot;IGE&quot;" target="&quot;MAST CELLS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"IgE activates mast cells leading to TH2 cytokine production and involvement in hypersensitivity reactions."</data>
  <data key="d5">"immune activation, cytokine response"</data>
  <data key="d6">chunk-3c10f775faa2c2d2c39dc1cd18158a80</data>
</edge>
<edge source="&quot;IGE&quot;" target="&quot;ATOPIC DERMATITIS&quot;">
  <data key="d3">16.0</data>
  <data key="d4">"Atopic Dermatitis is correlated with total serum immunoglobulin E levels, indicating an allergic response."</data>
  <data key="d5">"allergy correlation, serum IgE,"</data>
  <data key="d6">chunk-801108ac3e166907ed4b5f552b259a53</data>
</edge>
<edge source="&quot;INFLAMMATORY SKIN DISEASE&quot;" target="&quot;AUTOIMMUNE AND INFLAMMATORY CONDITIONS&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Inflammatory skin disease is categorized under autoimmune and inflammatory conditions."</data>
  <data key="d5">"category, relationship"</data>
  <data key="d6">chunk-2785ff077980c1b6099f6312917ba06c</data>
</edge>
<edge source="&quot;T CELLS&quot;" target="&quot;MAST CELLS&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Mast cells contribute to T cell activation and play roles in immune response modulation."</data>
  <data key="d5">"immune activation, cell interaction"</data>
  <data key="d6">chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</edge>
<edge source="&quot;MAST CELLS&quot;" target="&quot;IL-25&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"Mast cells produce IL-25, contributing to the TH2 driving response in AD."</data>
  <data key="d5">"cytokine production, immune response"</data>
  <data key="d6">chunk-3c10f775faa2c2d2c39dc1cd18158a80</data>
</edge>
<edge source="&quot;MAST CELLS&quot;" target="&quot;INTERLEUKIN-25&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Interleukin-25 is produced by mast cells upon Fc epsilon RI-mediated activation."</data>
  <data key="d5">"cytokine production"</data>
  <data key="d6">chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</edge>
<edge source="&quot;MAST CELLS&quot;" target="&quot;FC EPSILON RECEPTOR I (FCRI)&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"Mast cells undergo degranulation when activated via the FcRI receptor."</data>
  <data key="d5">"degranulation, receptor activation"</data>
  <data key="d6">chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</edge>
<edge source="&quot;ALLERGIC ASTHMA&quot;" target="&quot;OX40-OX40L AXIS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"OX40-OX40L axis role in allergic reactions contributes to the pathogenesis of allergic asthma."</data>
  <data key="d5">"pathogenesis, allergy"</data>
  <data key="d6">chunk-2785ff077980c1b6099f6312917ba06c</data>
</edge>
<edge source="&quot;ATOPIC DERMATITIS&quot;" target="&quot;TNF&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"TNF is involved in inflammatory responses, which are characteristic of atopic dermatitis."</data>
  <data key="d5">"inflammation"</data>
  <data key="d6">chunk-4684629b8113b2d7e0d8498ef744b84f</data>
</edge>
<edge source="&quot;ATOPIC DERMATITIS&quot;" target="&quot;GBR 830&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"GBR 830 treatment improves clinical scores in atopic dermatitis patients, indicating its effective role."</data>
  <data key="d5">"treatment, therapeutic effect"</data>
  <data key="d6">chunk-9ff7b47e334d062c5c0cc9daeae082d7</data>
</edge>
<edge source="&quot;ATOPIC DERMATITIS&quot;" target="&quot;CLINICAL SCORES&quot;">
  <data key="d3">9.0</data>
  <data key="d4">"Clinical scores are a measure of atopic dermatitis severity and are improved by GBR 830 treatment."</data>
  <data key="d5">"disease severity, measurement improvement"</data>
  <data key="d6">chunk-9ff7b47e334d062c5c0cc9daeae082d7</data>
</edge>
<edge source="&quot;SCORAD&quot;" target="&quot;CD4+CD45RO+OX40+ T CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"The percentage of CD4+CD45RO+OX40+ T cells inversely correlates with SCORAD, indicating disease activity in AD"</data>
  <data key="d5">8</data>
  <data key="d6">chunk-6fc49187b0de760cbc909d68cc6a21f0</data>
</edge>
<edge source="&quot;SCORAD&quot;" target="&quot;CLA T CELLS&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"CLA T cells' expression correlates with SCORAD, indicating disease activity in AD"</data>
  <data key="d5">8</data>
  <data key="d6">chunk-6fc49187b0de760cbc909d68cc6a21f0</data>
</edge>
<edge source="&quot;PBMCS&quot;" target="&quot;FICOLL-PAQUE&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Ficoll-Paque is used in the process of isolating PBMCs from blood samples."</data>
  <data key="d5">"isolation reagent, cell preparation"</data>
  <data key="d6">chunk-e0a177dbb0ea12fd8552823bfb451b34</data>
</edge>
<edge source="&quot;SOX40L&quot;" target="&quot;ELISA&quot;">
  <data key="d3">8.0</data>
  <data key="d4">"An inhouse ELISA technique was applied to quantify sOX40L in serum."</data>
  <data key="d5">8</data>
  <data key="d6">chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</edge>
<edge source="&quot;BIOPSIES&quot;" target="&quot;PARAFFIN&quot;">
  <data key="d3">5.0</data>
  <data key="d4">"Paraffin embedding was used for biopsies in histological studies."</data>
  <data key="d5">5</data>
  <data key="d6">chunk-e9209ae4bd253b98ba9d5d0f58659c20</data>
</edge>
<edge source="&quot;CD4&quot;" target="&quot;CD4+CD45RO+ T CELL&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"CD4 is expressed on the CD4+CD45RO+ T cell subset, enabling immune functions."</data>
  <data key="d5">"expressions, immune cells"</data>
  <data key="d6">chunk-6ef6d5065a278b01d19708d678d3b3e2</data>
</edge>
<edge source="&quot;CD8&quot;" target="&quot;CD8+CD45RO+ T CELL&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"CD8 is expressed on the CD8+CD45RO+ T cell subset, involved in immune defense."</data>
  <data key="d5">"expressions, immune defense, cell subset"</data>
  <data key="d6">chunk-6ef6d5065a278b01d19708d678d3b3e2</data>
</edge>
<edge source="&quot;CD45RO&quot;" target="&quot;CD4+CD45RO+ T CELL&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"CD45RO is expressed on CD4+ T cell subsets, marking memory T cells."</data>
  <data key="d5">"memory marker, immune cells"</data>
  <data key="d6">chunk-6ef6d5065a278b01d19708d678d3b3e2</data>
</edge>
<edge source="&quot;CLA&quot;" target="&quot;CD4+CD45RO+ T CELL&quot;">
  <data key="d3">7.0</data>
  <data key="d4">"CLA is expressed on the CD4+CD45RO+T cell subset indicating skin-homing functions."</data>
  <data key="d5">"skin-homing, cell functions"</data>
  <data key="d6">chunk-6ef6d5065a278b01d19708d678d3b3e2</data>
</edge>
<edge source="&quot;TRYPTASE&quot;" target="&quot;MAST CELL&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Tryptase is used as a marker to identify OX40L-expressing mast cells in AD skin."</data>
  <data key="d5">"marker identification"</data>
  <data key="d6">chunk-afdd4c61cd0aee9cfa4fdd53c26ad339</data>
</edge>
<edge source="&quot;HUMAN TONSILLAR MAST CELLS&quot;" target="&quot;LUNG-CULTURED MAST CELLS&quot;">
  <data key="d3">6.0</data>
  <data key="d4">"Comparison of gene expression profiles between human tonsillar and lung-cultured mast cells highlights differences in immune responses."</data>
  <data key="d5">"gene expression, immune comparison"</data>
  <data key="d6">chunk-4cc60d46174dbafbe3376fe5793a500f</data>
</edge>
</graph></graphml>